UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
DC 20549
FORM
8-K
CURRENT
REPORT PURSUANT
TO
SECTION 13 OR 15(D) OF THE
SECURITIES
EXCHANGE ACT OF 1934
Date
of
report (Date of earliest event reported) September
18, 2006
Mitek
Systems, Inc.
(Exact
Name of Registrant as Specified in Its Charter)
Delaware
(State
or
Other Jurisdiction of
Incorporation)
0-15235
|
87-0418827
|
(Commission
File Number)
|
(IRS
Employer Identification
No.)
|
|
|
8911
Balboa Ave, Suite B, San Diego,
California
|
92123
|
(Address
of Principal Executive
Offices)
|
(Zip
Code)
|
(858)
503-7810
(Registrant's
Telephone Number, Including Area Code)
(Former
Name or Former Address, if Changed Since Last Report)
Check
the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see
General
Instruction A.2. below):
x Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
x Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
o Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
o Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
Item
1.01 Entry
Into a Material Definitive Agreement.
Merger
Agreement
On
September 18, 2006, Mitek Systems, Inc., a Delaware corporation ("Mitek")
entered into a definitive Amended and Restated Agreement and Plan of Merger
(the
"Merger Agreement") with Mitek Acquisition Sub, LLC, a Wyoming limited liability
company (the "Acquisition Sub"), Parascript, LLC, a Wyoming limited liability
company ("Parascript") and Parascript Management, Inc., a Wyoming corporation,
pursuant to which Parascript will merge with and into the Acquisition Sub (the
"Merger"). Upon consummation of the Merger, Parascript will be the surviving
company and Mitek will be the holder of all of the outstanding limited liability
company interests of Parascript.
Mitek
had
previously entered into and announced a definitive Asset Purchase Agreement
(the
"Asset Purchase Agreement") with Parascript dated July 13, 2006, pursuant to
which Mitek would acquire substantially all of the assets and liabilities of
Parascript. Mitek and Parascript subsequently agreed to modify the transaction
structure as a result of certain tax issues affecting Parascript. Mitek and
Parascript have structured the Merger to result in substantially identical
economic results for Mitek and Parascript as those contemplated by the Asset
Purchase Agreement.
At
the
closing of the Merger, Parascript unitholders will receive $80 million in cash
and approximately 51.8 million shares of Mitek common stock. Mitek common stock
having a value of approximately $4 million will be placed in escrow to secure
any indemnity claims that Mitek may have under the Merger Agreement, which
escrow will generally last until one year after the effective time of the
Merger.
For
federal income tax purposes, the Merger will be treated with respect to Mitek
as
if Mitek purchased all of the assets of Parascript from the unitholders of
Parascript. In general, Mitek’s tax basis in the purchased assets will be equal
to the fair market value of the Merger consideration paid at closing that is
not
placed in escrow (i.e., $80 million of cash plus fair market of the
approximately 51.8 million shares of Mitek common stock issued less the fair
market value of the shares of Mitek common stock placed into escrow). Asset
basis may be adjusted for shares distributed or released from the escrow. Mitek
expects that a substantial portion of the consideration paid will be allocated
to goodwill for federal income tax purposes. Under current federal income tax
rules, such goodwill would be amortizable over a 15-year straight-line
period.
Under
the
Merger Agreement, the Parascript unitholders are permitted to receive from
Parascript a cash distribution equal, in general, to 30% of the taxable income
of Parascript for Parascript's taxable periods ending on the date of the Merger.
Because Parascript is taxed as a partnership for federal and state income tax
purposes, it is not subject to income tax; rather its unitholders will pay
tax
on their proportionate share of Parascript's taxable income. The distributions
are intended to provide the necessary funds to the Parascript unitholders to
satisfy their income tax. Mitek views this distribution as neutral to it since
if the taxable income were earned by Mitek, Mitek would be subject to tax on
such income (or such income would otherwise reduce Mitek's net operating
losses).
Mitek
and
Parascript have made customary representations and warranties and covenants
in
the Merger Agreement. The Merger Agreement contains certain termination rights
for both Mitek and Parascript and further provides that upon termination of
the
Merger Agreement under specified circumstances the parties may be required
to
pay a termination fee of up to $1,000,000.
The
closing of the Merger is subject to various closing conditions, including:
(i)
approval by the stockholders of Mitek of (a) an increase in the number of its
authorized shares to provide sufficient shares to be issued in connection with
the Merger and (b) a change of the name of Mitek to “Parascript, Inc.” after
closing; (ii) entry by Mitek into definitive financing agreements of from $85
million to $95 million in order to consummate the Merger; (iii) approval of
the
Merger Agreement by the unitholders of Parascript, (iv) regulatory approvals,
(v) the effectiveness of the registration statement to be filed by Mitek (the
"Registration Statement"), and (vi) the satisfaction or waiver of other
customary conditions.
Funding
for the Merger is to be provided by a combination of $35 million in subordinated
convertible notes and $55 million in senior debt obtained from or through
Plainfield Asset Management, LLC ("Plainfield"). The subordinated notes will
be
convertible into approximately 21.9 million shares of Mitek common stock at
a
conversion price of $1.60 per share. From the remaining funds obtained from
Plainfield, it is anticipated that approximately $10 million will be used for
expenses related to the Merger. In addition, Plainfield is expected to provide
a
revolving line of credit for up to $5 million. Upon completion of the Merger
and
on a fully-diluted basis, Mitek shareholders will own approximately 22% of
the
company, Parascript unitholders approximately 55% and Plainfield approximately
23% on an as-if-converted basis.
After
the
closing of the Merger, the executive offices will be located in Boulder,
Colorado. The board of directors will be composed of seven (7) members,
including, Mitek's President and Chief Executive Officer James DeBello,
Parascript's President and Chief Executive Officer Jeffrey Gilb, Mitek's
Chairman John M. Thornton, and a board member of Parascript's Manager, Aron
Katz, who will be Chairman of Mitek post-closing. Also included will be three
(3) independent directors to be mutually agreed upon who meet the independence
requirements of NASDAQ.
The
foregoing description of the Merger and the Merger Agreement does not purport
to
be complete and is qualified in its entirety by reference to the Merger
Agreement, which is filed as Exhibit 2.1 hereto, and is incorporated into this
report by reference. The Merger Agreement has been included to provide investors
and stockholders with information regarding its terms. It is not intended to
provide any other factual information about Mitek or Parascript. The Merger
Agreement contains representations and warranties that the parties to the Merger
Agreement made to and solely for the benefit of each other, and the assertions
embodied in such representations and warranties are qualified by information
contained in confidential disclosure schedules that the parties exchanged in
connection with signing the Merger Agreement. Accordingly, investors and
stockholders should not rely on such representations and warranties as
characterizations of the actual state of facts or circumstances, since they
were
only made as of the date of the Merger Agreement and are modified in important
part by the underlying disclosure schedules.
Additional
Information
The
Registration Statement will include a related joint proxy statement/prospectus.
Mitek stockholders are urged to read the joint proxy statement/prospectus
regarding the proposed transaction when it becomes available, because it will
contain important information. Mitek stockholders will be able to obtain a
free
copy of the proxy statement/prospectus (when available), as well as other
filings containing information about Mitek, without charge, at the SEC's
internet site (http://www.sec.gov). In addition, investors and security holders
may obtain free copies of the documents filed with the SEC by Mitek by directing
a request to Mitek Systems, Inc., 8911
Balboa Ave, Suite B, San Diego, California,
92123.
The respective directors and executive officers of Mitek and other persons
may
be deemed to be participants in the solicitation of proxies in respect of the
proposed Merger. Information regarding Mitek's directors and executive officers
is available in its Form 10-KSB for the year ended September 30, 2005, filed
with the SEC. Other information regarding the participants in the proxy
solicitation and a description of their direct and indirect interests, by
security holdings or otherwise, will be contained in the proxy
statement/prospectus and other relevant materials to be filed with the SEC
when
they become available.
Item
9.01 Financial
Statements and Exhibits.
(d) Exhibits
Exhibit
2.1 Amended
and Restated Agreement and Plan of Merger dated as of September 18, 2006 by
and
among Mitek Systems, Inc., Mitek Acquisition Sub, LLC, Parascript, LLC and
Parascript Management, Inc. (the schedules have been omitted pursuant to Item
601(b)(2) of Regulation S-B).
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant
has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
|
|
|
MITEK
SYSTEMS,
INC. |
|
|
|
Date: September
22, 2006 |
By: |
/s/ Tesfaye
Hailemichael |
|
Tesfaye
Hailemichael |
|
Chief
Financial Officer |
AMENDED
AND RESTATED AGREEMENT AND PLAN OF MERGER
by
and
among
MITEK
SYSTEMS, INC.
a
Delaware corporation
and
MITEK
ACQUISITION SUB, LLC
a
Wyoming
limited liability company
and
PARASCRIPT,
LLC
a
Wyoming
limited liability company
and
PARASCRIPT
MANAGEMENT, INC.,
a
Wyoming
corporation
as
the
Member Representative
Dated
September 18, 2006
TABLE
OF CONTENTS
|
|
|
Page
|
1. |
|
1
|
|
1.1
|
Definitions
|
1
|
|
1.2
|
Usage
|
12
|
2. |
THE
MERGER
|
13
|
|
2.1
|
Merger
|
13
|
|
2.2
|
Effective
Time
|
13
|
|
2.3
|
Effects
of the Merger
|
13
|
|
2.4
|
Articles
of Organization and LLC Agreement
|
13
|
|
2.5
|
Managers
and Officers
|
13
|
|
2.6
|
Conversion
|
13
|
|
2.7
|
Exchange
of Units
|
15
|
|
2.8
|
Closing
of Transfer Books
|
16
|
|
2.9
|
Closing
|
16
|
|
2.10
|
Closing
Obligations
|
16
|
3.
|
REPRESENTATIONS
AND WARRANTIES OF PARASCRIPT
|
17
|
|
3.1
|
Organization
and Good Standing
|
17
|
|
3.2
|
Enforceability;
Authority; No Conflict
|
18
|
|
3.3
|
Capitalization
|
19
|
|
3.4
|
Financial
Statements
|
19
|
|
3.5
|
Books
and Records
|
20
|
|
3.6
|
Sufficiency
of Assets
|
20
|
|
3.7
|
Description
of Leased Real Property
|
20
|
|
3.8
|
Title
to Assets; Encumbrances
|
20
|
|
3.9
|
Condition
of Assets
|
20
|
|
3.10
|
Accounts
Receivable
|
20
|
|
3.11
|
Inventories
|
21
|
|
3.12
|
No
Undisclosed Liabilities
|
21
|
|
3.13
|
Taxes
|
21
|
|
3.14
|
No
Material Adverse Change
|
22
|
|
3.15
|
Employee
Benefits
|
22
|
|
3.16
|
Compliance
with Legal Requirements; Governmental Authorizations
|
26
|
|
3.17
|
Legal
Proceedings; Orders
|
27
|
|
3.18
|
Absence
of Certain Changes and Events
|
28
|
|
3.19
|
Contracts;
No Defaults
|
29
|
|
3.20
|
Insurance
|
31
|
|
3.21
|
Employees
|
33
|
|
3.22
|
Labor
Disputes; Compliance
|
34
|
|
3.23
|
Parascript
Intellectual Property Assets
|
34
|
|
3.24
|
Relationships
With Related Persons
|
37
|
|
3.25
|
Brokers
or Finders
|
37
|
|
3.26
|
The
Parascript Data Room
|
37
|
|
3.27
|
Disclosure
|
38
|
4.
|
REPRESENTATIONS
AND WARRANTIES OF MERGER SUBSIDIARY
|
38
|
|
4.1
|
Organization,
Good Standing and Other Matters
|
38
|
|
4.2
|
Authority
|
38
|
|
4.3
|
No
Conflict
|
38
|
5.
|
REPRESENTATIONS
AND WARRANTIES OF MITEK
|
39
|
|
5.1
|
Organization
and Good Standing
|
39
|
|
5.2
|
Enforceability;
Authority; No Conflict
|
39
|
|
5.3
|
Capitalization
|
40
|
|
5.4
|
Financial
Statements
|
41
|
|
5.5
|
Books
and Records
|
41
|
|
5.6
|
Sufficiency
of Assets
|
41
|
|
5.7
|
Description
of Leased Real Property
|
41
|
|
5.8
|
Title
to Assets; Encumbrances
|
42
|
|
5.9
|
Condition
of Assets
|
42
|
|
5.10
|
Accounts
Receivable
|
42
|
|
5.11
|
Inventories
|
42
|
|
5.12
|
No
Undisclosed Liabilities
|
42
|
|
5.13
|
Taxes
|
42
|
|
5.14
|
No
Material Adverse Change
|
44
|
|
5.15
|
Employee
Benefits
|
44
|
|
5.16
|
Compliance
with Legal Requirements; Governmental Authorizations
|
47
|
|
5.17
|
Legal
Proceedings; Orders
|
49
|
|
5.18
|
Absence
of Certain Changes and Events
|
49
|
|
5.19
|
Contracts;
No Defaults
|
50
|
|
5.20
|
Insurance
|
53
|
|
5.21
|
Employees
|
54
|
|
5.22
|
Labor
Disputes; Compliance
|
54
|
|
5.23
|
Mitek
Intellectual Property Assets
|
55
|
|
5.24
|
Relationships
With Related Persons
|
58
|
|
5.25
|
Brokers
or Finders
|
58
|
|
5.26
|
SEC
Reports
|
58
|
|
5.27
|
NASDAQ
Listing
|
59
|
|
5.28
|
The
Mitek Data Room
|
59
|
|
5.29
|
Disclosure
|
59
|
6.
|
COVENANTS
OF PARASCRIPT PRIOR TO CLOSING
|
59
|
|
6.1
|
Access
and Investigation
|
59
|
|
6.2
|
Operation
of the Business of Parascript
|
60
|
|
6.3
|
Negative
Covenant
|
61
|
|
6.4
|
Required
Approvals
|
62
|
|
6.5
|
Notification
|
62
|
|
6.6
|
No
Shopping
|
63
|
|
6.7
|
Best
Efforts
|
63
|
|
6.8
|
Interim
Financial Statements
|
63
|
|
6.9
|
Payment
of Liabilities
|
63
|
7.
|
ADDITIONAL
AGREEMENTS
|
64
|
|
7.1
|
Preparation
of the Proxy Statement; Mitek Stockholders Meeting; Parascript
Members
Meeting
|
64
|
|
7.2
|
Initial
Disclosure Letter
|
65
|
|
7.3
|
Supplemental
Disclosure Letter
|
66
|
|
7.4
|
Authorization
of the Member Representative
|
66
|
|
7.5
|
Tax
Distributions
|
69
|
8.
|
COVENANTS
OF MITEK PRIOR TO CLOSING
|
69
|
|
8.1
|
Access
and Investigation
|
69
|
|
8.2
|
Operation
of the Business of Mitek
|
70
|
|
8.3
|
Negative
Covenants
|
71
|
|
8.4
|
Required
Approvals
|
73
|
|
8.5
|
Notification
|
73
|
|
8.6
|
No
Shopping
|
73
|
|
8.7
|
Best
Efforts
|
74
|
|
8.8
|
Payment
of Liabilities
|
74
|
9.
|
CONDITIONS
PRECEDENT TO MITEK’S OBLIGATION TO CLOSE
|
74
|
|
9.1
|
Accuracy
of Representations
|
74
|
|
9.2
|
Parascript’s
Performance
|
74
|
|
9.3
|
Consents
|
74
|
|
9.4
|
Additional
Documents
|
74
|
|
9.5
|
No
Proceedings
|
75
|
|
9.6
|
No
Conflict
|
75
|
|
9.7
|
Governmental
Authorizations
|
75
|
|
9.8
|
Silicon
Valley Bank Loan
|
75
|
|
9.9
|
Assignment
of Assets, Liabilities and Contracts
|
75
|
|
9.10
|
Financing
|
75
|
|
9.11
|
Material
Adverse Change
|
76
|
|
9.12
|
Certificate
Amendment
|
76
|
|
9.13
|
Appointment
to Audit Committee
|
76
|
|
9.14
|
Affiliates
|
76
|
|
9.15
|
[RESERVED]
|
76
|
|
9.16
|
AIS
License
|
76
|
10.
|
CONDITIONS
PRECEDENT TO PARASCRIPT’S OBLIGATION TO CLOSE
|
76
|
|
10.1
|
Accuracy
of Representations
|
76
|
|
10.2
|
Mitek’s
Performance
|
76
|
|
10.3
|
Consents
and Release
|
76
|
|
10.4
|
Additional
Documents
|
77
|
|
10.5
|
No
Proceedings
|
77
|
|
10.6
|
No
Conflict
|
77
|
|
10.7
|
Governmental
Authorizations
|
77
|
|
10.8
|
Employees
|
78
|
|
10.9
|
Certificate
Amendment
|
78
|
|
10.10
|
Financing
|
78
|
|
10.11
|
Board
Composition; Chief Executive Officer
|
78
|
|
10.12
|
Name
Change
|
78
|
|
10.13
|
Material
Adverse Change
|
78
|
|
10.14
|
Registration
Statement
|
78
|
|
10.15
|
Appointment
of Audit Committee
|
79
|
11.
|
TERMINATION
|
79
|
|
11.1
|
Termination
Events
|
79
|
|
11.2
|
Effect
Of Termination
|
80
|
|
11.3
|
Fees,
Expenses and Other Payments
|
80
|
|
12.
|
POST-CLOSING
COVENANTS OF PARTIES
|
81
|
|
12.1
|
Reverse
Stock Split
|
81
|
|
12.2
|
NASDAQ
Listing
|
81
|
|
12.3
|
Governance
and Management
|
81
|
|
12.4
|
Change
of Fiscal Year
|
81
|
13. |
ADDITIONAL
COVENANTS
|
81
|
|
13.1
|
Employees
and Employee Benefits
|
81
|
|
13.2
|
Tax
Matters
|
82
|
|
13.3
|
[RESERVED.]
|
83
|
|
13.4
|
[RESERVED.]
|
83
|
|
13.5
|
[RESERVED.]
|
84
|
|
13.6
|
[RESERVED.]
|
84
|
|
13.7
|
Retention
of and Access to Records
|
84
|
|
13.8
|
Further
Assurances
|
84
|
14. |
INDEMNIFICATION;
REMEDIES
|
84
|
|
14.1
|
Survival
|
84
|
|
14.2
|
Indemnification
and Reimbursement of Mitek
|
84
|
|
14.3
|
Decision
to Seek Indemnification
|
85
|
|
14.4
|
Limitations
on Amount and Recovery
|
85
|
|
14.5
|
Time
Limitations
|
85
|
|
14.6
|
Escrow
|
85
|
|
14.7
|
Third-Party
Claims
|
85
|
|
14.8
|
Other
Claims
|
87
|
|
14.9
|
Waiver
of Contribution and Indemnification
|
87
|
15.
|
CONFIDENTIALITY
|
87
|
|
15.1
|
Definition
of Confidential Information
|
87
|
|
15.2
|
Restricted
Use Of Confidential Information
|
88
|
|
15.3
|
Exceptions
|
88
|
|
15.4
|
Legal
Proceedings
|
89
|
|
15.5
|
Return
or Destruction of Confidential Information
|
89
|
|
15.6
|
Attorney-Client
Privilege
|
89
|
16. |
GENERAL
PROVISIONS
|
90
|
|
16.1
|
Expenses
|
90
|
|
16.2
|
Public
Announcements
|
90
|
|
16.3
|
Notices
|
90
|
|
16.4
|
Arbitration
|
91
|
|
16.5
|
Enforcement
of Agreement
|
92
|
|
16.6
|
Waiver;
Remedies Cumulative
|
93
|
|
16.7
|
Entire
Agreement and Modification
|
93
|
|
16.8
|
Assignments,
Successors and No Third-Party Rights
|
93
|
|
16.9
|
Severability
|
93
|
|
16.10
|
Construction
|
93
|
|
16.11
|
Time
of Essence
|
94
|
|
16.12
|
Governing
Law
|
94
|
|
16.13
|
Execution
of Agreement
|
94
|
EXHIBITS
|
Exhibit
2.6(c)(v)
|
Example
of Merger Consideration
|
|
Exhibit
2.7(b)
|
Form
of Transmittal Letter
|
|
Exhibit
2.10(a)(i)(A) to (D)
|
Agreement
Regarding Certain Employees
|
|
Exhibit
2.10(a)(ii)
|
Noncompetition
Agreements
|
|
Exhibit
2.10(a)(iii)
|
Escrow
Agreement
|
|
Exhibit
2.10(a)(vi)
|
Services
Agreement
|
|
Exhibit
2.10(a)(vii)
|
Voting
Agreement
|
|
Exhibit
2.10(a)(viii)
|
Assumption
Agreement
|
|
Exhibit
9.3
|
Parascript
Consents
|
|
Exhibit
9.14
|
Affiliate
Letters
|
|
Exhibit
10.3
|
Mitek
Consents
|
|
Exhibit
10.11
|
Duties
and Responsibilities
|
AMENDED
AND RESTATED AGREEMENT AND PLAN OF MERGER
This
Amended and Restated Agreement and Plan of Merger (“Agreement”) is dated
September 18, 2006, by and among Mitek Systems, Inc., a Delaware
corporation (“Mitek”), Mitek Acquisition Sub, LLC, a Wyoming limited liability
company (“Merger Subsidiary”), Parascript, LLC, a Wyoming limited liability
company (“Parascript”), and Parascript Management, Inc., a Wyoming corporation
(the “Member Representative”), solely in the role as the Member Representative.
This Agreement amends, restates and replaces in its entirety that certain Asset
Purchase Agreement dated July 13, 2006 by and between Mitek and Parascript
(the
“Original Agreement”).
RECITALS
WHEREAS,
Mitek and Parascript entered into the Original Agreement providing for the
sale
of substantially all of the assets of Parascript to Mitek.
WHEREAS,
Mitek and Parascript have mutually agreed to amend and restate such Original
Agreement with this Agreement pursuant to which the
acquisition of Parascript by Mitek be accomplished by the merger of Merger
Subsidiary with and into Parascript, with Parascript being the surviving entity,
in accordance with the Wyoming Limited Liability Company Act (the
“WLLCA”).
AGREEMENT
The
parties, intending to be legally bound, agree as follows:
1. DEFINITIONS
AND USAGE.
1.1 Definitions.
For
purposes of this Agreement, the following capitalized terms and variations
thereof have the meanings specified or referred to in this Section 1.1:
“Accounts
Receivable”--(a)
all
trade accounts receivable and other rights to payment from customers of such
Person and the full benefit of all security for such accounts or rights to
payment, including all trade accounts receivable representing amounts receivable
in respect of goods shipped or products sold or services rendered to customers
of such Person, (b)
all
other accounts or notes receivable of such Person and the full benefit of all
security for such accounts or notes and (c)
any
claim, remedy or other right related to any of the foregoing.
“Acquisition
Proposal”--means any offer, proposal, inquiry or indication of interest (other
than an offer, proposal, inquiry or indication of interest by Mitek to
Parascript) to enter into any transaction or series of transactions involving
(a) any merger, consolidation, share exchange, business combination, issuance
of
securities, acquisition of securities, tender offer, exchange offer or other
similar transaction in which Parascript is a constituent entity; or (b) other
than in the Ordinary Course of Business, any sale, lease, exchange, transfer,
license, acquisition or disposition of any business or businesses or assets
that
constitute or account for 20% or more of the consolidated net revenues, net
income or assets of such Person.
“Affiliate
Letters”--as defined in Section 9.14.
“AIS”--means
Applied Intelligence Solutions LLC, a Colorado limited liability
company.
“AIS
Cash
Contribution” -as defined in Section 2.6(c)(iii).
“AIS
Holdings”--means AIS Holdings, LLC, a Colorado limited liability
company.
“AIS
Separation”--means the formation of AIS Holdings as a wholly owned subsidiary of
Parascript, the contribution of the interests of AIS owned by Parascript to
AIS
Holdings, the transfer of those assets listed on Part 1.1 of Parascript’s
Initial Disclosure Letter to AIS that are not already owned by AIS, the
assumption of the Retained Liabilities by, and the AIS Cash Contribution to,
AIS
Holdings, the distribution of the interests of AIS Holdings to the Members,
the
establishment of all operational aspects of AIS and AIS Holdings, including
employee benefits, payroll, insurance, assignment of contracts in the name
of
other entities but primarily performed by AIS, and similar matters.
“Ancillary
Agreements”--shall mean, without limitation, any or all of the Mitek Agreements
with Employees, the Noncompetition Agreement, the Assumption Agreement, the
Escrow Agreement, Affiliate Letters and any other agreement mutually agreed
upon
in writing by Mitek and Parascript.
“Appurtenances”--all
privileges, rights, easements, hereditaments and appurtenances belonging to
or
for the benefit of the Land, including all easements appurtenant to and for
the
benefit of any Land (a “Dominant Parcel”) for, and as the primary means of
access between, the Dominant Parcel and a public way, or for any other use
upon
which lawful use of the Dominant Parcel for the purposes for which it is
presently being used is dependent, and all rights existing in and to any
streets, alleys, passages and other rights-of-way included thereon or adjacent
thereto (before or after vacation thereof) and vaults beneath any such
streets.
“Articles
of Merger”--as defined in Section 2.2.
“Articles
of Organization”--as defined in Section 2.4.
“Assumption
Agreement”--as defined in Section 2.10(a)(viii).
“Balance
Sheet”--as defined in Section 3.4.
“Best
Efforts”--the efforts that a prudent Person desirous of achieving a result would
use in similar circumstances to achieve that result as expeditiously as
possible; provided, however, an obligation to use Best Efforts under this
Agreement (except as that term is used in Section 7.1 and Section 12.2 of this
Agreement) does not require a Person subject to that obligation to take actions
that would result in a materially adverse change in the benefits to such Person
of this Agreement and the Contemplated Transactions or require the incurring
of
material expense or liability to obtain such result.
“Breach”--any
breach of, or any inaccuracy in, any representation or warranty or any breach
of, or failure to perform or comply with, any covenant or obligation, in or
of
this Agreement or any other Contract, or any event which with the passing of
time or the giving of notice, or both, would constitute such a breach,
inaccuracy or failure.
“Bulk
Sales Laws”--as defined in Section 6.9.
“Business
Day”--any day other than (a)
Saturday
or Sunday or (b)
any
other day on which banks in California or Colorado are permitted or required
to
be closed.
“Certificate
Amendment”--as defined in Section 7.1(e).
“Closing”--as
defined in Section 2.9.
“Closing
Date”--the date on which the Closing actually takes place.
“COBRA”--as
defined in Section 3.15(f).
“Code”--means
the Internal Revenue Code of 1986, as amended.
“Common
Units”--means the Common Units of Parascript.
“Competing
Transaction”--shall mean any of the following (other than the transactions
contemplated by this Agreement) involving Mitek, Parascript, or any of their
respective subsidiaries: (i) any merger, consolidation, share exchange, business
combination or similar transaction; (ii) any sale, lease, exchange, mortgage,
pledge, transfer or other disposition of 20% or more of the assets of Mitek
and
its subsidiaries, taken as a whole, or Parascript and its subsidiaries, taken
as
a whole, (iii) any tender offer or exchange offer for 20% or more of the
outstanding shares of capital stock of Mitek or 20% or more of the outstanding
Units of Parascript or the filing of a registration statement under the
Securities Act in connection therewith; (iv) any Person (other than stockholders
or Members as of the date of this Agreement) having acquired beneficial
ownership of, or any group (as such term is defined under Section 13(d) of
the
Exchange Act and the rules and regulations promulgated thereunder) having been
formed which beneficially owns or has the right to acquire beneficial ownership
of, 20% or more of the outstanding shares of capital stock of Mitek or 20%
or
more of the outstanding Units of Parascript; or (v) any public announcement
of a
proposal, plan or intention to do any of the foregoing or any agreement to
engage in any of the foregoing.
“Confidential
Information”--as defined in Section 15.1.
“Consent”--any
approval, consent, ratification, waiver or other authorization.
“Contemplated
Transactions”--all of the transactions contemplated by this Agreement,
including, but not limited to, the Merger, the Name Change, the Certificate
Amendment, and the AIS Separation.
“Contract”--any
agreement, contract, Lease, consensual obligation, promise or undertaking
(whether written or oral and whether express or implied), that is legally
binding.
“Damages”--as
defined in Section 14.2.
“Disclosure
Letter”--means the Initial Disclosure Letter as defined in Section 7.2 or the
Supplemental Disclosure Letter as defined in Section 7.3 delivered by Parascript
to Mitek or by Mitek to Parascript.
“Effective
Time”--as defined in Section 2.2.
“Encumbrance”--any
charge, claim, community or other marital property interest, condition,
equitable interest, lien, option, pledge, security interest, mortgage, right
of
way, easement, encroachment, servitude, right of first option, right of first
refusal or similar restriction, including any restriction on use, voting (in
the
case of any security or equity interest), transfer, receipt of income or
exercise of any other attribute of ownership.
“ERISA”--the
Employee Retirement Income Security Act of 1974.
“Escrow
Agreement”--as defined in Section 2.10(a)(iii).
“Escrow
Shares”--as defined in Section 2.6(b).
“Exchange
Act”--the Securities Exchange Act of 1934.
“Expense
Funds”--as defined in Section 7.4(b).
“Expenses”--shall
mean those fees and expenses actually incurred by a party in connection with
this Agreement and the transactions contemplated hereby, including fees and
expenses of outside counsel, investment bankers, accountants, experts,
consultants and other representatives.
“Facilities”--any
real property, leasehold or other interest in real property currently operated
by such Person, including the Tangible Personal Property used or operated by
such Person.
“Final
Parascript Tax Returns”--as defined in Section 13.2(b).
“GAAP”--generally
accepted accounting principles for financial reporting in the United States,
applied on a consistent basis in accordance with past practice.
“Governing
Documents”--with respect to any particular entity, (a)
if a
corporation, the articles or certificate of incorporation and the bylaws;
(b)
if a
general partnership, the partnership agreement and any statement of partnership;
(c)
if a
limited partnership, the limited partnership agreement and the certificate
of
limited partnership; (d)
if a
limited liability company, the articles of organization and operating agreement;
(e)
if
another type of Person, any other charter or similar document adopted or filed
in connection with the creation, formation or organization of the Person;
(f)
all
equityholders’ agreements, voting agreements, voting trust agreements, joint
venture agreements, registration rights agreements or other agreements or
documents relating to the organization, management or operation of any Person
or
relating to the rights, duties and obligations of the equityholders of any
Person; and (g)
any
amendment or supplement to any of the foregoing.
“Governmental
Authorization”--any Consent, license, registration or permit issued, granted,
given or otherwise made available by or under the authority of any Governmental
Body or pursuant to any Legal Requirement.
“Governmental
Body”--any:
(a) nation,
state, county, city, town, borough, village, district or other
jurisdiction;
(b) federal,
state, local, municipal, foreign or other government;
(c) governmental
or quasi-governmental authority of any nature (including any agency, branch,
department, board, commission, court, tribunal or other entity exercising
governmental or quasi-governmental powers); or
(d) multinational
organization or body;
(e) body
exercising, or entitled or purporting to exercise, any administrative,
executive, judicial, legislative, police, regulatory or taxing authority or
power, or
(f) official
of any of the foregoing.
“Ground
Lease”--any long-term lease of land in which most of the rights and benefits
comprising ownership of the land and the improvements thereon or to be
constructed thereon, if any, are transferred to the tenant for the term
thereof.
“Ground
Lease Property”--any land, improvements and Appurtenances subject to a Ground
Lease in favor of such Person.
“Improvements”--all
buildings, structures, fixtures and improvements located on the Land or included
in Parascript’s assets, including those under construction.
“Indemnified
Person”--as defined in Section 14.7.
“Indemnifying
Person”--as defined in Section 14.7.
“IRS”--the
United States Internal Revenue Service and, to the extent relevant, the United
States Department of the Treasury.
“Knowledge”--an
individual will be deemed to have Knowledge of a particular fact or other matter
if that individual is actually aware of that fact or matter, or that individual
would reasonably be expected to discover or otherwise become aware of that
fact
or matter in the course of conducting a reasonable investigation regarding
the
accuracy of any representation or warranty contained in this Agreement. For
purposes of this Agreement, Knowledge of Parascript, Parascript’s Knowledge or
Parascript has no Knowledge shall mean solely the Knowledge of Jeff Gilb and
Alan Williamson, and the Knowledge of Mitek, Mitek’s Knowledge or Mitek has no
Knowledge shall mean solely the Knowledge of James DeBello and Tesfaye
Hailemichael.
“Land”--all
parcels and tracts of land in which such Person has an ownership
interest.
“Lease”--any
Real Property Lease or any lease or rental agreement, license, right to use
or
installment and conditional sale agreement to which such Person is a party
and
any other Contract pertaining to the leasing or use of any Tangible Personal
Property.
“Legal
Requirement”--any applicable federal, state, local, municipal, foreign,
international, multinational or other constitution, law, ordinance, principle
of
common law, code, regulation, statute or treaty, including, without limitation,
any environmental law.
“Liability”--with
respect to any Person, any liability or obligation of such Person of any kind,
character or description, whether known or unknown, absolute or contingent,
accrued or unaccrued, disputed or undisputed, liquidated or unliquidated,
secured or unsecured, joint or several, due or to become due, vested or
unvested, executory, determined, determinable or otherwise, and whether or
not
the same is required to be accrued on the financial statements of such Person,
provided, however, in the case of Parascript, “Liabilities” shall not include
the Retained Liabilities.
“Loan
Agreement” --means the Amended and Restated Loan and Security Agreement between
Parascript and Silicon Valley Bank, effective July 25, 2004.
“Manager”--means
Parascript Management, Inc., the managing Member of Parascript.
“Material”--means
a single event, violation, inaccuracy, circumstance, undertaking, occurrence
or
other matter which will result in Damages of at least Ten Thousand Dollars
($10,000) to Parascript or Mitek.
“Material
Adverse Effect”--A single event, violation, inaccuracy, circumstance or other
matter will be deemed to have a “Parascript Material Adverse Effect” on
Parascript if such single event, violation, inaccuracy, circumstance or other
matter had or would reasonably be expected to have a material adverse effect
on
the business, condition (financial or otherwise), capitalization, assets,
liabilities, operations or results of operations of Parascript. A single event,
violation, inaccuracy, circumstance or other matter will be deemed to have
a
“Mitek Material Adverse Effect” on Mitek if such single event, violation,
inaccuracy, circumstance or other matter had or would reasonably be expected
to
have a material adverse effect on the business, condition (financial or
otherwise), capitalization, assets, liabilities, operations or results of
operations of Mitek. Notwithstanding the foregoing, no event, violation,
inaccuracy, circumstance or other matter which arises out of general economic
or
industry conditions shall be considered in determining whether a Material
Adverse Effect has occurred. For the purposes of this definition, a single
event, violation, inaccuracy, circumstance or other matter would have a material
adverse effect on such business, condition, capitalization, assets, liabilities,
operations or results of operations of Parascript or Mitek if such single event,
violation, inaccuracy, circumstance or other matter results in Damages of at
least Ten Thousand Dollars ($10,000) to Parascript or Mitek, as
applicable.
“Material
Mitek Consent”--means any approval, consent, ratification, waiver or other
authorization required by a Material Mitek Contract.
“Material
Mitek Contract”--as defined in Section 5.19(a).
“Material
Parascript Consent”--means any approval, consent, ratification, waiver or other
authorization required by a Material Parascript Contract.
“Material
Parascript Contract”--as defined in Section 3.19(a).
“Member”
or “Members”--means a Person or the Persons defined as “Members” in Parascript’s
Fourth Amended and Restated Operating Agreement, dated as of January 1,
2005 as may be amended or supplemented from time to time, including to add
additional Persons as Members of Parascript.
“Member
Advances”--means the advances on distributions made by Parascript to Members on
or after January 1, 2006 and prior to the Closing Date.
“Member
Representative”--as defined in the first paragraph of this
Agreement.
“Merger”--as
defined in Section 2.1.
“Merger
Consideration”--as defined in Section 2.6(b).
“Merger
Subsidiary”--as defined in the first paragraph of this Agreement.
“Mitek”--as
defined in the first paragraph of this Agreement.
“Mitek
401(k) Plan”--as defined in Section 13.1(c).
“Mitek
Agreements with Employees”--shall mean the employment agreements referred to in
Section 2.7(a)(vi) and 2.7(b)(v).
“Mitek
Cafeteria Plan”--as defined in Section 13.1(d).
“Mitek
Common Stock”-- Mitek’s common stock, par value $0.01 per share.
“Mitek
Copyrights”--as defined in Section 5.23(a)(iii)
“Mitek
Data Room contains”--as defined in Section 5.28.
“Mitek
Employee Plans”--as defined in Section 5.13(a).
“Mitek
Group” --as defined in Section 6.1.
“Mitek
Indemnified Persons”--as defined in Section 14.2.
“Mitek
Interim Balance Sheet”--as defined in Section 5.4.
“Mitek
Intellectual Property Assets”--as defined in Section 5.23.
“Mitek
Marks”--as defined in Section 5.23(a)(i).
“Mitek
Net Names”--as defined in Section 5.23(a)(vi).
“Mitek
Patents”--as defined in Section 5.23(a)(ii).
“Mitek
SEC Documents”--as defined in Section 5.26.
“Mitek
Trade Secrets”--as defined in Section 5.23(a)(v).
“Name
Change”--the change of the legal name of Mitek to Parascript, Inc. (also
referred to herein as the “Mitek Name Change”).
“Options”
shall mean an option to purchase a specified number of Preferred Units pursuant
to a written Preferred Unit Option Agreement between Parascript and such option
holder.
“Order”--any
order, injunction, judgment, decree, ruling, assessment or arbitration award
of
any Governmental Body or arbitrator.
“Ordinary
Course of Business”--an action taken by a Person will be deemed to have been
taken in the Ordinary Course of Business only if that action is consistent
in
nature, scope and magnitude with the past practices of such Person and is taken
in the ordinary course of the normal operations of such Person, including,
in
the case of Parascript, distributions of cash to its Members.
“Parascript”--as
defined in the first paragraph of this Agreement.
“Parascript
401(k) Plan”--as defined in Section 13.1(c).
“Parascript
Cafeteria Plan”--as defined in Section 13.1(d).
“Parascript
Consent”--as defined in Section 9.3.
“Parascript
Contract”--any Contract (a)
under
which Parascript has or may acquire any rights or benefits; (b)
under
which Parascript has or may become subject to any obligation or liability;
or
(c)
by which
Parascript or any of its assets is bound.
“Parascript
Copyrights”--as defined in Section 3.23(a)(iii).
“Parascript
Data Room contains”--as defined in Section 3.26.
“Parascript
Employee Plans”--as defined in Section 3.15(a).
“Parascript
Intellectual Property Assets”--as defined in Section 3.23.
“Parascript
Interim Balance Sheet”--as defined in Section 3.4.
“Parascript
Marks”--as defined in Section 3.23(a)(i).
“Parascript
Net Names”--as defined in Section 3.23(a)(vi).
“Parascript
Patents”--as defined in Section 3.23(a)(ii).
“Parascript
Payments”--means (i) the
aggregate amount of principal and interest owing to Silicon Valley Bank as
of
the Effective Time, (ii) the Expense Funds and (iii) an amount of cash
determined by Parascript to be paid to and, as required by applicable law,
withheld on behalf of, certain Persons who provide services to Parascript plus
any amounts to be paid for Medicare and other Taxes payable by Merger Subsidiary
and/or the Surviving Company to a Governmental Body as a result of such
payments.
“Parascript
Trade Secrets”--as defined in Section 3.23(a)(v).
“Part”--a
part or section of the Disclosure Letter.
“Person”--an
individual, partnership, corporation, business trust, limited liability company,
limited liability partnership, joint stock company, trust, unincorporated
association, joint venture or other entity or a Governmental Body.
“Plan
Year”--as defined in Section 13.1(d).
“Preferred
Units”--means the Preferred Units of Parascript.
“Proceeding”--any
action, arbitration, audit, hearing, investigation, litigation or suit (whether
civil, criminal, administrative, judicial or investigative, whether formal
or
informal, whether public or private) commenced, brought, conducted or heard
by
or before, or otherwise involving, any Governmental Body or
arbitrator.
“Proxy
Statement”--as defined in Section 7.1.
“Real
Property”--the Land and Improvements and all Appurtenances thereto and any
Ground Lease Property.
“Real
Property Lease”--any Ground Lease or Space Lease.
“Record”--information
that is inscribed on a tangible medium or that is stored in an electronic or
other medium and is retrievable in perceivable form.
“Related
Person”--
With
respect to a particular individual:
(g) each
other member of such individual’s Family (as defined below);
(h) any
Person that is directly or indirectly controlled by any one or more members
of
such individual’s Family;
(i) any
Person in which members of such individual’s Family hold (individually or in the
aggregate) a Material Interest (as defined below); and
(j) any
Person with respect to which one or more members of such individual’s Family
serves as a director, officer, partner, executor or trustee (or in a similar
capacity).
With
respect to a specified Person other than an individual:
(k) any
Person that directly or indirectly controls, is directly or indirectly
controlled by or is directly or indirectly under common control with such
specified Person;
(l) any
Person that holds a Material Interest in such specified Person;
(m) each
Person that serves as a director, officer, partner, executor or trustee of
such
specified Person (or in a similar capacity);
(n) any
Person in which such specified Person holds a Material Interest;
and
(o) any
Person with respect to which such specified Person serves as a general partner
or a trustee (or in a similar capacity).
For
purposes of this definition, (a)“control”
(including “controlling,” “controlled by,” and “under common control with”)
means the possession, direct or indirect, of the power to direct or cause the
direction of the management and policies of a Person, whether through the
ownership of voting securities, by Contract or otherwise, and shall be construed
as such term is used in the rules promulgated under the Securities Act;
(b)
the
“Family” of an individual includes (i)
the
individual, (ii)
the
individual’s spouse, (iii)
any
other individual who is related to the individual or the individual’s spouse
within the second degree and (iv)
any
other natural Person who resides with such individual; and (c)“Material
Interest” means direct or indirect beneficial ownership (as defined in Rule
13d-3 under the Exchange Act) of voting securities or other voting interests
representing at least ten percent (10%) of the outstanding voting power of
a
Person or equity securities or other equity interests representing at least
ten
percent (10%) of the outstanding equity securities or equity interests in a
Person.
“Registration
Statement”--as defined in Section 7.1.
“Representative”--with
respect to a particular Person, any director, officer, manager, employee, agent,
consultant, advisor, accountant, financial advisor, legal counsel or other
representative of that Person.
“Retained
Liabilities”--means the Liabilities listed on Part 2.4 of the Parascript Initial
Disclosure Letter.
“Sarbanes-Oxley
Act”--as defined in Section 5.26.
“SEC”--the
United States Securities and Exchange Commission.
“Securities
Act”--as defined in Section 3.3.
“Software”--all
computer software and subsequent versions thereof, including source code,
object, executable or binary code, objects, comments, screens, user interfaces,
report formats, templates, menus, buttons and icons and all files, data,
materials, manuals, design notes and other items and documentation related
thereto or associated therewith.
“Space
Lease”--any lease or rental agreement pertaining to the occupancy of any
improved space on any Land.
“Subsidiary”--with
respect to any Person (the “Owner”), any corporation or other Person of which
securities or other interests having the power to elect a majority of that
corporation’s or other Person’s board of directors or similar governing body, or
otherwise having the power to direct the business and policies of that
corporation or other Person (other than securities or other interests having
such power only upon the happening of a contingency that has not occurred),
are
held by the Owner or one or more of its Subsidiaries.
“Surviving
Company”--as defined in Section 2.1
“Tangible
Personal Property”--all machinery, equipment, tools, furniture, office
equipment, computer hardware, supplies, materials, vehicles and other items
of
tangible personal property of every kind owned or leased (wherever located
and
whether or not carried on Parascript’s books), together with any express or
implied warranty by the manufacturers or sellers or lessors of any item or
component part thereof and all maintenance records and other documents relating
thereto.
“Tax”--any
income, gross receipts, license, payroll, employment, excise, severance, stamp,
occupation, premium, property, environmental, windfall profit, customs, vehicle,
airplane, boat, vessel or other title or registration, capital stock, franchise,
employees’ income withholding, foreign or domestic withholding, social security,
unemployment, disability, real property, personal property, sales, use,
transfer, value added, alternative, add-on minimum and other tax, fee,
assessment, levy, tariff, charge or duty of any kind whatsoever and any
interest, penalty, addition or additional amount thereon imposed, assessed
or
collected by or under the authority of any Governmental Body or payable under
any tax-sharing agreement or any other Contract.
“Tax
Return”--any return (including any information return), report, statement,
schedule, notice, form, declaration, claim for refund or other document or
information filed with or submitted to, or required to be filed with or
submitted to, any Governmental Body in connection with the determination,
assessment, collection or payment of any Tax or in connection with the
administration, implementation or enforcement of or compliance with any Legal
Requirement relating to any Tax.
“Third
Party”--a Person that is not a party to this Agreement.
“Third-Party
Claim”--any claim against any Indemnified Person by a Third Party, whether or
not involving a Proceeding.
“Unit”
--a unit of ownership in Parascript.
“WARN
Act”--as defined in Section 3.21(d).
“WLLCA”--as
defined in the Recitals to this Agreement.
1.2 Usage.
(a) Interpretation.
In this
Agreement, unless a clear contrary intention appears:
(i) the
singular number includes the plural number and vice versa;
(ii) reference
to any Person includes such Person’s successors and assigns but, if applicable,
only if such successors and assigns are not prohibited by this Agreement, and
reference to a Person in a particular capacity excludes such Person in any
other
capacity or individually;
(iii) reference
to any gender includes each other gender;
(iv) reference
to any agreement, document or instrument means such agreement, document or
instrument as amended or modified and in effect from time to time in accordance
with the terms thereof;
(v) reference
to any Legal Requirement means such Legal Requirement as amended, modified,
codified, replaced or reenacted, in whole or in part, and in effect from time
to
time, including rules and regulations promulgated thereunder, and reference
to
any section or other provision of any Legal Requirement means that provision
of
such Legal Requirement from time to time in effect and constituting the
substantive amendment, modification, codification, replacement or reenactment
of
such section or other provision;
(vi) “hereunder,”
“hereof,” “hereto,” and words of similar import shall be deemed references to
this Agreement as a whole and not to any particular Article, Section or other
provision hereof;
(vii) “including”
(and with correlative meaning “include”) means including without limiting the
generality of any description preceding such term;
(viii) “or”
is
used in the inclusive sense of “and/or”;
(ix) with
respect to the determination of any period of time, “from” means “from and
including” and “to” means “to but excluding”; and
(x) references
to documents, instruments or agreements shall be deemed to refer as well to
all
addenda, exhibits, schedules or amendments thereto.
(b) Accounting
Terms and Determinations.
Unless
otherwise specified herein, all accounting terms used herein shall be
interpreted and all accounting determinations hereunder shall be made in
accordance with GAAP.
(c) Legal
Representation of the Parties.
This
Agreement was negotiated by the parties with the benefit of legal
representation, and any rule of construction or interpretation otherwise
requiring this Agreement to be construed or interpreted against any party shall
not apply to any construction or interpretation hereof.
2. THE
MERGER.
2.1 Merger.
Upon
the terms and subject to the conditions set forth in this Agreement, at the
Effective Time, Merger Subsidiary shall be merged with and into Parascript
(the
“Merger”) in accordance with the terms of, and subject to the conditions set
forth in, this Agreement and the WLLCA. At the Effective Time, Parascript shall
continue as the surviving limited liability company in the Merger (sometimes
hereinafter referred to as the “Surviving Company”) and the separate limited
liability company existence of Merger Subsidiary shall cease.
2.2 Effective
Time.
Upon
the terms and subject to the conditions set forth in this Agreement, Parascript,
Mitek and Merger Subsidiary shall cause Articles of Merger meeting the
requirements of the WLLCA (the “Articles
of
Merger”)
to be
properly executed and filed with the Secretary of State of the State of Wyoming
in accordance with the terms and conditions of the WLLCA. The Merger shall
become effective at the time of filing of the Articles of Merger with the
Secretary of State of the State of Wyoming in accordance with the WLLCA or
at
such subsequent date and time as Mitek and Parascript shall agree and specify
in
the Articles of Merger (the “Effective
Time”).
2.3 Effects
of the Merger.
At and
after the Effective Time, the Merger shall have the effects set forth in the
WLLCA. Without limiting the generality of the foregoing and subject thereto,
at
the Effective Time all the property, rights, privileges
and
powers
of
Parascript and Merger Subsidiary shall vest in the Surviving Company, and,
subject to the Assumption Agreement, all debts, liabilities
and
duties of Parascript and Merger Subsidiary shall attach to the
Surviving Company.
2.4 Articles
of Organization
and
LLC
Agreement.
From
and
after the Effective Time, (a)
the
articles of organization of Merger Subsidiary (the “Articles of Organization”)
as
in
effect immediately prior to the Effective Time shall be the articles of
organization of
the
Surviving Company, until
duly amended in accordance with applicable Legal
Requirements and (b) the operating agreement of Merger Subsidiary as in effect
immediately prior to the Effective Time shall be the operating agreement of
the
Surviving Company until amended in accordance with its terms.
2.5 Managers
and Officers.
The
manager and officers of Merger Subsidiary immediately prior to the Effective
Time shall automatically become
the
manager and officers of the Surviving Company as of the Effective
Time.
2.6 Conversion.
At the
Effective Time, by virtue of the Merger and without any action on the part
of
any party:
(a) Each
limited liability company
interest
of Merger Subsidiary issued and outstanding immediately prior to the Effective
Time shall be converted into one
limited
liability company interest of Parascript, so that, after the Effective Time,
Mitek shall be the holder of all of the issued and outstanding
limited
liability company interests of Parascript.
(b) At
the
Effective Time, all of the Units collectively, by virtue of the Merger and
without any action on the part of the holders thereof, shall be converted into
the right to receive (collectively, the “Merger Consideration”):
(i) Eighty
Million Dollars ($80,000,000) in cash; plus
(ii) Fifty-one
Million, Eight Hundred Sixty-nine Thousand, Four Hundred Fifty-eight
(51,869,458) shares of Mitek Common Stock.
(c) The
Merger Consideration shall be payable by Mitek, in amounts represented by
Parascript to be correct, as follows:
(i) the
Parascript Payments to the Persons entitled to receive the Parascript Payments,
to the extent not paid by Parascript prior to the Closing; provided, however,
that Merger Subsidiary and/or the Surviving Company may withhold and pay to
any
appropriate Governmental Body any amounts from such Parascript Payments required
to be so withheld and paid for applicable Taxes or applicable law;
(ii) delivery
of a number of shares to the escrow agent pursuant to the Escrow Agreement,
which number shall be determined by dividing (i) Four Million Dollars
($4,000,000) by (ii) the average for the ten (10) Business Days prior to the
Closing of the daily final closing price as reported on the OTC Bulletin Board
or the daily final closing price on any other exchange upon which the Escrow
Shares are listed. The Escrow Shares shall be titled in the name of the escrow
agent under the Escrow Agreement and shall be subject to the terms and
conditions of the Escrow Agreement, but shall be treated as owned by the Member
Representative for purposes of voting and by the Members for purposes of the
receipt of dividends, and as owned by Mitek for tax purposes, all subject to
the
terms of the Escrow Agreement;
(iii) an
amount
of cash determined by Parascript, but which amount shall not be less than
$2,000,000, to be paid, on behalf of the holders of Units as a contribution
to
capital, to AIS Holdings (the “AIS Cash Contribution”); and
(iv) the
balance of the Merger Consideration shall be delivered by Mitek, in amounts
represented by Parascript to be correct, to the Members as follows:
(A) first,
to
the Members holding Preferred Units and Persons holding Options, an aggregate
amount of cash equal to Forty-Four Million Four Hundred Fifteen Thousand Dollars
($44,415,000) on an equal per-Preferred Unit basis, which shall include as
Preferred Units the number of Preferred Units subject to the Options;
and
(B) second,
to the Members holding Preferred Units, Persons holding Options and Members
holding Common Units, the remainder of the Merger Consideration on an equal
per-Unit basis, which will include as Units the number of Preferred Units
subject to an Option; provided, that, the amount of Merger Consideration payable
under either Section 2.6(c)(iv)(A) or under this Section 2.6(c)(iv)(B), without
duplication, in cash to any Member or Option holder shall be:
a. reduced
by the amount of any Member Advance paid to such Member, provided, that any
reduction in the Merger Consideration for payment of Member Advances pursuant
to
this subparagraph will constitute full satisfaction of the obligation of such
Member to repay any Member Advances; and
b. increased
by such Member’s and Option holder’s pro rata portion (based upon the number of
Preferred Units, Preferred Units subject to an Option and Common Units owned
by
such Member) of the aggregate amount of the Member Advances.
(v) The
provisions of this Section 2.6(c) are illustrated in Exhibit 2.6(c)(v).
(d) At
and as
of the Effective Time, the holders of Units at the Effective Time shall cease
to
have any rights as members of Parascript, except the right to receive Merger
Consideration in accordance with Article II hereof and such rights, if any,
as
they may have pursuant to Wyoming law. Except as provided above, until an
executed letter of transmittal is submitted by a holder of Units, each such
Unit
shall, after the Effective Time, represent for all purposes only the right
to
receive the Merger Consideration as reduced above.
2.7 Exchange
of Units.
(a) After
the
Effective Time, each Member and Option holder shall be entitled, upon surrender
of the letter of transmittal described in Section 2.7(b), to receive such
Member’s and Option holder’s portion of the Merger Consideration from Mitek
through such reasonable procedures as Mitek may adopt (including but not limited
to those set forth in this Agreement).
(b) Promptly
after the Effective Time and no later than 10 Business Days after the Effective
Time, Mitek shall deliver to each Member and each Option holder (i) a letter
of
transmittal in substantially the form set forth in Exhibit 2.7(b) or such other
form as agreed to by the parties, and completed in a manner approved by
Parascript, and (ii) instructions for use in effecting the surrender of the
letter of transmittal in exchange for such Member’s or Option holder’s portion
of the Merger Consideration, which instructions shall be approved by Mitek
and
Parascript. Promptly after receipt of such letter of transmittal by a Member
or
Option holder, such Member or Option holder shall surrender to Mitek an executed
letter of transmittal. Upon surrender by a Member or Option holder of the
executed letter of transmittal and after the Effective Time, such Member or
Option holder shall be entitled to receive in exchange therefor such Member’s or
Option holder’s portion of the Merger Consideration provided for above. No
interest shall accrue or be payable with respect to any Merger Consideration
which any person shall be so entitled to receive.
(c) Prior
to
the Effective Time, the Board of Directors of Mitek shall reserve for issuance
a
sufficient number of shares of Mitek Common Stock for the purpose of issuing
its
shares to the Members and Option holders in accordance herewith.
2.8 Closing
of Transfer Books.
From
and after the Effective Time, the transfer books of Parascript shall be closed
and no transfer of Units shall thereafter be made. From and after the Effective
Time, the holders of certificates evidencing ownership of Units and Persons
holding an Option shall cease to have any rights with respect to such Units
or
Options, except as otherwise provided for in this Agreement or by applicable
Legal Requirements.
2.9 Closing.
The
Merger will take place at the offices of Duane Morris LLP at 101 West Broadway,
Suite 900, San Diego, CA 92101, commencing at 10:00 a.m. (local time) on the
date that is two (2) Business Days following the waiver or satisfaction of
each
of the Closing obligations set forth in Section 9 and 10 (the “Closing”),
unless Mitek and Parascript otherwise agree. Subject to the provisions of
Article 10.14,
failure
to consummate the purchase and sale provided for in this Agreement on the date
and time and at the place determined pursuant to this Section 2.9 will not
result in the termination of this Agreement and will not relieve any party
of
any obligation under this Agreement. In such a situation, the Closing will
occur
as soon as practicable, subject to Article 10.14.
2.10 Closing
Obligations.
In
addition to any other documents to be delivered under other provisions of this
Agreement, at the Closing:
(a) Parascript
shall deliver to Mitek:
(i) the
agreement attached hereto as Exhibit
2.10(a)(i)(A) and (B),
executed on the date hereof but effective only as of the Closing Date, by Jeff
Gilb and Alexander Filatov, respectively, and Mitek;
(ii) noncompetition
agreements in the form of Exhibit
2.10(a)(ii),
executed by the Persons identified on Exhibit
2.10(a)(ii)
(the
“Noncompetition Agreements”);
(iii) an
escrow
agreement substantially in the form of Exhibit 2.10(a)(iii),
executed by Parascript and the escrow agent (the “Escrow
Agreement”);
(iv) a
certificate executed by Parascript as to the accuracy of its representations
and
warranties as of the date of this Agreement and as of the Closing in accordance
with Section 9.1
and as
to its compliance with and performance in all material respects of its covenants
and obligations to be performed or complied with at or before the Closing in
accordance with Section 9.2;
(v) a
certificate of the Secretary of Parascript certifying, as complete and accurate
as of the Closing and attaching all requisite resolutions or actions of
Parascript’s Members or shareholders approving (A) the execution and
delivery of this Agreement and the consummation of the Contemplated
Transactions, and (B) the incumbency and signatures of the officers of
Parascript executing this Agreement and any other document relating to the
Contemplated Transactions;
(vi) a
Services Agreement between AIS and Mitek substantially in the form attached
hereto as Exhibit 2.10(a)(vi)
(the
“Services Agreement”) whereby Mitek will provide certain business support
services to AIS;
(vii) a
Voting
Agreement executed by the Katz Family Limited Partnership, the Pearlman Family
Limited Partnership and the Pachikov Limited Partnership and effective as of
the
date hereof in the form attached hereto as Exhibit
2.10(a)(vii)
(the
“Voting Agreement”); and
(viii) evidence
of AIS Holdings undertaking and assumption of the Retained Liabilities (the
“Assumption Agreement”) in the form attached hereto as Exhibit
2.10(a)(viii),
executed by Parascript and AIS Holdings.
(b) Mitek
shall deliver to Parascript:
(i) the
Merger Consideration in accordance with Section 2.6(c);
(ii) the
Escrow Agreement executed by Mitek and the escrow agent, together with the
delivery of the Escrow Shares to the escrow agent and established pursuant
to
the Escrow Agreement thereunder (the “Escrow Account”);
(iii) the
employment agreements attached hereto as Exhibit 2.10(a)(i)(C)
and (D)
executed
on the date hereof but effective only as of the Closing Date by James DeBello
and Tesfaye Hailemichael, respectively, and by Mitek;
(iv) to
Parascript a certificate executed by Mitek as to the accuracy of Mitek’s
representations and warranties as of the date of this Agreement and as of the
Closing in accordance with Section 10.1
and as
to its compliance with and performance of Mitek’s covenants and obligations to
be performed or complied with at or before the Closing in accordance with
Section 10.2;
(v) to
Parascript a certificate of the Secretary of Mitek certifying, as complete
and
accurate as of the Closing, and attaching all requisite resolutions or actions
of Mitek’s board of directors and stockholders, as applicable, approving (A) the
execution and delivery of this Agreement and the consummation of the
Contemplated Transactions, (B) the Mitek Name Change, (C) the incumbency and
signatures of the officers of Mitek executing this Agreement and any other
document relating to the Contemplated Transactions and (D) accompanied by the
requisite documents for amending the relevant Governing Documents of Mitek
required to effect the Mitek Name Change in form sufficient for filing with
the
appropriate Governmental Body; and
(vi) the
Services Agreement signed by Mitek.
3. REPRESENTATIONS
AND WARRANTIES OF PARASCRIPT.
Subject
to disclosures and information contained in the Parascript Disclosure Letter,
Parascript represents and warrants to Mitek as follows:
3.1 Organization
and Good Standing.
(a) The
Parascript Data Room contains a list of Parascript’s jurisdiction of
organization and any other jurisdictions in which it is qualified to do business
as a foreign limited liability company. Parascript is a limited liability
company duly formed, validly existing and in good standing under the laws of
the
State of Wyoming, with full limited liability company or corporate power and
authority to conduct its business as it is now being conducted, to own or use
the properties and assets that it purports to own or use, and to perform all
its
obligations under the Parascript Contracts. Parascript is duly qualified to
do
business as a foreign limited liability company and is in good standing under
the laws of each state or other jurisdiction in which either the ownership
or
use of the properties owned or used by it, or the nature of the activities
conducted by it, requires such qualification except where the failure to so
qualify would not have a Parascript Material Adverse Effect.
(b) The
Parascript Data Room contains copies of the Governing Documents of Parascript,
as currently in effect. Except as disclosed in Part 3.1(b), Parascript has
no
Subsidiary and does not own any shares of capital stock or other securities
of
any other Person.
3.2 Enforceability;
Authority; No Conflict.
(a) This
Agreement constitutes the legal, valid and binding obligation of Parascript,
enforceable against Parascript in accordance with its terms. Upon the execution
and delivery by Parascript of the Escrow Agreement, and each other agreement
to
be executed or delivered by Parascript at the Closing (collectively, the
“Parascript’s Closing Documents”), each of Parascript’s Closing Documents will
constitute the legal, valid and binding obligation of Parascript, enforceable
against Parascript in accordance with its terms. Parascript has the absolute
and
unrestricted right, power and authority to execute and deliver this Agreement
and Parascript’s Closing Documents and to perform its obligations under this
Agreement and Parascript’s Closing Documents, and such action has been duly
authorized by all necessary action by Parascript’s Members and
Manager.
(b) Except
as
set forth in Part 3.2(b), neither the execution and delivery of this Agreement
nor the consummation or performance of any of the Contemplated Transactions
will, directly or indirectly (with or without notice or lapse of
time):
(i) Breach
any provision of any of the Governing Documents of Parascript or any resolution
adopted by the Manager or the Members of Parascript;
(ii) Breach
or
give any Governmental Body or other Person the right to challenge any of the
Contemplated Transactions, or to exercise any remedy or obtain any relief under,
any Legal Requirement or any Order to which each Parascript, or any of its
assets, may be subject, except where such Breach or challenge would not have
a
Parascript Material Adverse Effect;
(iii) contravene,
conflict with or result in a violation of any of the terms or requirements
of,
or give any Governmental Body the right to revoke, withdraw, suspend, cancel,
terminate or modify, any Governmental Authorization that is held by Parascript
or that otherwise relates to the assets or the business of Parascript, except
where such contravention, conflict, violation, revocation, withdrawal,
suspension, cancellation, termination or modification would not have a
Parascript Material Adverse Effect;
(iv) Breach
any provision of, or give any Person the right to declare a default or exercise
any remedy under, or to accelerate the maturity or performance of, or payment
under, or to cancel, terminate or modify, any Material Parascript Contract;
(v) result
in
the imposition or creation of any material Encumbrance upon or with respect
to
any of Parascript’s assets; or
(c) Except
as
set forth in Part 3.2(c), Parascript is not required to give any notice to
or
obtain any Material Parascript Consent in connection with the execution and
delivery of this Agreement or the consummation or performance of any of the
Contemplated Transactions.
3.3 Capitalization.
The
authorized equity securities of Parascript consist of 14,000,000 Units,
consisting of 4,000,000 Common Units and 10,000,000 Preferred Units, of which
205,000 Common Units, 9,804,653 Preferred Units, and 42,071 options to buy
Preferred Units (the “Parascript Options”) are issued and outstanding on the
date hereof. Other than for the Parascript Options, there are no Contracts
relating to the issuance, sale or transfer of any equity securities or other
securities of Parascript. None of the outstanding equity securities of
Parascript was issued in violation of the Securities Act of 1933, as amended
(the “Securities Act”), or any other Legal Requirement.
3.4 Financial
Statements.
The
Parascript Data Room contains copies of: (a)
audited
balance sheets of Parascript as of December 31 in each of the fiscal years
2003
and 2004, and the related audited statements of income, changes in Members’
equity and cash flows for each of the fiscal years then ended, including in
each
case the notes thereto together with the report thereon of Mayer Hoffman
McCann PC, independent certified public accountants; and (b) an unaudited
balance sheet of Parascript as of March 31, 2006, (the “Parascript Interim
Balance Sheet”) and the related unaudited statements of income, changes in
Members’ equity, and cash flows for the three (3) months then ended
(collectively, the “Parascript Financial Statements”) and will contain, as soon
as practicable after completion thereof, an audited balance sheet of Parascript
as of December 31, 2005 (including the notes thereto, the “Parascript Balance
Sheet”), and the related audited statements of income, Members’ equity and cash
flows for the fiscal year then ended, including in each case the notes thereto,
together with the report thereon of Anton Collins Mitchell LLP, independent
certified public accountants. The
Parascript Financial Statements fairly present in all material respects (and
the
financial statements delivered pursuant to Section 6.8
will
fairly present in all material respects) the financial condition and the results
of operations, changes in Members’ equity and cash flows of Parascript as at the
respective dates of and for the periods referred to in the Parascript Financial
Statements, all in accordance with GAAP in all material respects. The Parascript
Financial Statements reflect and the financial statements delivered pursuant
to
Section 6.8
will
reflect, the consistent application of such accounting principles throughout
the
periods involved, except as disclosed in the notes to such financial statements.
The Parascript Financial Statements have been prepared from and are in
accordance with the accounting Records of Parascript. The Parascript Data Room
contains copies of all letters from Parascript’s auditors to Parascript’s
Manager during the thirty-six (36) months preceding the execution of this
Agreement, together with copies of all responses thereto.
3.5 Books
and Records.
The
books of account and other financial Records of Parascript, all of which have
been made available to Mitek, are complete and correct in all material respects
and represent actual, bona fide transactions and have been maintained in
accordance with sound business practices, including the maintenance of an
adequate system of internal controls. The minute books or equivalent records
of
Parascript, all of which have been made available to Mitek, contain accurate
and
complete Records of all properly called meetings of, or actions taken by, the
Members, the Manager and committees of Parascript, and no properly called
meeting of any such Members, Manager or committee has been held for which
minutes or equivalent records have not been prepared or are not contained in
such minute books or equivalent records.
3.6 Sufficiency
of Assets.
Except
as set forth in Part 3.6, the assets owned, leased or licensed by Parascript
constitute all of the material assets, tangible and intangible, of any nature
whatsoever, that are, to Parascript’s Knowledge, necessary to operate
Parascript’s business in the manner presently operated by
Parascript.
3.7 Description
of Leased Real Property.
Part
3.7 contains the correct street address of all real property leased by
Parascript and an accurate description by location of the name of lessor, the
date of lease, a brief description of any rights to renew or extend the term
and
the term expiration date of all such real property leases, including any
amendments thereof or options to renew thereon.
3.8 Title
to Assets; Encumbrances.
Parascript owns good and transferable title to all of the assets purported
to be
owned by Parascript, subject to all Liabilities and Encumbrances thereon, except
where failure to own such title would not have a material adverse effect on
Parascript.
3.9 Condition
of Assets.
(a) Parascript
owns no Real Property. Use of the Real Property leased by Parascript for the
various purposes for which it is presently being used by Parascript is permitted
by the terms of the lease agreement related and, to Parascript’s Knowledge, all
Legal Requirements pertaining thereto.
(b) The
Tangible Personal Property owned by Parascript taken as a whole is in good
repair and good operating condition, ordinary wear and tear excepted and, to
the
Knowledge of Parascript, is suitable for immediate use by Mitek in its Ordinary
Course of Business. To the Knowledge of Parascript, no item of material Tangible
Personal Property owned by Parascript is in need of repair or replacement other
than as part of routine maintenance in the Ordinary Course of Business of
Parascript.
3.10 Accounts
Receivable.
All
Accounts Receivable that are reflected on the Balance Sheet or the Parascript
Interim Balance Sheet or on the accounting Records of Parascript as of the
Closing Date represent or will represent valid obligations arising from sales
actually made or services actually performed by Parascript in Parascript’s
Ordinary Course of Business. Except as set forth on Part 3.10 and to the
extent paid prior to the Closing Date, such Accounts Receivable of Parascript
are or will be as of the Closing Date current net of the respective reserves
shown on the Parascript Balance Sheet or the Parascript Interim Balance Sheet
(which reserves are calculated consistent with past practice). There is no
contest, claim, defense or right of setoff, under any Parascript Contract with
any account debtor of an Account Receivable of Parascript relating to the amount
or validity of such Account Receivable. The Parascript Data Room contains a
listing and aging of all Accounts Receivable as of the date of the Parascript
Interim Balance Sheet.
3.11 Inventories.
Other
than immaterial quantities of Parascript’s products held for sale in CD-ROM
form, Parascript has no inventories as that term is used in GAAP.
3.12 No
Undisclosed Liabilities.
Except
as set forth in Part 3.12, to the Knowledge of Parascript, Parascript has no
Liabilities except for Liabilities reflected or reserved against in the
Parascript Balance Sheet or the Parascript Interim Balance Sheet and current
Liabilities incurred in the Ordinary Course of Business of Parascript since
the
date of the Parascript Interim Balance Sheet.
3.13 Taxes.
(a) Tax
Returns Filed and Taxes Paid.
Parascript is a partnership for federal income tax purposes and has not elected
to be treated as other than a partnership for such purposes. Parascript has
filed or caused to be filed on a timely basis all Tax Returns and all reports
with respect to Taxes that are or were required to be filed by Parascript
pursuant to applicable Legal Requirements, except where the failure to so file
would not have a Parascript Material Adverse Effect. Except as set forth in
Part 3.13(a), all Tax Returns and reports filed by Parascript are true,
correct and complete in all material respects. Parascript has paid, or made
provision for the payment of, all material Taxes that have or may have become
due for all periods covered by the Tax Returns or otherwise, or pursuant to
any
assessment received by Parascript, except such Taxes, if any, as are being
contested in good faith. Except as provided in Part 3.13(a), Parascript
currently is not the beneficiary of any extension of time within which to file
any Tax Return. No claim has ever been made or is expected to be made by any
Governmental Body in a jurisdiction where Parascript does not file Tax Returns
that it is or may be subject to taxation by that jurisdiction. There are no
Encumbrances on any of Parascript’s assets that arose in connection with any
failure (or alleged failure) to pay any Tax and Parascript has no Knowledge
of
any basis for assertion of any claims attributable to Taxes which, if adversely
determined, would result in any such Encumbrance except as provided in Part
3.13(a).
(b) Delivery
of Tax Returns and Information Regarding Audits and Potential
Audits.
The
Parascript Data Room contains copies and a list of all of Parascript’s Tax
Returns filed since January 1, 2003. The federal and state income or
franchise Tax Returns of Parascript have been audited by the IRS or relevant
state tax authorities or are closed by the applicable statute of limitations
for
all taxable years through January 1, 2003. The Parascript Data Room
contains a list of all Tax Returns of Parascript that have been audited after
January 1, 2003 or are currently under audit and accurately describes any
deficiencies or other amounts that were paid or are currently being contested.
No undisclosed deficiencies are expected to be asserted with respect to any
such
audit. All deficiencies proposed as a result of such audits have been paid,
reserved against, settled or are being contested in good faith by appropriate
proceedings as described in Part 3.13(b). The Parascript Data Room contains
copies of any examination reports, statements or deficiencies or similar items
with respect to such audits. Except as provided in Part 3.13(b), to the
Knowledge of Parascript, no Governmental Body is likely to assess any additional
taxes for any period for which Tax Returns have been filed. There is no dispute
or claim concerning any Taxes of Parascript claimed or raised by any
Governmental Body in writing. Parascript has not extended the applicable statute
of limitations on any Tax Return. Except as described in Part 3.13(b),
Parascript has not given or been requested to give waivers or extensions (or
is
or would be subject to a waiver or extension given by any other Person) of
any
statute of limitations relating to the payment of Taxes of Parascript or for
which Parascript may be liable.
(c) Specific
Potential Tax Liabilities and Tax Situations.
(i) Withholding.
Except
as provided in Part 3.13(c)(i), to Parascript’s Knowledge, all Taxes that
Parascript is or was required by Legal Requirements to withhold, deduct or
collect have been duly withheld, deducted and collected and, to the extent
required, have been paid to the proper Governmental Body or other Person except
where the failure to do so would not have a material adverse effect on
Parascript.
(ii) Tax
Sharing or Similar Agreements.
There
is no tax sharing agreement, tax allocation agreement, tax indemnity obligation
or similar written or unwritten agreement, arrangement, understanding or
practice with respect to Taxes (including any advance pricing agreement, closing
agreement or other arrangement relating to Taxes) that will require any payment
by Parascript.
(iii) Substantial
Understatement Penalty.
Parascript has disclosed on its federal income Tax Returns all positions taken
therein that could give rise to a substantial understatement of federal income
Tax within the meaning of Code Section 6662, except where the failure to do
so
would not have a Parascript Material Adverse Effect.
(d) Proper
Accrual.
The
charges, accruals and reserves with respect to Taxes on the Records of
Parascript are adequate (determined in accordance with GAAP) and are at least
equal to Parascript’s liability for Taxes. There exists no proposed tax
assessment or deficiency against Parascript except as disclosed in the
Parascript Interim Balance Sheet or in Part 5.11(d).
3.14 No
Material Adverse Change.
To the
Knowledge of Parascript, since the date of the Parascript Balance Sheet, there
has not been any material adverse change in the business, operations, assets,
results of operations or condition (financial or other) of Parascript, and
no
event has occurred or circumstance exists within the control of Parascript
that
would result in such a material adverse change.
3.15 Employee
Benefits.
For the
purposes of this Section 3.15 a reference to Parascript will also include
Manager, as appropriate.
(a) The
Parascript Data Room contains a list of all of Parascript’s “employee benefit
plans” as defined by Section 3(3) of ERISA, all specified fringe benefit plans
as defined in Section 6039D of the Code, and all other bonus,
incentive-compensation, deferred-compensation, profit-sharing, stock-option,
stock-appreciation-right, stock-bonus, stock-purchase, employee-stock-ownership,
savings, severance, change-in-control, supplemental-unemployment, layoff,
salary-continuation, retirement, pension, health, life-insurance, disability,
accident, group-insurance, vacation, holiday, sick-leave, fringe-benefit or
welfare plan, and any other employee compensation or benefit plan, agreement,
policy, practice, commitment, contract or understanding (whether qualified
or
nonqualified, subject to ERISA or not, defined under Section 3(3) of ERISA
or not, currently effective or terminated, written or unwritten) and any trust,
escrow or other agreement related thereto that (i)
is
maintained or contributed to by Parascript or any other corporation, entity
or
trade or business controlled by, controlling or under common control with
Parascript (within the meaning of Section 414 of the Code or Section 4001(a)(14)
or 4001(b) of ERISA) (“ERISA Affiliate”) or has been maintained or contributed
to in the last six (6) years by Parascript or any ERISA Affiliate, or that
Parascript or any ERISA Affiliate has committed to implement, establish, adopt
or contribute to in the future (other than Parascript Employee Plans implemented
or established pursuant to this Agreement) or with respect to which Parascript
or any ERISA Affiliate has or may have any liability, and (ii)
provides
benefits, or describes policies or procedures applicable to any current or
former director, officer, employee or service provider of Parascript or any
ERISA Affiliate, or the dependents of any thereof, regardless of how (or
whether) liabilities for the provision of benefits are accrued or assets are
acquired or dedicated with respect to the funding thereof (collectively the
“Parascript Employee Plans”). Such list identifies as such any Parascript
Employee Plan that is a plan intended to meet the requirements of Section 401(a)
of the Code. Such list also sets forth a complete and correct list of all ERISA
Affiliates of Parascript during the last six (6) years.
(b) Except
as
disclosed in Part 3.15(b), neither Parascript nor its ERISA Affiliates are
or
have ever maintained or been obligated to contribute to a multiple employer
plan
(as defined in Section 413(c) of the Code), a multiemployer plan (as defined
in
Section 3(37) of ERISA), a defined benefit pension plan (as defined in Section
3(35) of ERISA) subject to Title IV of ERISA, a Benefit Plan subject to the
minimum funding standards under Section 302 of ERISA or Section 412 of the
Code,
a Benefit Plan that owns employer stock or a Benefit Plan that is funded, in
whole or in part, through a voluntary employees’ beneficiary association exempt
from Tax under Section 501(c)(9) of the Code.
(c) The
Parascript Data Room contains copies of (i)
the
documents comprising each Parascript Employee Plan (or, with respect to any
Parascript Employee Plan which is unwritten, a detailed written description
of
eligibility, participation, benefits, funding arrangements, assets and any
other
matters which relate to the obligations of Parascript or any ERISA Affiliate);
(ii)
all
trust agreements, insurance contracts or any other funding instruments related
to the Parascript Employee Plans; (iii)
all
rulings, determination letters, no-action letters or advisory opinions from
the
IRS, the U.S. Department of Labor or any other Governmental Body that pertain
to
each Parascript Employee Plan and any open requests therefor; (iv)
the most
recent financial reports (audited and/or unaudited) and the annual reports
filed
with any Government Body with respect to the Parascript Employee Plans during
the current year and each of the three preceding years; (v)
all
contracts with third-party administrators, investment managers, consultants
and
other independent contractors that relate to any Parascript Employee Plan,
and
(vi) all summary plan descriptions, summaries of material modifications and
memoranda, employee handbooks and other written communications regarding the
Parascript Employee Plans.
(d) Except
as
disclosed in Part 3.15(d), full payment has been made of all amounts that are
required under the terms of each Parascript Employee Plan to be paid as
contributions with respect to all periods prior to and including the last day
of
the most recent fiscal year of such Parascript Employee Plan ended on or before
the date of this Agreement and all periods thereafter prior to the Closing
Date.
Parascript has paid in full all required insurance premiums, subject only to
normal retrospective adjustments in the ordinary course, with regard to the
Parascript Employee Plans for all policy years or other applicable policy
periods ending on or before the Closing Date.
(e) Neither
Parascript nor any ERISA Affiliate has any liability and no facts or
circumstances exist that would give rise to any liability (either directly
or as
a result of indemnification), and the Contemplated Transactions will not result
in any liability, (i)
for any
excise tax imposed by Section 4971 through Section 4980B,
Section 4999, Section 5000 or any other Section of the Code, (ii) any
penalty under Section 502(i), Section 502(l), Part 6 of Title I
or any other provision of ERISA, (iii) any excise taxes, penalties, damages
or
equitable relief as a result of any prohibited transaction, breach of fiduciary
duty or other violation under ERISA, the Code or any other applicable law.
No
Parascript Employee Plan has been completely or partially terminated.
(f) Parascript
has, at all times, complied, and currently complies, in all material respects
with the applicable continuation requirements for its welfare benefit plans,
including (i) Section 4980B of the Code (as well as its predecessor provision,
Section 162(k) of the Code) and Sections 601 through 608, inclusive, of ERISA,
and any similar state law, which provisions are hereinafter referred to
collectively as “COBRA” and (ii) any applicable state statutes mandating health
insurance continuation coverage for employees.
(g) Except
as
provided in Part 3.15(g), the form of all Parascript Employee Plans is in
material compliance with the applicable terms of ERISA, the Code, and any other
applicable laws, including the Americans with Disabilities Act of 1990, the
Family Medical Leave Act of 1993 and the Health Insurance Portability and
Accountability Act of 1996, and such plans have been operated in material
compliance with such laws and the written Parascript Employee Plan documents.
Neither Parascript nor any fiduciary of any Parascript Employee Plan has
committed a material violation of the requirements of Section 404 of ERISA.
Each
Parascript Employee Plan has been maintained, operated, and administered in
material compliance with its terms and any related documents or agreements
and
the applicable provisions of ERISA, the Code and any other applicable laws,
including, but not limited to, rules and regulations promulgated by the
Department of Labor, the PBGC and the Department of Treasury. All required
reports and descriptions of the Parascript Employee Plans (including Internal
Revenue Service Form 5500 Annual Reports, Summary Annual Reports and Summary
Plan Descriptions and Summaries of Material Modifications) have been (when
required) timely filed with the IRS, the U.S. Department of Labor or other
Governmental Body and distributed as required, and all notices required by
ERISA
or the Code or any other Legal Requirement with respect to the Parascript
Employee Plans have been appropriately given. No Parascript Employee Plan is
presently under audit or examination (nor has notice been received of a
potential audit or examination) by the IRS, the U.S. Department of Labor or
any
other Governmental Body, and no matters are pending with respect to a Parascript
Employee Plan under the IRS Voluntary Correction Program, Audit Closing
Agreement Program, or other similar programs.
(h) Each
Parascript Employee Plan that is intended to be qualified under Section 401(a)
of the Code is either a prototype plan entitled to rely on the opinion letter
issued by the IRS as to the qualified status of such Parascript Employee Plan
under Section 401(a) of the Code to the extent provided in Revenue
Procedure 2005-16 or has received a favorable determination letter from the
IRS, and, to the Knowledge of Parascript, no circumstances exist that will
result in a Parascript Material Adverse Effect as a result of such reliance
or
would result in revocation of any such favorable determination letter. Each
trust created under any Parascript Employee Plan has been determined to be
exempt from taxation under Section 501(a) of the Code, and Parascript is not
aware of any circumstance that will or would result in a revocation of such
exemption. With respect to each Parascript Employee Plan, to the Knowledge
of
Parascript, no event has occurred or condition exists that will or would give
rise to a loss of any intended material tax consequence or to any material
Tax
under Section 511 of the Code.
(i) Any
Parascript Employee Plan that is a “nonqualified deferred compensation plan” (as
defined in Section 409A(d)(1) of the Code): (A) has been operated since January
1, 2005 in good faith compliance in all material respects with Section 409A
of
the Code, IRS Notice 2005-1, and the proposed regulations under Section 409A
of
the Code; (B) has not been materially modified (as determined under the proposed
regulations) after October 3, 2004, if it was in effect prior to January 1,
2005; (C) has not participated in a transaction that would be treated by Section
409A(b) of the Code as a transfer of property for purposes of Section 83 of
the
Code; and (D) does not have a stock option, equity unit option, or stock
appreciation right granted under the Parascript Employee Plan with an exercise
price or measurement floor that has been or may be less than the fair market
value of the underlying stock or equity units (as the case may be) as of the
date such option or stock appreciation right was granted or has any feature
for
the deferral of compensation other than the deferral of recognition of income
until the later of exercise or disposition of such option or stock appreciation
right.
(j) There
is
no material pending or, to Parascript’s Knowledge, threatened, Proceeding (other
than routine claims for benefits in Parascript’s Ordinary Course of Business)
relating to any Parascript Employee Plan, nor is there any basis for any such
Proceeding.
(k) Parascript
has maintained workers’ compensation coverage as required by applicable state
law through purchase of insurance and not by self-insurance or otherwise except
as disclosed to Mitek on Part 3.15(k).
(l) Except
as
required by Legal Requirements, the consummation of the Contemplated
Transactions will not (i) entitle any current or former employee of Parascript
to severance pay, unemployment compensation or any other payment, benefit or
award or (ii) accelerate the time of vesting or the time of payment, or
increase the amount, of compensation due to any director, employee, officer,
former employee or former officer of Parascript. There are no contracts or
arrangements providing for payments that could subject any person to liability
for tax under Section 4999 of the Code. No contribution, premium payment or
other payment has been or will be made in support of any Parascript Employee
Plan that is in excess of the allowable deduction for federal income Tax
purposes for the year with respect to which the contribution was made or will
be
made (whether under Section 162, Section 280G, Section 404, Section 419, Section
419A of the Code or otherwise).
(m) Except
for the continuation coverage requirements of COBRA or death benefits under
the
Parascript Employee Plans, Parascript has no obligations or potential liability
for benefits to employees, former employees or their respective dependents
following termination of employment or retirement under any of the Parascript
Employee Plans that are Employee Welfare Benefit Plans (as defined in Section
3(1) of ERISA).
(n) Except
as
necessary to implement the Contemplated Transaction, including the AIS
Separation, none of the Contemplated Transactions will result in an amendment,
modification or termination of any of the Parascript Employee Plans. No written
representations have been made to any employee or former employee of Parascript
promising or guaranteeing any employer payment or funding for the continuation
of medical, dental, life or disability coverage for any period of time beyond
the end of the current plan year (except to the extent of coverage required
under COBRA). No written representations have been made to any employee or
former employee of Parascript concerning the employee benefits of
Mitek.
3.16 Compliance
with Legal Requirements; Governmental Authorizations.
Except
as set forth in Part 3.16(a):
(i) Parascript
is, and at all times since January 1, 2003, has been, in full compliance with
each Legal Requirement that is or was applicable to it or to the conduct or
operation of its business or the ownership or use of any of its assets, except
where non-compliance would reasonably be expected not to have a Parascript
Material Adverse Effect;
(ii) To
the
Knowledge of Parascript, no event has occurred or circumstance exists that
(with
or without notice or lapse of time) (A)
may
constitute or result in a material violation by Parascript of, or a failure
on
the part of Parascript to comply with, any Legal Requirement or (B)
may give
rise to any material obligation on the part of Parascript to undertake, or
to
bear all or any portion of the cost of, any remedial action of any nature;
and
(iii) Parascript
has not received, at any time since January 1, 2003, any written notice or
other
written communication from any Governmental Body or any other Person regarding
(A)
any
actual, alleged, possible or potential violation of, or failure to comply with,
any Legal Requirement or (B)
any
actual, alleged, possible or potential obligation on the part of Parascript
to
undertake, or to bear all or any portion of the cost of, any remedial action
of
any nature.
(b) The
Parascript Data Room contains a complete and accurate list of each Governmental
Authorization that is held by Parascript or that otherwise relates to such
Parascript’s business or its assets. Each such Governmental Authorization is
valid and in full force and effect. Except as set forth in Part
3.16(b):
(i) Parascript
is, and at all times since January 1, 2003, has been, in material compliance
with all of the terms and requirements of each such Governmental Authorization,
except where non-compliance would not have a Parascript Material Adverse
Effect;
(ii) to
the
Knowledge of Parascript, no event has occurred or circumstance exists that
would
(with or without notice or lapse of time) (A) constitute or result directly
or
indirectly in a violation of or a failure to materially comply with any term
or
requirement of any such Governmental Authorization, except where such violation
or non-compliance would not have a Parascript Material Adverse Effect or (B)
result directly or indirectly in the revocation, withdrawal, suspension,
cancellation or termination of, or any modification to, any such Governmental
Authorization, except where such revocation, withdrawal, suspension,
cancellation, termination or modification would not have a Parascript Material
Adverse Effect;
(iii) Parascript
has not received, at any time since January 1, 2003, any written notice or
other
written communication from any Governmental Body or any other Person regarding
(A) any actual, alleged, possible or potential violation of or failure to comply
with any term or requirement of any Governmental Authorization or (B) any
actual, proposed, possible or potential revocation, withdrawal, suspension,
cancellation, termination of or modification to any Governmental
Authorization;
(iv) to
the
Knowledge of Parascript, all applications required to have been filed for the
renewal of such Governmental Authorizations have been duly filed on a timely
basis with the appropriate Governmental Bodies, and all other filings required
to have been made with respect to such Governmental Authorizations have been
duly made on a timely basis with the appropriate Governmental Bodies, except
where failure to so file would not have a Parascript Material Adverse Effect;
and
(v) Such
Governmental Authorizations collectively constitute, in all material respects,
the Governmental Authorizations necessary to permit Parascript to lawfully
conduct and operate its business in the manner in which it currently conducts
and operates such business and to permit Parascript to own and use the its
assets in the manner in which it currently owns and uses such
assets.
3.17 Legal
Proceedings; Orders.
(a) Except
as
set forth in Part 3.17(a), there is no pending or, to the Knowledge of
Parascript, threatened Proceeding:
(i) by
or
against Parascript that may have a Parascript Material Adverse Effect;
or
(ii) that
challenges, or that would have the effect of preventing, delaying, making
illegal or otherwise interfering with, any of the Contemplated
Transactions.
To
Parascript’s Knowledge, no event has occurred or circumstance exists that is
reasonably likely to give rise to or serve as a reasonable basis for the
commencement of any such Proceeding. Parascript has delivered to Mitek copies
of
all pleadings, correspondence and other documents relating to any Proceeding
listed in Part 3.17(a). There are no Proceedings listed or required to be listed
in Part 3.17(a) that would have a Material Adverse Effect on the business,
operations, or condition of Parascript.
(b) Except
as
set forth in Part 3.17(b):
(i) there
is
no Order to which Parascript, its business or any of its assets is subject;
and
(ii) to
the
Knowledge of Parascript, no officer, Member, Manager, or employee of Parascript
is subject to any Order that prohibits such officer, Member, Manager, agent
or
employee from engaging in or continuing any conduct, activity or practice
relating to the business of Parascript.
(c) Except
as
set forth in Part 3.17(c):
(i) Parascript
is, and, at all times since January 1, 2003, has been in material compliance
with all of the terms and requirements of each Order to which it or any of
its
assets is or has been subject;
(ii) to
the
Knowledge of Parascript, no event has occurred or circumstance exists that
is
reasonably likely to constitute or result in (with or without notice or lapse
of
time) a violation of or failure to comply with any term or requirement of any
Order to which Parascript or any of its assets is subject which would result
in
a Parascript Material Adverse Effect; and
(iii) Parascript
has not received, at any time since January 1, 2003, any written notice or
other
written communication from any Governmental Body or any other Person regarding
any actual, alleged, possible or potential violation of, or failure to comply
with, any term or requirement of any Order to which Parascript or any of its
assets is or has been subject.
3.18 Absence
of Certain Changes and Events.
Except
as set forth in Part 3.18 and except for the actions taken related to the
Contemplated Transactions, since the date of the Parascript Balance Sheet,
Parascript has conducted its business only in the Ordinary Course of Business
and there has not been any:
(a) change
in
Parascript’s authorized capital;
(b) amendment
to the Governing Documents of Parascript;
(c) payment
(except in its Ordinary Course of Business, including monthly cash advances
to
certain Members) or increase by Parascript of any bonuses, salaries or other
compensation to any Member, Manager, officer or employee or entry into any
employment, severance or similar Contract with any Member, Manager, officer
or
employee;
(d) adoption
of, amendment to or increase in the payments to or benefits under, any
Parascript Employee Plan;
(e) damage
to
or destruction or loss of any material Asset, whether or not covered by
insurance;
(f) entry
into, termination of or receipt of notice of termination of (i)
any
material license, distributorship, dealer, sales representative, joint venture,
credit or similar Contract to which Parascript is a party, or (ii)
any
Contract or transaction involving total remaining payments by Parascript of
at
least One Hundred Thousand Dollars ($100,000);
(g) sale
(other than sales in its Ordinary Course of Business), or other disposition
of
any Asset or property of Parascript (including the Parascript Intellectual
Property Assets) or the creation of any Encumbrance on any Asset other than
sales of assets or property of Parascript which would not have a Parascript
Material Adverse Effect;
(h) resolution,
termination or waiver of any claims or rights with a value to Parascript in
excess of One Hundred Thousand Dollars ($100,000);
(i) indication
in writing by any customer of an intention to discontinue or change the terms
of
its relationship with Parascript, which discontinuation or change would have
a
Parascript Material Adverse Effect;
(j) material
change in the accounting methods used by Parascript; or
(k) to
Parascript’s Knowledge, Contract by Parascript to do any of the
foregoing.
3.19 Contracts;
No Defaults.
(a) Part
3.19(a) contains an accurate and complete list, and the Parascript Data Room
contains, accurate and complete copies, of the following Contracts which are
referred to herein as “Material Parascript Contracts”:
(i) each
Parascript Contract that involves a remaining obligation of performance of
services or delivery of goods or materials by Parascript of an amount or value
certain to be in excess of One Hundred Thousand Dollars ($100,000) per
year;
(ii) each
Parascript Contract that involves performance of services or delivery of goods
or materials to Parascript of an amount or value in excess of One Hundred
Thousand Dollars ($100,000);
(iii) each
Parascript Contract that was not entered into in its Ordinary Course of Business
and that involves expenditures or receipts of Parascript certain to be in excess
of One Hundred Thousand Dollars ($100,000);
(iv) each
Parascript Contract affecting the ownership of, leasing of, title to, use of
or
any leasehold or other interest in any real or personal property (except
personal property leases and installment and conditional sales agreements having
a value per item or aggregate payments of less than One Hundred Thousand Dollars
($100,000) and with a term of less than one year);
(v) each
Parascript Contract with any labor union or other employee representative of
a
group of employees relating to wages, hours and other conditions of
employment;
(vi) each
Parascript Contract (however named) involving a sharing of profits, losses,
costs or liabilities by Parascript with any other Person;
(vii) each
Parascript Contract containing covenants that in any way purports to restrict
Parascript’s business activity or limits the freedom of Parascript to engage in
any line of business or to compete with any Person;
(viii) each
Parascript Contract providing for payments to or by any Person based on sales,
purchases or profits, other than direct payments for goods;
(ix) each
power of attorney of Parascript that is currently effective and
outstanding;
(x) each
Parascript Contract entered into other than in its Ordinary Course of Business
that contains or provides for an express undertaking by Parascript to be
responsible for consequential damages;
(xi) each
Parascript Contract for capital expenditures in excess of One Hundred Thousand
Dollars ($100,000);
(xii) each
written warranty, guaranty and/or other similar undertaking with respect to
contractual performance extended by Parascript other than in its Ordinary Course
of Business; and
(xiii) each
amendment, supplement and modification (whether oral or written) in respect
of
any of the foregoing.
Part
3.19(a) sets forth the parties to each Material Parascript Contract, the
effective date of each Material Parascript Contract, the term of each Material
Parascript Contract, the goods or services to which each Material Parascript
Contract relates and the amount of the remaining commitment of Parascript under
each Material Parascript Contract.
(b) Except
as
set forth in Part 3.19(b), no Member has or may acquire any rights under, and
no
Member has or may become subject to any obligation or liability under, any
Material Parascript Contract that relates to the business of Parascript or
any
of its assets.
(c) Except
as
set forth in Part 3.19(c):
(i) each
Material Parascript Contract identified or required to be identified in
Part 3.19(a) has not been orally modified (other than as described in
Part 3.19(c)) and is in full force and effect and is valid and enforceable
in accordance with its terms except, as to any party other than Parascript,
as
may be limited by applicable bankruptcy, insolvency, reorganization, moratorium
and other laws of general application affecting enforcement of creditors’ rights
generally and as limited by laws relating to the availability of specific
performance, injunctive relief or other equitable remedies; and
(ii) each
such
Material Parascript Contract identified or required to be identified in Part
3.19(a) shall not require the consent of any other Person as a result of the
Contemplated Transactions.
(d) Except
as
set forth in Part 3.19(d):
(i) Parascript
is, and at all times since January 1, 2003, has been, in compliance with all
material terms and requirements of each Material Parascript
Contract;
(ii) to
the
Knowledge of Parascript, each other Person that has any obligation or liability
under any Material Parascript Contract is, and at all times since January 1,
2003, has been, in full compliance with all material terms and requirements
of
such Material Parascript Contract;
(iii) to
the
Knowledge of Parascript, no event has occurred or circumstance exists that
(with
or without notice or lapse of time) may contravene, conflict with or result
in a
Breach of, or give Parascript or any other Persons the right to declare a
default or exercise any remedy under, or to accelerate the maturity or
performance of, or payment under, or to cancel, terminate or modify, any
Material Parascript Contract, except where the occurrence of such event or
existence of such circumstance would not have a Parascript Material Adverse
Effect;
(iv) to
the
Knowledge of Parascript, no event has occurred or circumstance exists under
or
by virtue of any Material Parascript Contract that (with or without notice
or
lapse of time) would cause the creation of any Encumbrance affecting any of
Parascript’s assets which would have a Parascript Material Adverse Effect;
and
(v) Parascript
has not given to or received from any other Person, at any time since January
1,
2003, any written notice or other written communication regarding any actual,
alleged, possible or potential violation or Breach of, or default under, any
Parascript Material Contract.
(e) There
are
no renegotiations of, written requests to renegotiate or outstanding rights
to
renegotiate any material amounts paid or payable to Parascript under any
Parascript Material Contracts.
(f) Each
Parascript Contract relating to the sale, design, manufacture or provision
of
products or services by Parascript has been entered into in the Ordinary Course
of Business of Parascript and has been entered into without the commission
of
any act alone or in concert with any other Person, or any consideration having
been paid or promised, that is or would be in violation of any Legal
Requirement.
3.20 Insurance.
(a) The
Parascript Data Room contains:
(i) copies
of
all policies of insurance (and correspondence relating to coverage thereunder)
to which Parascript is a party or under which Parascript is or has been covered
at any time since January 1, 2003 a list of which is included in Part 3.20(a);
and
(ii) copies
of
all pending applications by Parascript for policies of insurance.
(b) Part
3.20(b) describes:
(i) any
self-insurance arrangement by or affecting Parascript, including any reserves
established thereunder and description of loss experience for all claims that
were self insured, including the number and aggregate cost of such
claims;
(ii) any
Contract or arrangement, other than a policy of insurance, for the transfer
or
sharing of any risk to which Parascript is a party or which involves the
business of Parascript; and
(iii) all
obligations of Parascript to provide insurance coverage to Third Parties (for
example, under Leases or service agreements) and identifies the policy under
which such coverage is provided.
(c) Part
3.20(c) sets forth, by year, for the current policy year and each of the three
(3) preceding policy years a summary of the loss experience for an amount in
excess of Five Hundred Thousand Dollars ($500,000) under each policy of
insurance. Such summary includes the name of claimant, description of the policy
by insurer, type of insurance, and period of coverage and amount and brief
description of the claim.
(d) Except
as
set forth in Part 3.20(d):
(i) to
the
Knowledge of Parascript, all policies of insurance to which Parascript is a
party or that provide coverage to Parascript are valid, outstanding and
enforceable and are sufficient for compliance with all Legal
Requirements;
(ii) Parascript
has not received (A) any refusal of coverage or any notice that a defense will
be afforded with reservation of rights or (B) any written notice of cancellation
or any other written indication that any policy of insurance is no longer in
full force or effect or that the issuer of any policy of insurance is not
willing or able to perform its obligations thereunder;
(iii) Parascript
has paid all premiums due, and has otherwise performed all of its obligations,
under each policy of insurance to which it is a party; and
(iv) to
the
Knowledge of Parascript, Parascript has given notice to the insurer of all
claims that may be insured thereby.
3.21 Employees.
For the
purposes of this Section 3.21 a reference to Parascript will also include
Manager, as appropriate.
(a) The
Parascript Data Room contains a list of the following information for
Parascript’s ten (10) most highly compensated employees, including executive
officers and all persons nominated or chosen to become such:
(i) positions
and offices currently held;
(ii) a
brief
description of each executive officer’s business experience during the past five
years;
(iii) any
family relationships among executive officers and directors;
(iv) any
legal
proceedings (including any bankruptcy petition filed by or against any business
of which an executive officer was a general partner or executive officer either
at the time of the bankruptcy or within two years prior to that time) material
to an evaluation of such executive officer’s ability or integrity;
(v) annual
compensation which shall include total annual salary and bonus for the last
completed fiscal year;
(vi) perquisites
and other personal benefits, securities or property;
(vii) above-market
or preferential earnings on restricted stock, options, SARS or deferred
compensation paid during the fiscal year or payable during that period but
deferred at the election of the named employee; and
(viii) any
amounts reimbursed during the fiscal year for the payment of taxes.
(b) Part
3.21(a) contains a list of all retired employees of Parascript receiving any
retirement benefits from plans or arrangements maintained by Parascript and
the
amounts thereof.
(c) Part
3.21(b) states the number of employees terminated by Parascript since January
1,
2003, and contains a complete and accurate list of the following information
for
each employee of Parascript who has been terminated or laid off, or whose hours
of work have been reduced by more than fifty percent (50%) by Parascript, in
the
six (6) months prior to the date of this Agreement: (i)
the date
of such termination, layoff or reduction in hours; (ii)
the
reason for such termination, layoff or reduction in hours; and (iii)
the
location to which the employee was assigned, if applicable.
(d) Parascript
has not violated the Worker Adjustment and Retraining Notification Act (the
“WARN Act”) or any similar state or local Legal Requirement. During the ninety
(90) day period prior to the date of this Agreement, Parascript has terminated
no employees.
(e) Except
for an Employee Confidentiality, Assignment and Noncompetition Agreement, to
the
Knowledge of Parascript, no officer, Manager, Member, agent, employee,
consultant, or contractor of Parascript is bound by any Contract that purports
to limit the ability of such Person (i) to engage in or continue or perform
any
conduct, activity, duties or practice relating to the business of Parascript
or
(ii) to assign to Parascript or to any other Person any rights to any invention,
improvement, or discovery. No former or current employee of Parascript is a
party to, or is otherwise bound by, any Contract that materially adversely
affects the ability of Parascript to conduct the business carried on by
Parascript as of the date hereof.
3.22 Labor
Disputes; Compliance.
For the
purposes of this Section 3.22 a reference to Parascript will also include
Manager, as appropriate.
(a) Parascript
has complied in all material respects with all Legal Requirements relating
to
employment practices, terms and conditions of employment, equal employment
opportunity, nondiscrimination, immigration, wages, hours, benefits, collective
bargaining and other requirements, the payment of social security and similar
Taxes and occupational safety and health. Parascript is not liable for the
payment of any Taxes, fines, penalties, or other amounts, however designated,
for failure to comply with any of the foregoing Legal Requirements except where
the failure to comply would not have a Parascript Material Adverse
Effect.
(b) Except
as
disclosed in Part 3.22(b), (i)
Parascript has not been, and are not now, a party to any collective bargaining
agreement or other labor contract; (ii)
since
January 1, 2003, there has not been, there is not presently pending or existing,
and, to the Knowledge of Parascript, there is not threatened, any strike,
slowdown, picketing, work stoppage or employee grievance process involving
Parascript; (iii)
to the
Knowledge of Parascript, no event has occurred or circumstance exists that
would
provide the basis for any work stoppage or other labor dispute; (iv)
there is
not pending or, to the Knowledge of Parascript, threatened against or affecting
Parascript any Proceeding relating to the alleged violation of any Legal
Requirement pertaining to labor relations or employment matters, including
any
charge or complaint filed with the National Labor Relations Board or any
comparable Governmental Body, and, to the Knowledge of Parascript, there is
no
organizational activity or other labor dispute against or affecting Parascript;
(v)
no
application or petition for an election of or for certification of a collective
bargaining agent is pending; (vi)
no
grievance or arbitration Proceeding exists that would have a Material Adverse
Effect upon Parascript or the conduct of its business; (vii)
there is
no lockout of any employees by Parascript, and no such action is contemplated
by
Parascript; and (viii)
there
has been no charge of discrimination filed against or, to Parascript’s
Knowledge, threatened against Parascript with the Equal Employment Opportunity
Commission or similar Governmental Body.
3.23 Parascript
Intellectual Property Assets.
(a) The
term
“Parascript Intellectual Property Assets” means all assets that are intellectual
property owned or licensed (as licensor or licensee) by Parascript in which
Parascript has a material proprietary interest, including:
(i) Parascript’s
name, all assumed fictional business names, trade names, registered and
unregistered trademarks, service marks and applications owned by Parascript
(collectively, “Parascript Marks”);
(ii) all
patents, patent applications and inventions and discoveries that may be
patentable and owned by Parascript (collectively, “Parascript
Patents”);
(iii) all
registered and unregistered copyrights in both published works and unpublished
works owned by Parascript (collectively, “Parascript Copyrights”);
(iv) all
rights in mask works owned by each Parascript;
(v) all
know-how, trade secrets, confidential or proprietary information, customer
lists, source code to Software, technical information, data, process technology,
plans, drawings and blue prints owned by Parascript (collectively, “Parascript
Trade Secrets”); and
(vi) all
rights in internet web sites and internet domain names presently owned by
Parascript (collectively “Parascript Net Names”).
(b) Part
3.23(b) contains a complete and accurate list and summary description, including
royalties paid or received by Parascript and the Parascript Data Room contains
accurate and complete copies of all Parascript Contracts (other than Material
Parascript Contracts referred to in Section 3.19 hereof or listed in Part 3.19)
relating to the Parascript Intellectual Property Assets, except for any license
implied by the sale of a product, Parascript Contracts related to the
distribution, resale or similar arrangement of Parascript Intellectual Property
Assets in the Ordinary Course of Business, and licenses for commonly available
Software programs under which Parascript is the licensee. There are no
outstanding and, to the Knowledge of Parascript, no threatened disputes or
disagreements with respect to any such Parascript Contract.
(c) Except
as
set forth in Part 3.23(c),
(i) the
Parascript Intellectual Property Assets are all those used in the operation
of
Parascript’s business as it is currently conducted and as it is contemplated to
be conducted in the future. Such Parascript is the owner or licensee of all
right, title and interest in and to each of the Parascript Intellectual Property
Assets, and has the right to use all of the Parascript Intellectual Property
Assets subject to any Parascript Contracts with Third Parties related to such
Parascript Intellectual Property Assets which are listed in Part
3.23(c).
(ii) all
former and current employees of Parascript have executed written Contracts
with
Parascript that assign to Parascript all rights to any inventions, improvements,
discoveries or information relating to the business of Parascript.
(iii) all
Parascript Contracts related to Parascript Intellectual Property Assets with
any
Related Person of Parascript are upon commercially reasonable
terms.
(d) Part
3.23(d) contains a complete and accurate list of all Parascript Patents. With
respect to subsections (i), (ii) and (iii) below, except where the failure
to do
so or failure thereof would not have a Parascript Material Adverse
Effect:
(i) All
of
the issued Parascript Patents are currently in compliance with formal legal
requirements (including payment of filing, examination and maintenance fees
and
proofs of working or use), are valid and enforceable, and are not subject to
any
maintenance fees or taxes or actions falling due within ninety (90) days after
the Closing Date.
(ii) No
Parascript Patent has been or is now involved in any interference, reissue,
reexamination, or opposition Proceeding. To the Knowledge of Parascript, there
is no interfering patent or patent application of any Third Party.
(iii) Except
as
set forth in Part 3.23(d), to the Knowledge of Parascript (A) no Parascript
Patent is infringed or has been challenged or threatened in any way and (B)
none
of the products manufactured or sold, nor any process or know-how used by
Parascript infringes or is alleged to infringe any patent or other proprietary
right of any other Person.
(e) Part
3.23(e) contains a complete and accurate list of all Parascript Marks. With
respect to subsections (i), (ii), (iii) and (iv) below, except where the failure
to do so or failure thereof would not have a Parascript Material Adverse
Effect:
(i) All
Parascript Marks that have been registered with the United States Patent and
Trademark Office are currently in compliance with all formal Legal Requirements
(including the timely post-registration filing of affidavits of use and
incontestability and renewal applications), and are valid and enforceable and
are not subject to any maintenance fees or taxes or actions falling due within
ninety (90) days after the Closing Date.
(ii) No
Parascript Mark has been or is now involved in any opposition, invalidation
or
cancellation Proceeding and no such action is, to Parascript’s Knowledge,
threatened with respect to any of the Parascript Marks.
(iii) There
is,
to Parascript’s Knowledge, no potentially interfering trademark or trademark
application of any other Person related to any Parascript Marks.
(iv) To
Parascript’s Knowledge, no Parascript Mark is infringed or has been challenged
or threatened in any way. None of the Parascript Marks infringes or is alleged
to infringe any trade name, trademark or service mark of any other
Person.
(f) Part
3.23(f) contains a complete and accurate list of all Parascript Copyrights.
With
respect to subsections (i) and (ii) below, except where the failure to do so
or
failure thereof would not have a Parascript Material Adverse
Effect:
(i) All
of
the registered Parascript Copyrights are currently in compliance with formal
Legal Requirements and are valid and enforceable and are not subject to any
maintenance fees or taxes or actions falling due within ninety (90) days after
the date of Closing.
(ii) To
Parascript’s Knowledge, no Parascript Copyright is infringed or has been
challenged or threatened in any way. None of the subject matter of any of the
Parascript Copyrights infringes or is alleged to infringe any copyright of
any
Third Party or is a derivative work based upon the work of any other
Person.
(g) Parascript
has taken reasonable precautions to protect the secrecy, confidentiality and
value of its material Trade Secrets. No Parascript Trade Secret is subject
to
any adverse claim or has been challenged or, to Parascript’s Knowledge,
threatened in any way or, to the Knowledge of Parascript, infringes any
intellectual property right of any other Person.
(h) Part
3.23(h) contains a complete and accurate list of all Parascript Net Names.
With
respect to subsections (i), (ii), (iii) and (iv) below, except where the failure
to do so or failure thereof would not have a Parascript Material Adverse
Effect:
(i) All
Parascript Net Names have been registered in the name of Parascript and are
in
compliance with all formal Legal Requirements.
(ii) No
Parascript Net Name has been or is now involved in any dispute, opposition,
invalidation or cancellation Proceeding and no such action is, to Parascript’s
Knowledge, threatened with respect to any Net Name.
(iii) To
the
Knowledge of Parascript, there is no domain name application pending of any
other person which would or would potentially interfere with or infringe any
Parascript Net Name.
(iv) To
the
Knowledge of Parascript, no Parascript Net Name is infringed or has been
challenged, interfered with or threatened in any way. No Parascript Net Name
infringes, interferes with or is alleged to interfere with or infringe the
trademark, copyright or domain name of any other Person.
3.24 Relationships
With Related Persons.
Except
as disclosed in Part 3.24, no Related Person of Parascript has or, since January
1, 2003, has had, any interest in any of Parascript’s assets. No Related Person
of Parascript owns or, since January 1, 2003, has owned, of record or as a
beneficial owner, an equity interest or any other financial or profit interest
in any Person that has had business dealings or a material financial interest
in
any transaction with Parascript other than business dealings or transactions
disclosed in Part 3.24, each of which has been conducted in the Ordinary Course
of Business with Parascript at substantially prevailing market prices and on
substantially prevailing market terms. Except as set forth in Part 3.24, no
Related Person of Parascript is a party to any Contract with or has any claim
or
right against Parascript.
3.25 Brokers
or Finders.
Except
as disclosed in Part 3.25, neither Parascript nor any of its Representatives
have incurred any obligation or liability, contingent or otherwise, for
brokerage or finders’ fees or agents’ commissions or other similar payments in
connection with the sale of Parascript’s business or its assets or the
Contemplated Transactions.
3.26 The
Parascript Data Room.
Parascript has established a limited access, coded data room through the
services of Merrill Corporation as a repository for certain of Parascript’s
documents and information in electronically readable and retrievable form.
The
phrase “The Parascript Data Room contains. . .” means that the document, list,
schedule or other information or matter referred to as being contained in the
Parascript Data Room is a true and complete copy of the original of the
referenced document, is a complete and accurate listing, schedule or other
presentation of information or matter to which reference is made (unless
otherwise clearly noted or explained in such reference), is listed in and may
be
located by referring to the index for the contents of the Parascript Data Room
and is readable by computer access and may be reproduced in full by
printer.
3.27 Disclosure.
No
representation or warranty contained in this Agreement, the Parascript
Disclosure Letter, any supplement to the Parascript Disclosure Letter or any
certificates delivered by Parascript pursuant to this Agreement and any
information provided by Parascript for use in the Registration Statement and
the
Proxy Statement contains any untrue statement or omits to state a material
fact
necessary to make any of them, in light of the circumstances in which it was
made, not misleading.
4. REPRESENTATIONS
AND WARRANTIES OF MERGER SUBSIDIARY.
Subject
to disclosures and information contained in the Mitek Disclosure Letter, Mitek
and Merger Subsidiary represent and warrant to Parascript as follows:
4.1 Organization,
Good Standing and Other Matters.
Merger
Subsidiary is a limited liability company duly organized, validly existing
and
in good standing under the laws of Wyoming. A true, correct and complete copy
of
the articles of organization and operating agreement of Merger Subsidiary has
been furnished to Parascript or its representatives.
4.2 Authority.
Merger
Subsidiary has all requisite power and authority to execute and deliver this
Agreement, to perform its obligations hereunder, and to consummate the
transactions contemplated herein. The execution, delivery and performance of
this Agreement by Merger Subsidiary and the consummation of the transactions
contemplated herein have been duly and validly authorized by all necessary
limited liability company action, and by all of its managers and member.
Except
for the filing of
the
Articles of Merger, no other proceedings or approvals on the part of Merger
Subsidiary are necessary to authorize this Agreement, perform Merger
Subsidiary’s obligations hereunder or for Merger Subsidiary to consummate the
Merger and other transactions contemplated herein and therein. This Agreement
has been, or upon execution and delivery will be, duly and validly executed
and
delivered by Merger Subsidiary, and, assuming that this Agreement constitutes
the valid and binding agreement of the other parties hereto, constitutes, or
upon execution and delivery will constitute, the valid and binding obligations
of Merger Subsidiary, enforceable against Merger Subsidiary in accordance with
its terms and conditions, except that the enforcement hereof and thereof may
be
limited by (i) applicable bankruptcy, insolvency, reorganization,
moratorium, fraudulent conveyance or other similar laws now or hereafter in
effect relating to creditors’ rights generally and (ii) general principles
of equity (regardless of whether enforceability is considered in a proceeding
at
law or in equity).
4.3 No
Conflict.
The
execution, delivery and performance by Merger Subsidiary of this Agreement
and
consummation of the transactions contemplated herein will not violate, conflict
with, or result in any breach of any provisions of the certificate of formation
or limited liability company agreement of Merger Subsidiary.
5. REPRESENTATIONS
AND WARRANTIES OF MITEK.
Subject
to disclosures and information contained in the Mitek Disclosure Letter, Mitek
represents and warrants to Parascript as follows:
5.1 Organization
and Good Standing.
(a) The
Mitek
Data Room complete and accurate list of Mitek’s jurisdiction of organization and
any other jurisdictions in which it is qualified to do business as a foreign
corporation. Mitek is a corporation duly formed, validly existing and in good
standing under the laws of the State of Delaware, with full corporate power
and
authority to conduct its business as it is now being conducted, to own or use
the properties and assets that it purports to own or use, and to perform all
its
obligations under the Mitek Contracts. Mitek is duly qualified to do business
as
a foreign corporation and is in good standing under the laws of each state
or
other jurisdiction in which either the ownership or use of the properties owned
or used by it, or the nature of the activities conducted by it, requires such
qualification, except where the failure to so qualify would not have a Mitek
Material Adverse Effect.
(b) The
Mitek
Data Room copies of the Governing Documents of Mitek, as currently in effect.
Except as disclosed in Part 5.1(b), Mitek has no Subsidiary and does not own
any
shares of capital stock or other securities of any other Person.
5.2 Enforceability;
Authority; No Conflict.
(a) This
Agreement constitutes the legal, valid and binding obligation of Mitek,
enforceable against Mitek in accordance with its terms. Upon the execution
and
delivery by Mitek of the Escrow Agreement, and each other agreement to be
executed or delivered by Mitek at the Closing (collectively, the “Mitek’s
Closing Documents”), each of Mitek’s Closing Documents will constitute the
legal, valid and binding obligation of Mitek, enforceable against Mitek in
accordance with its terms. Mitek has the absolute and unrestricted right, power
and authority to execute and deliver this Agreement and Mitek’s Closing
Documents and to perform its obligations under this Agreement and Mitek’s
Closing Documents, and such action has been duly authorized by all necessary
action by Mitek’s Board of Directors and stockholders.
(b) Except
as
set forth in Part 5.2(b), neither the execution and delivery of this Agreement
nor the consummation or performance of any of the Contemplated Transactions
will, directly or indirectly (with or without notice or lapse of
time):
(i) Breach
any provision of any of the Governing Documents of Mitek or any resolution
adopted by the Board of Directors or stockholders of Mitek;
(ii) Breach
or
give any Governmental Body or other Person the right to challenge any of the
Contemplated Transactions, other than as related to the HSR Act, or to exercise
any remedy or obtain any relief under, any Legal Requirement or any Order to
which Mitek, or any of its assets, may be subject, except where such Breach
or
challenge would not have a Mitek Material Adverse Effect;
(iii) contravene,
conflict with or result in a violation of any of the terms or requirements
of,
or give any Governmental Body the right to revoke, withdraw, suspend, cancel,
terminate or modify, any Governmental Authorization that is held by Mitek or
that otherwise relates to its assets or to the business of Mitek, except where
such contravention, conflict, violation, revocation, withdrawal, suspension,
cancellation, termination or modification would not have a Mitek Material
Adverse Effect;
(iv) Breach
any provision of, or give any Person the right to declare a default or exercise
any remedy under, or to accelerate the maturity or performance of, or payment
under, or to cancel, terminate or modify, any Material Mitek Contract;
(v) result
in
the imposition or creation of any material Encumbrance upon or with respect
to
any of its assets; or
(c) Except
as
set forth in Part 5.2(c), Mitek is not required to give any notice to or obtain
any Material Mitek Consent from any Person in connection with the execution
and
delivery of this Agreement or the consummation or performance of any of the
Contemplated Transactions.
5.3 Capitalization.
The
authorized capital stock of Mitek consists of 40,000,000 shares of Mitek Common
Stock. As of the date hereof, (a) 16,739,498 shares of Mitek Common Stock are
issued and outstanding, all of which are duly authorized, validly issued, fully
paid and nonassessable, (b) 2,626,857 shares of Mitek Common Stock are
reserved for issuance upon the exercise of outstanding stock options granted
pursuant to Mitek’s employee stock plans (“Mitek Stock Options”),
(c) 1,381,428 shares of Mitek Common Stock are reserved for issuance upon
exercise of outstanding warrants of Mitek, and (d) 487,972 shares of Mitek
Common Stock are reserved for issuance pursuant to Mitek Stock Options not
yet
granted. There are not any bonds, debentures, notes or other indebtedness or
securities of Mitek having the right to vote (or convertible into, or
exchangeable for, securities having the right to vote) on any matters on
which stockholders of Mitek may vote. Except as set forth above, as of the
date
hereof, no shares of capital stock or other voting securities of Mitek are
issued, reserved for issuance or outstanding and no shares of capital stock
or
other voting securities of Mitek will be issued or become outstanding after
the
date hereof other than upon exercise of Mitek Stock Options and Mitek Warrants
outstanding as of the date hereof. Except as set forth in this Section 5.3
or
Part 5.3, there are no options, stock appreciation rights, warrants or other
rights, Contracts, arrangements or commitments of any character (collectively,
“Options”) relating to the issued or unissued capital stock of Mitek, or
obligating Mitek to issue, grant or sell any shares of capital stock of, or
other equity interests in, or securities convertible into equity interests
in,
Mitek. Since July 10, 2006, Mitek has not issued any shares of its capital
stock
or Options in respect thereof, except upon the conversion of the securities
or
the exercise of the options and warrants referred to above. All shares of Mitek
Common Stock subject to issuance as described above will, upon issuance on
the
terms and conditions specified in the instruments pursuant to which they are
issuable, be duly authorized, validly issued, fully paid and nonassessable.
Except as set forth in Part 5.3, Mitek is not a party to any Contract or other
obligation to repurchase, redeem or otherwise acquire any shares of Mitek Common
Stock, or make any investment (in the form of a loan, capital contribution
or
otherwise) in any Person. None of the outstanding equity securities or other
securities of Mitek was issued in violation of the Securities Act or any other
Legal Requirement. Except as set forth in Part 5.3, Mitek does not own, or
have
any Contract or other obligation to acquire, any equity securities or other
securities of any Person or any direct or indirect equity or ownership interest
in any other business. Mitek is not and has never been a general partner of
any
general or limited partnership.
5.4 Financial
Statements.
The
Mitek Data Room contains: (a)
an
audited balance sheet of Mitek as of September 30, 2005 (including the notes
thereto, the “Mitek Balance Sheet”), and the related audited statements of
income, changes in stockholders’ equity and cash flows for the fiscal year then
ended, including in each case the notes thereto, together with the report
thereon of Stonefield Josephson LLP, independent certified public accountants;
(b)
audited
balance sheets of Mitek as of September 30 in each of the fiscal years 2003
and
2004, and the related audited statements of income, changes in stockholders’
equity and cash flows for each of the fiscal years then ended, including in
each
case the notes thereto together with the report thereon of Deloitte &
Touche, LLP, independent certified public accountants, for fiscal year 2003
and
Stonefield Josephson LLP, independent certified public accountants, for fiscal
year 2004; and (c)
an
unaudited balance sheet of Mitek as of March 31, 2006, (the “Mitek Interim
Balance Sheet”) and the related unaudited statements of income, changes in
stockholders’ equity, and cash flows for the three (3) months then ended
(collectively, the “Mitek Financial Statements”). The Mitek Financial Statements
fairly present in all material respects the financial condition and the results
of operations, changes in stockholders’ equity and cash flows of Mitek as at the
respective dates of and for the periods referred to in such Mitek Financial
Statements, all in accordance with GAAP in all material respects. The Mitek
Financial Statements reflect the consistent application of such accounting
principles throughout the periods involved, except as disclosed in the notes
to
such financial statements. The Mitek Financial Statements have been prepared
from and are in accordance with the accounting Records of Mitek. The Mitek
Data
Room contains copies of all letters from Mitek’s auditors to Mitek during the
thirty-six (36) months preceding the execution of this Agreement, together
with
copies of all responses thereto.
5.5 Books
and Records.
The
books of account and other financial Records of Mitek, all of which have been
made available to Parascript, are complete and correct in all material respects
and represent actual, bona fide transactions and have been maintained in
accordance with sound business practices, including the maintenance of an
adequate system of internal controls. The minute books or equivalent records
of
Mitek, all of which have been made available to Parascript, contain accurate
and
complete Records of all properly called meetings of, or actions taken by, the
stockholders, the Board of Directors and committees of Mitek, and no properly
called meeting of any such stockholders, Board of Directors or committee has
been held for which minutes or equivalent records have not been prepared or
are
not contained in such minute books or equivalent records.
5.6 Sufficiency
of Assets.
Except
as set forth in Part 5.6, Mitek’s assets (a) constitute all of the
material assets, tangible and intangible, of any nature whatsoever; to Mitek’s
belief, necessary to operate Mitek’s business in the manner presently operated
by Mitek and (b) include all of the operating assets of Mitek.
5.7 Description
of Leased Real Property.
Part
5.7 contains a correct street address of all real property leased by Mitek
and
an accurate description by location, name of lessor, date of lease, a brief
description of any rights to renew or extend the term and term expiration date
of all real property leases including any amendments thereof or options to
renew
thereon.
5.8 Title
to Assets; Encumbrances.
Mitek
owns good and transferable title to all of its assets subject to all Liabilities
and Encumbrances thereon, except where failure to own such title would not
have
a material adverse effect on Mitek.
5.9 Condition
of Assets.
(a) Mitek
owns no Real Property. Use of the Real Property leased by Mitek for the various
purposes for which it is presently being used by Mitek is permitted by the
terms
of the lease agreement related and, to Mitek’s Knowledge, all Legal Requirements
pertaining thereto.
(b) The
Tangible Personal Property owned by Mitek taken as a whole is in good repair
and
good operating condition, ordinary wear and tear excepted, and, to the Knowledge
of Mitek, is suitable for immediate use by Mitek in its Ordinary Course of
Business. To the Knowledge of Mitek, no item of material Tangible Personal
Property owned by Mitek is in need of repair or replacement other than as part
of routine maintenance in the Ordinary Course of Business of Mitek.
5.10 Accounts
Receivable.
All
Accounts Receivable that are reflected on the Mitek Balance Sheet or the Mitek
Interim Balance Sheet or on the accounting Records of Mitek as of the Closing
Date represent or will represent valid obligations arising from sales actually
made or services actually performed by Mitek in Mitek’s Ordinary Course of
Business. Except as set forth on Part 5.10 and to the extent paid prior to
the
Closing Date, such Accounts Receivable are or will be as of the Closing Date
current, and collectible net of the respective reserves shown on the Mitek
Balance Sheet or the Mitek Interim Balance Sheet (which reserves are calculated
consistent with past practice). There is no contest, claim, defense or right
of
setoff, under any Contract with any account debtor of an Account Receivable
relating to the amount or validity of such Account Receivable. Part 5.10
contains a listing and aging of all Accounts Receivable as of the date of the
Interim Balance Sheet.
5.11 Inventories.
Except
as set forth in Part 5.11 or the Mitek SEC Documents, Mitek has no
inventories as that term is used in GAAP.
5.12 No
Undisclosed Liabilities.
Except
as set forth in Part 5.12, to the Knowledge of Mitek, Mitek has no Liabilities
except for Liabilities reflected or reserved against in the Mitek Balance Sheet
or the Mitek Interim Balance Sheet and current liabilities incurred in the
Ordinary Course of Business of Mitek since the date of the Mitek Interim Balance
Sheet.
5.13 Taxes.
(a) Tax
Returns Filed and Taxes Paid.
Mitek
has filed or caused to be filed on a timely basis all Tax Returns and all
reports with respect to Taxes that are or were required to be filed pursuant
to
applicable Legal Requirements, except where the failure to so file would not
have a Mitek Material Adverse Effect. All Tax Returns and reports filed by
Mitek
are true, correct and complete in all material respects. Mitek has paid, or
made
provision for the payment of, all Taxes that have or may have become due for
all
periods covered by the Tax Returns or otherwise, or pursuant to any assessment
received by Mitek, except such Taxes, if any, as are being contested in good
faith. Except as provided in Part 5.13(a), Mitek currently is not the
beneficiary of any extension of time within which to file any Tax Return. No
claim has ever been made or is expected to be made by any Governmental Body
in a
jurisdiction where Mitek does not file Tax Returns that it is or may be subject
to taxation by that jurisdiction. There are no Encumbrances on any of its assets
that arose in connection with any failure (or alleged failure) to pay any Tax
and Mitek has no Knowledge of any basis for assertion of any claims attributable
to Taxes exists which, if adversely determined, would result in any such
Encumbrance except as provided in Part 5.13(a).
(b) Delivery
of Tax Returns and Information Regarding Audits and Potential
Audits.
The
Mitek Data Room contains copies and a list of all Tax Returns filed since
January 1, 2003. The federal and state income or franchise Tax Returns of
Mitek have been audited by the IRS or relevant state tax authorities or are
closed by the applicable statute of limitations for all taxable years through
January 1, 2003. The Mitek Data Room contains a complete and accurate list
of all Tax Returns of Mitek that have been audited or are currently under audit
and accurately describes any deficiencies or other amounts that were paid or
are
currently being contested. No undisclosed deficiencies are expected to be
asserted with respect to any such audit. All deficiencies proposed as a result
of such audits have been paid, reserved against, settled or are being contested
in good faith by appropriate proceedings as described in Part 5.13(b). The
Mitek
Data Room contains copies of any examination reports, statements or deficiencies
or similar items with respect to such audits. Except as provided in Part
5.13(b), to the Knowledge of Mitek, no Governmental Body is likely to assess
any
additional taxes for any period for which Tax Returns have been filed. There
is
no dispute or claim concerning any Taxes of Mitek claimed or raised by any
Governmental Body in writing. The Mitek Data Room contains a list of all Tax
Returns for which the applicable statute of limitations has not run. Except
as
described in Part 5.13(b), Mitek has not given or been requested to give waivers
or extensions (or is or would be subject to a waiver or extension given by
any
other Person) of any statute of limitations relating to the payment of Taxes
of
Mitek or for which Mitek may be liable.
(c) Specific
Potential Tax Liabilities and Tax Situations.
(i) Withholding.
Except
as provided in Part 5.13 (c)(i), all material Taxes that Mitek is or was
required by Legal Requirements to withhold, deduct or collect have been duly
withheld, deducted and collected and, to the extent required, have been paid
to
the proper Governmental Body or other Person, except where the failure to do
so
would not have a Mitek Material Adverse Effect.
(ii) Tax
Sharing or Similar Agreements.
There
is no tax sharing agreement, tax allocation agreement, tax indemnity obligation
or similar written or unwritten agreement, arrangement, understanding or
practice with respect to Taxes (including any advance pricing agreement, closing
agreement or other arrangement relating to Taxes) that will require any payment
by Mitek.
(iii) Substantial
Understatement Penalty.
Mitek
has disclosed on its federal income Tax Returns all positions taken therein
that
could give rise to a substantial understatement of federal income Tax within
the
meaning of Code Section 6662, except where the failure to do so would not have
a
Mitek Material Adverse Effect.
(d) Proper
Accrual.
The
charges, accruals and reserves with respect to Taxes on the Records of Mitek
are
adequate (determined in accordance with GAAP) and are at least equal to Mitek’s
liability for Taxes. There exists no proposed tax assessment or deficiency
against Mitek except as disclosed in the Mitek Interim Balance Sheet or in
Part 5.11(d).
5.14 No
Material Adverse Change.
To the
Knowledge of Mitek, since the date of the Mitek Balance Sheet, there has not
been any material adverse change in the business, operations, assets, results
of
operations or condition (financial or other) of Mitek, and no event has occurred
or circumstance exists within the control of Mitek that may result in such
a
material adverse change.
5.15 Employee
Benefits.
(a) The
Mitek
Data Room contains a list of all of Mitek’s “employee benefit plans” as defined
by Section 3(3) of ERISA, all specified fringe benefit plans as defined in
Section 6039D of the Code, and all other bonus, incentive-compensation,
deferred-compensation, profit-sharing, stock-option, stock-appreciation-right,
stock-bonus, stock-purchase, employee-stock-ownership, savings, severance,
change-in-control, supplemental-unemployment, layoff, salary-continuation,
retirement, pension, health, life-insurance, disability, accident,
group-insurance, vacation, holiday, sick-leave, fringe-benefit or welfare plan,
and any other employee compensation or benefit plan, agreement, policy,
practice, commitment, contract or understanding (whether qualified or
nonqualified, subject to ERISA or not, defined under Section 3(3) of ERISA
or not, currently effective or terminated, written or unwritten) and any trust,
escrow or other agreement related thereto that (i)
is
maintained or contributed to by Mitek or any other corporation, entity or trade
or business controlled by, controlling or under common control with Mitek
(within the meaning of Section 414 of the Code or Section 4001(a)(14) or 4001(b)
of ERISA) (“ERISA Affiliate”) or has been maintained or contributed to in the
last six (6) years by Mitek or any ERISA Affiliate, or that Mitek or any ERISA
Affiliate has committed to implement, establish, adopt or contribute to in
the
future (other than Mitek Employee Plans implemented or established pursuant
to
this Agreement) or with respect to which Mitek or any ERISA Affiliate has or
may
have any liability, and (ii)
provides
benefits, or describes policies or procedures applicable to any current or
former director, officer, employee or service provider of Mitek or any ERISA
Affiliate, or the dependents of any thereof, regardless of how (or whether)
liabilities for the provision of benefits are accrued or assets are acquired
or
dedicated with respect to the funding thereof (collectively the “Mitek Employee
Plans”). Such list identifies as such any Mitek Employee Plan that is a plan
intended to meet the requirements of Section 401(a) of the Code. Such list
also
sets forth a complete and correct list of all ERISA Affiliates of Mitek during
the last six (6) years.
(b) Except
as
disclosed in Part 5.15(b), neither Mitek nor its ERISA Affiliates are or have
ever maintained or been obligated to contribute to a multiple employer plan
(as
defined in Section 413(c) of the Code), a multiemployer plan (as defined in
Section 3(37) of ERISA), a defined benefit pension plan (as defined in Section
3(35) of ERISA) subject to Title IV of ERISA, a Benefit Plan subject to the
minimum funding standards under Section 302 of ERISA or Section 412 of the
Code,
a Benefit Plan that owns employer stock or a Benefit Plan that is funded, in
whole or in part, through a voluntary employees’ beneficiary association exempt
from Tax under Section 501(c)(9) of the Code.
(c) The
Mitek
Data Room contains copies of (i)
the
documents comprising each Mitek Employee Plan (or, with respect to any Mitek
Employee Plan which is unwritten, a detailed written description of eligibility,
participation, benefits, funding arrangements, assets and any other matters
which relate to the obligations of Mitek or any ERISA Affiliate); (ii)
all
trust agreements, insurance contracts or any other funding instruments related
to the Mitek Employee Plans; (iii)
all
rulings, determination letters, no-action letters or advisory opinions from
the
IRS, the U.S. Department of Labor or any other Governmental Body that pertain
to
each Mitek Employee Plan and any open requests therefor; (iv)
the most
recent financial reports (audited and/or unaudited) and the annual reports
filed
with any Government Body with respect to the Mitek Employee Plans during the
current year and each of the three preceding years; (v)
all
contracts with third-party administrators, investment managers, consultants
and
other independent contractors that relate to any Mitek Employee Plan, and (vi)
all summary plan descriptions, summaries of material modifications and
memoranda, employee handbooks and other written communications regarding the
Mitek Employee Plans.
(d) Except
as
disclosed in Part 5.15(d), full payment has been made of all amounts that are
required under the terms of each Mitek Employee Plan to be paid as contributions
with respect to all periods prior to and including the last day of the most
recent fiscal year of such Mitek Employee Plan ended on or before the date
of
this Agreement and all periods thereafter prior to the Closing Date. Mitek
has
paid in full all required insurance premiums, subject only to normal
retrospective adjustments in the ordinary course, with regard to the Mitek
Employee Plans for all policy years or other applicable policy periods ending
on
or before the Closing Date.
(e) Neither
Mitek nor any ERISA Affiliate has any liability and no facts or circumstances
exist that would give rise to any liability (either directly or as a result
of
indemnification), and the Contemplated Transactions will not result in any
liability, (i)
for any
excise tax imposed by Section 4971 through Section 4980B,
Section 4999, Section 5000 or any other Section of the Code, (ii) any
penalty under Section 502(i), Section 502(l), Part 6 of
Title I or any other provision of ERISA, (iii) any excise taxes, penalties,
damages or equitable relief as a result of any prohibited transaction, breach
of
fiduciary duty or other violation under ERISA, the Code or any other applicable
law. No Mitek Employee Plan has been completely or partially
terminated.
(f) Mitek
has, at all times, complied and currently complies in all material respects
with
the applicable continuation requirements for its welfare benefit plans,
including (i) Section 4980B of the Code (as well as its predecessor provision,
Section 162(k) of the Code) and Sections 601 through 608, inclusive, of ERISA,
and any similar state law, which provisions are hereinafter referred to
collectively as “COBRA” and (ii) any applicable state statutes mandating health
insurance continuation coverage for employees.
(g) Except
as
provided in Part 5.15(g), the form of all Mitek Employee Plans is in material
compliance with the applicable terms of ERISA, the Code, and any other
applicable laws, including the Americans with Disabilities Act of 1990, the
Family Medical Leave Act of 1993 and the Health Insurance Portability and
Accountability Act of 1996, and such plans have been operated in material
compliance with such laws and the written Mitek Employee Plan documents. Neither
Mitek nor any fiduciary of any Mitek Employee Plan has committed a material
violation of the requirements of Section 404 of ERISA. Each Mitek Employee
Plan
has been maintained, operated, and administered in material compliance with
its
terms and any related documents or agreements and the applicable provisions
of
ERISA, the Code and any other applicable laws, including, but not limited to,
rules and regulations promulgated by the Department of Labor, the PBGC and
the
Department of Treasury. All required reports and descriptions of the Mitek
Employee Plans (including Internal Revenue Service Form 5500 Annual Reports,
Summary Annual Reports and Summary Plan Descriptions and Summaries of Material
Modifications) have been (when required) timely filed with the IRS, the U.S.
Department of Labor or other Governmental Body and distributed as required,
and
all notices required by ERISA or the Code or any other Legal Requirement with
respect to the Mitek Employee Plans have been appropriately given. No Mitek
Employee Plan is presently under audit or examination (nor has notice been
received of a potential audit or examination) by the IRS, the U.S. Department
of
Labor or any other Governmental Body, and no matters are pending with respect
to
a Mitek Employee Plan under the IRS Voluntary Correction Program, Audit Closing
Agreement Program, or other similar programs.
(h) Each
Mitek Employee Plan that is intended to be qualified under Section 401(a) of
the
Code is either a prototype plan entitled to rely on the opinion letter issued
by
the IRS as to the qualified status of such Mitek Employee Plan under
Section 401(a) of the Code to the extent provided in Revenue
Procedure 2005-16 or has received a favorable determination letter from the
IRS, and, to the Knowledge of Mitek, no circumstances exist that will result
in
a Mitek Material Adverse Effect as a result of such reliance or would result
in
revocation of any such favorable determination letter. Each trust created under
any Mitek Employee Plan has been determined to be exempt from taxation under
Section 501(a) of the Code, and Mitek is not aware of any circumstance that
will
or would result in a revocation of such exemption. With respect to each Mitek
Employee Plan, to the Knowledge of Mitek, no event has occurred or condition
exists that will or would give rise to a loss of any intended material tax
consequence or to any material Tax under Section 511 of the Code.
(i) Any
Mitek
Employee Plan that is a “nonqualified deferred compensation plan” (as defined in
Section 409A(d)(1) of the Code): (A) has been operated since January 1, 2005
in
good faith compliance in all material respects with Section 409A of the Code,
IRS Notice 2005-1, and the proposed regulations under Section 409A of the Code;
(B) has not been materially modified (as determined under the proposed
regulations) after October 3, 2004, if it was in effect prior to January 1,
2005; (C) has not participated in a transaction that would be treated by Section
409A(b) of the Code as a transfer of property for purposes of Section 83 of
the
Code; and (D) does not have a stock option, equity unit option, or stock
appreciation right granted under the Mitek Employee Plan with an exercise price
or measurement floor that has been or may be less than the fair market value
of
the underlying stock or equity units (as the case may be) as of the date such
option or stock appreciation right was granted or has any feature for the
deferral of compensation other than the deferral of recognition of income until
the later of exercise or disposition of such option or stock appreciation
right.
(j) There
is
no material pending or, to Mitek’s Knowledge, threatened Proceeding (other than
routine claims for benefits in the Ordinary Course of Business of Mitek)
relating to any Mitek Employee Plan, nor is there any basis for any such
Proceeding.
(k) Mitek
has
maintained workers’ compensation coverage as required by applicable state law
through purchase of insurance and not by self-insurance or otherwise except
as
disclosed to Parascript on Part 5.15(k).
(l) Except
as
required by Legal Requirements, the consummation of the Contemplated
Transactions will not (i) entitle any current or former employee of Mitek to
severance pay, unemployment compensation or any other payment, benefit or award
or (ii) accelerate the time of vesting or the time of payment, or increase
the amount, of compensation due to any director, employee, officer, former
employee or former officer of Mitek. There are no contracts or arrangements
providing for payments that could subject any Person to liability for tax under
Section 4999 of the Code. No contribution, premium payment or other payment
has
been or will be made in support of the any Mitek Employee Plan that is in excess
of the allowable deduction for federal income Tax purposes for the year with
respect to which the contribution was made or will be made (whether under
Section 162, Section 280G, Section 404, Section 419, Section 419A of the Code
or
otherwise).
(m) Except
for the continuation coverage requirements of COBRA or death benefits under
the
Mitek Employee Plans, Mitek has no obligations or potential liability for
benefits to employees, former employees or their respective dependents following
termination of employment or retirement under any of the Mitek Employee Plans
that are Employee Welfare Benefit Plans (as defined in Section 3(l) of
ERISA).
(n) Except
as
contemplated in Section 13, none of the Contemplated Transactions will result
in
an amendment, modification or termination of any of the Mitek Employee Plans.
No
written representations have been made to any employee or former employee of
Mitek promising or guaranteeing any employer payment or funding for the
continuation of medical, dental, life or disability coverage for any period
of
time beyond the end of the current plan year (except to the extent of coverage
required under COBRA). No written representations have been made to any employee
or former employee of Mitek concerning the employee benefits of
Parascript.
5.16 Compliance
with Legal Requirements; Governmental Authorizations.
(a) Except
as
set forth in Part 5.16(a):
(i) Mitek
is,
and at all times since January 1, 2003, has been, in full compliance with each
Legal Requirement that is or was applicable to it or to the conduct or operation
of its business or the ownership or use of any of its assets, except where
non-compliance would reasonably be expected to have a Mitek Material Adverse
Effect on Mitek’s assets taken as a whole;
(ii) To
the
Knowledge of Mitek, no event has occurred or circumstance exists that (with
or
without notice or lapse of time) (A)
may
constitute or result in a material violation by Mitek of, or a failure on the
part of Mitek to comply with, any Legal Requirement or (B)
may give
rise to any material obligation on the part of Mitek to undertake, or to bear
all or any portion of the cost of, any remedial action of any nature;
and
(iii) Mitek
has
not received, at any time since January 1, 2003, any written notice or other
written communication from any Governmental Body or any other Person regarding
(A)
any
actual, alleged, possible or potential violation of, or failure to comply with,
any Legal Requirement or (B)
any
actual, alleged, possible or potential obligation on the part of Mitek to
undertake, or to bear all or any portion of the cost of, any remedial action
of
any nature.
(b) Part
5.16(b) contains a complete and accurate list of each Governmental Authorization
that is held by Mitek or that otherwise relates to Mitek’s business or its
assets. Each such Governmental Authorization is valid and in full force and
effect. Except as set forth in Part 5.16(b):
(i) Mitek
is,
and at all times since January 1, 2003, has been, in material compliance with
all of the terms and requirements of each such Governmental
Authorization;
(ii) To
the
Knowledge of Mitek, no event has occurred or circumstance exists that would
(with or without notice or lapse of time) (A) constitute or result directly
or
indirectly in a violation of or a failure to materially comply with any term
or
requirement of any such Governmental Authorization, except where such violation
or non-compliance would not have a Mitek Material Adverse Effect or (B) result
directly or indirectly in the revocation, withdrawal, suspension, cancellation
or termination of, or any modification to, any such material Governmental
Authorization, except where such revocation, withdrawal, suspension,
cancellation, termination or modification would not have a Mitek Material
Adverse Effect;
(iii) Mitek
has
not received, at any time since January 1, 2003, any written notice or other
written communication from any Governmental Body or any other Person regarding
(A) any actual, alleged, possible or potential violation of or failure to comply
with any term or requirement of any Governmental Authorization or (B) any
actual, proposed, possible or potential revocation, withdrawal, suspension,
cancellation, termination of or modification to any Governmental
Authorization;
(iv) To
the
knowledge of Mitek, all applications required to have been filed for the renewal
of such Governmental Authorizations have been duly filed on a timely basis
with
the appropriate Governmental Bodies, and all other filings required to have
been
made with respect to such Governmental Authorizations have been duly made on
a
timely basis with the appropriate Governmental Bodies, except where failure
to
so file would not have a Mitek Material Adverse Effect;
(v) Such
Governmental Authorizations collectively constitute, in all material respects,
the Governmental Authorizations necessary to permit Mitek to lawfully conduct
and operate its business in the manner in which it currently conducts and
operates such business and to permit Mitek to own and use its assets in the
manner in which it currently owns and uses such assets.
5.17 Legal
Proceedings; Orders.
(a) Except
as
set forth in Part 5.17(a), there is no pending or, to the Knowledge of Mitek,
threatened Proceeding:
(i) by
or
against Mitek that may have a Mitek Material Adverse Effect; or
(ii) that
challenges, or that would have the effect of preventing, delaying, making
illegal or otherwise interfering with, any of the Contemplated
Transactions.
To
Mitek’s Knowledge, no event has occurred or circumstance exists that is
reasonably likely to give rise to or serve as a reasonable basis for the
commencement of any such Proceeding. Mitek has delivered to Parascript copies
of
all pleadings, correspondence and other documents relating to any Proceeding
listed in Part 5.17(a). There are no Proceedings listed or required to be listed
in Part 5.17(a) that would have a Mitek Material Adverse Effect.
(b) Except
as
set forth in Part 5.17 (b):
(i) there
is
no Order to which Mitek, its business or any of its assets is subject;
and
(ii) to
the
Knowledge of Mitek, no officer, stockholder, director or employee of Mitek
is
subject to any Order that prohibits such officer, stockholder, director, agent
or employee from engaging in or continuing any conduct, activity or practice
relating to the business of Mitek.
(c) Except
as
set forth in Part 5.17(c):
(i) Mitek
is,
and, at all times since January 1, 2003, has been in material compliance with
all of the terms and requirements of each Order to which it or any of its assets
is or has been subject;
(ii) to
the
Knowledge of Mitek, no event has occurred or circumstance exists that is
reasonably likely to constitute or result in (with or without notice or lapse
of
time) a violation of or failure to comply with any term or requirement of any
Order to which Mitek or any of its assets is subject which would result in
a
Mitek Material Adverse Effect; and
(iii) Mitek
has
not received, at any time since January 1, 2003, any written notice or other
written communication from any Governmental Body or any other Person regarding
any actual, alleged, possible or potential violation of, or failure to comply
with, any term or requirement of any Order to which Mitek or any of its assets
is or has been subject.
5.18 Absence
of Certain Changes and Events.
Except
as set forth in Part 5.18 and except for the actions taken related to the
Contemplated Transactions, since the date of the Mitek Balance Sheet, Mitek
has
conducted its business only in its Ordinary Course of Business and there has
not
been any:
(a) change
in
Mitek’s authorized stock;
(b) amendment
to the Governing Documents of Mitek;
(c) payment
(except in its Ordinary Course of Business) or increase by Mitek of any bonuses,
salaries or other compensation to any stockholder, director, officer or employee
or entry into any employment, severance or similar Contract with any
stockholder, director, officer or employee;
(d) adoption
of, amendment to or increase in the payments to or benefits under, any Mitek
Employee Plan;
(e) damage
to
or destruction or loss of any material asset of Mitek, whether or not covered
by
insurance;
(f) entry
into, termination of or receipt of notice of termination of (i)
any
material license, distributorship, dealer, sales representative, joint venture,
credit or similar Contract to which Mitek is a party, or (ii)
any
Contract or transaction involving a total remaining payments by Mitek of at
least One Hundred Thousand Dollars ($100,000);
(g) sale
(other than sales in its Ordinary Course of Business), lease or other
disposition of any asset or property of Mitek (including the Mitek Intellectual
Property Assets) or the creation of any Encumbrance on any asset of Mitek other
than sales of assets or property of Mitek which would not have a Mitek Material
Adverse Effect;
(h) resolution,
termination or waiver of any claims or rights with a value to Mitek in excess
of
One Hundred Thousand Dollars ($100,000);
(i)
indication
in writing by any customer of an intention to discontinue or change the terms
of
its relationship with Mitek, which discontinuation or change would have a Mitek
Material Adverse Effect;
(j)
material
change in the accounting methods used by Mitek; or
(k) To
Mitek’s Knowledge, Contract by Mitek to do any of the foregoing.
5.19 Contracts;
No Defaults.
(a) Part
5.19(a) contains an accurate and complete list, and Mitek has delivered to
Parascript accurate and complete copies, of the following Contracts, which
are
referred to herein as “Material Mitek Contracts”:
(i) each
Mitek Contract that involves performance of services or delivery of goods or
materials by Mitek of an amount or value in excess of One Hundred Thousand
Dollars ($100,000);
(ii) each
Mitek Contract that involves performance of services or delivery of goods or
materials to Mitek of an amount or value in excess of One Hundred Thousand
Dollars ($100,000);
(iii) each
Mitek Contract that was not entered into in its Ordinary Course of Business
and
that involves expenditures or receipts of Mitek in excess of One Hundred
Thousand Dollars ($100,000);
(iv) each
Mitek Contract affecting the ownership of, leasing of, title to, use of or
any
leasehold or other interest in any real or personal property (except personal
property leases and installment and conditional sales agreements having a value
per item or aggregate payments of less than One Hundred Thousand Dollars
($100,000) and with a term of less than one year);
(v) each
Mitek Contract with any labor union or other employee representative of a group
of employees relating to wages, hours and other conditions of
employment;
(vi) each
Mitek Contract (however named) involving a sharing of profits, losses, costs
or
liabilities by Mitek with any other Person;
(vii) each
Mitek Contract containing covenants that in any way purport to restrict Mitek’s
business activity or limit the freedom of Mitek to engage in any line of
business or to compete with any Person;
(viii) each
Mitek Contract providing for payments to or by any Person based on sales,
purchases or profits, other than direct payments for goods;
(ix) each
power of attorney of Mitek that is currently effective and
outstanding;
(x) each
Mitek Contract entered into other than in its Ordinary Course of Business that
contains or provides for an express undertaking by Mitek to be responsible
for
consequential damages;
(xi) each
Mitek Contract for capital expenditures in excess of One Hundred Thousand
Dollars ($100,000);
(xii) each
written warranty, guaranty and/or other similar undertaking with respect to
contractual performance extended by Mitek other than in its Ordinary Course
of
Business; and
(xiii) each
amendment, supplement and modification (whether oral or written) in respect
of
any of the foregoing.
Part 5.19(a)
sets forth the parties to each Material Mitek Contract, the effective date
of
each Material Mitek Contract, the term of each Material Mitek Contract, the
goods or services to which each Material Mitek Contract relates and the amount
of the remaining commitment of Mitek under each Material Mitek
Contract.
(b) Except
as
set forth in Part 5.19(b), no stockholder of Mitek has or may acquire any rights
under, and no stockholder of Mitek has or may become subject to any obligation
or liability under, any Contract that relates to the business of Mitek or any
of
its assets.
(c) Except
as
set forth in Part 5.19(c):
(i) each
Material Mitek Contract identified or required to be identified in
Part 5.19(a) has not been orally modified in any material respect (other
than as described in Part 5.19(c)) and is in full force and effect and is
valid and enforceable in accordance with its terms except, as to any party
other
than such Parascript, as may be limited by applicable bankruptcy, insolvency,
reorganization, moratorium and other laws of general application affecting
enforcement of creditors’ rights generally and as limited by laws relating to
the availability of specific performance, injunctive relief or other equitable
remedies; and
(ii) each
such
Material Mitek Contract identified or required to be identified in Part 5.19(a)
does not require the receipt of consent of any other Person as a result of
the
contemplated Transactions.
(d) Except
as
set forth in Part 5.19(d):
(i) Mitek
is,
and at all times since January 1, 2003, has been, in compliance with all
material terms and requirements of each Material Mitek Contract;
(ii) to
the
Knowledge of Mitek, each other Person that has any obligation or liability
under
any Material Mitek Contract, and at all times since January 1, 2003, has been,
in full compliance with all material terms and requirements of such Material
Mitek Contract;
(iii) to
the
Knowledge of Mitek, no event has occurred or circumstance exists that (with
or
without notice or lapse of time) may contravene, conflict with or result in
a
Breach of, or give Mitek or other Person the right to declare a default or
exercise any remedy under, or to accelerate the maturity or performance of,
or
payment under, or to cancel, terminate or modify, any Material Mitek Contract,
except where the occurrence of such event or existence of such circumstance
would not have a Mitek Material Adverse Effect;
(iv) to
the
Knowledge of Mitek, no event has occurred or circumstance exists under or by
virtue of any Material Mitek Contract that (with or without notice or lapse
of
time) would cause the creation of any Encumbrance affecting any of its assets
which would have a Mitek Material Adverse Effect; and
(v) Mitek
has
not given to or received from any other Person, at any time since January 1,
2003, any written notice or other written communication regarding any actual,
alleged, possible or potential violation or Breach of, or default under, any
Material Mitek Contract.
(e) There
are
no renegotiations of, written requests to renegotiate or outstanding rights
to
renegotiate any material amounts paid or payable to Mitek under any Mitek
Contracts.
(f) Each
Mitek Contract relating to the sale, design, manufacture or provision of
products or services by Mitek has been entered into in the Ordinary Course
of
Business of Mitek and has been entered into without the commission of any act
alone or in concert with any other Person, or any consideration having been
paid
or promised, that is or would be in violation of any Legal
Requirement.
5.20 Insurance.
(a) The
Mitek
Data Room contains:
(i) copies
of
all policies of insurance (and correspondence relating to coverage thereunder)
to which Mitek is a party or under which Mitek is or has been covered at any
time since January 1, 2003 a list of which is included in Part 5.20(a);
and
(ii) copies
of
all pending applications by Mitek for policies of insurance.
(b) Part
5.20(b) describes:
(i) any
self-insurance arrangement by or affecting Mitek, including any reserves
established thereunder and description of loss experience for all claims that
were self insured, including the number and aggregate cost of such
claims;
(ii) any
Contract or arrangement, other than a policy of insurance, for the transfer
or
sharing of any risk to which Mitek is a party or which involves the business
of
Mitek; and
(iii) all
obligations of Mitek to provide insurance coverage to Third Parties (for
example, under Leases or service agreements) and identifies the policy under
which such coverage is provided.
(c) Part
5.20(c) sets forth, by year, for the current policy year and each of the three
(3) preceding policy years, a summary of the loss experience for an amount
in
excess of Five Hundred Thousand Dollars ($500,000) under each policy of
insurance. Such summary includes the name of claimant, description of the policy
by insurer, type of insurance, and period of coverage and amount and brief
description of the claim.
(d) Except
as
set forth in Part 5.20(d):
(i) to
the
Knowledge of Parascript, all policies of insurance to which Mitek is a party
or
that provide coverage to Mitek are valid, outstanding and enforceable and are
sufficient for compliance with all Legal Requirements;
(ii) Mitek
has
not received (A) any refusal of coverage or any notice that a defense will
be
afforded with reservation of rights or (B) any written notice of cancellation
or
any other written indication that any policy of insurance is no longer in full
force or effect or that the issuer of any policy of insurance is not willing
or
able to perform its obligations thereunder;
(iii) Mitek
has
paid all premiums due, and has otherwise performed all of its obligations,
under
each policy of insurance to which it is a party; and
(iv) to
the
Knowledge of Mitek, Mitek has given notice to the insurer of all claims that
may
be insured thereby.
5.21 Employees.
(a) The
Mitek
Data Room contains a complete and accurate list of the following information
for
each employee, officer, independent contractor, consultant and agent of Mitek,
including each employee on leave of absence or layoff status: employer; name;
job title; date of hiring or engagement; date of commencement of employment
or
engagement; current compensation paid or payable and any change in compensation
since January 1, 2003; sick and vacation leave that is accrued but unused;
and
service credited for purposes of vesting and eligibility to participate under
any Mitek Employee Plan, or any other employee or director benefit plan. Part
5.21(a) contains a list of all retired employees of Mitek receiving any
retirement benefits from plans or arrangements maintained by Mitek and the
amounts thereof.
(b) Part
5.21(b) states the number of employees terminated by Mitek since January 1,
2003, and contains a complete and accurate list of the following information
for
each employee of Mitek who has been terminated or laid off, or whose hours
of
work have been reduced by more than fifty percent (50%) by Mitek, in the six
(6)
months prior to the date of this Agreement: (i)
the date
of such termination, layoff or reduction in hours; (ii)
the
reason for such termination, layoff or reduction in hours; and (iii)
the
location to which the employee was assigned, if applicable.
(c) Mitek
has
not violated the WARN Act or any similar state or local Legal Requirement.
During the ninety (90) day period prior to the date of this Agreement, Mitek
has
terminated no employees.
(d) To
the
Knowledge of Mitek, no officer, stockholder, director, agent, employee,
consultant, or contractor of Mitek is bound by any Contract that purports to
limit the ability of such Person (i) to engage in or continue or perform any
conduct, activity, duties or practice relating to the business of Mitek or
(ii)
to assign to Mitek or to any other Person any rights to any invention,
improvement, or discovery. No former or current employee of Mitek is a party
to,
or is otherwise bound by, any Contract that materially adversely affects the
ability of Mitek to conduct the business carried on by Mitek as of the date
hereof.
5.22 Labor
Disputes; Compliance.
(a) Mitek
has
complied in all material respects with all Legal Requirements relating to
employment practices, terms and conditions of employment, equal employment
opportunity, nondiscrimination, immigration, wages, hours, benefits, collective
bargaining and other requirements, the payment of social security and similar
Taxes and occupational safety and health. Mitek is not liable for the payment
of
any Taxes, fines, penalties, or other amounts, however designated, for failure
to comply with any of the foregoing Legal Requirements except where the failure
to comply would not have a Material Adverse Effect on Mitek.
(b) Except
as
disclosed in Part 5.22(b), (i)
Mitek
has not been, and is not now, a party to any collective bargaining agreement
or
other labor contract; (ii)
since
January 1, 2003, there has not been, there is not presently pending or existing,
and, to the Knowledge of Mitek, there is not threatened, any strike, slowdown,
picketing, work stoppage or employee grievance process involving Mitek;
(iii)
to the
Knowledge of Mitek, no event has occurred or circumstance exists that would
provide the basis for any work stoppage or other labor dispute; (iv)
there is
not pending or, to the Knowledge of Mitek, threatened against or affecting
Mitek
any Proceeding relating to the alleged violation of any Legal Requirement
pertaining to labor relations or employment matters, including any charge or
complaint filed with the National Labor Relations Board or any comparable
Governmental Body, and, to the Knowledge of Mitek, there is no organizational
activity or other labor dispute against or affecting Mitek; (v)
no
application or petition for an election of or for certification of a collective
bargaining agent is pending; (vi)
no
grievance or arbitration Proceeding exists that would have a Material Adverse
Effect upon Mitek or the conduct of its business; (vii)
there is
no lockout of any employees by Mitek, and no such action is contemplated by
Mitek; and (viii)
there
has been no charge of discrimination filed against or, to Mitek’s Knowledge,
threatened against Mitek with the Equal Employment Opportunity Commission or
similar Governmental Body.
5.23 Mitek
Intellectual Property Assets.
(a) The
term
“Mitek Intellectual Property Assets” means all intellectual property owned or
licensed (as licensor or licensee) by Mitek in which Mitek has a material
proprietary interest, including:
(i) Mitek’s
name, all assumed fictional business names, trade names, registered and
unregistered trademarks, service marks and applications owned by Mitek
(collectively, “Mitek Marks”);
(ii) all
patents, patent applications and inventions and discoveries that may be
patentable and owned by Mitek (collectively, “Mitek Patents”);
(iii) all
registered and unregistered copyrights in both published works and unpublished
works owned by Mitek (collectively, “Mitek Copyrights”);
(iv) all
rights in mask works owned by Mitek;
(v) all
know-how, trade secrets, confidential or proprietary information, customer
lists, source code to Software, technical information, data, process technology,
plans, drawings and blue prints owned by Mitek (collectively, “Mitek Trade
Secrets”); and
(vi) all
rights in internet web sites and internet domain names presently owned by Mitek
(collectively “Mitek Net Names”).
(b) Part
5.23(b) contains a complete and accurate list and summary description including
royalties paid or received by Mitek and the Mitek Data Room contains accurate
and complete copies of all Mitek Contracts (other than Material Mitek Contracts
referred to in Section 5.19 or listed in Part 5.19) relating to the
Mitek Intellectual Property Assets, except for any license implied by the sale
of a product, Mitek Contracts related to the distribution, resale or similar
arrangement of Mitek Intellectual Property Assets in the Ordinary Course of
Business and licenses for commonly available Software programs under which
Mitek
is the licensee. There are no outstanding and, to the Knowledge of Mitek, no
threatened disputes or to disagreements with respect to any such
Contract.
(c) Except
as
set forth in Part 5.23(c),
(i) the
Mitek
Intellectual Property Assets are all those used in the operation of Mitek’s
business as it is currently conducted. Mitek is the owner or licensee of all
right, title and interest in and to each of the Mitek Intellectual Property
Assets, and has the right to use all of the Mitek Intellectual Property Assets,
subject to any Mitek Contracts with Third Parties related to such Mitek
Intellectual Property Assets which are listed on Part 5.23(c).
(ii) all
former and current employees of Mitek have executed written Contracts with
Mitek
that assign to Mitek all rights to any inventions, improvements, discoveries
or
information relating to the business of Mitek.
(iii) all
contracts or license agreements with any Related Person of Mitek are arms-length
transactions.
(d) Part
5.23(d) contains a complete and accurate list of all Mitek Patents. With respect
to subsections (i), (ii) and (iii) below, except where the failure to do so
or
failure thereof would not have a Mitek Material Adverse Effect:
(i) All
of
the issued Mitek Patents are currently in compliance with formal legal
requirements (including payment of filing, examination and maintenance fees
and
proofs of working or use), are valid and enforceable, and are not subject to
any
maintenance fees or taxes or actions falling due within ninety (90) days after
the Closing Date.
(ii) No
Mitek
Patent has been or is now involved in any interference, reissue, reexamination,
or opposition Proceeding. To the Knowledge of Mitek, there is no potentially
interfering patent or patent application of any Third Party.
(iii) Except
as
set forth in Part 5.23(d), to the Knowledge of Mitek (A) no Mitek Patent is
infringed or has been challenged or threatened in any way and (B) none of the
products manufactured or sold, nor any process or know-how used, by Mitek
infringes or is alleged to infringe any patent or other proprietary right of
any
other Person.
(e) Part
5.23(e) contains a complete and accurate list of all Mitek Marks. With respect
to subsections (i), (ii), (iii) and (iv) below, except where the failure to
do
so or failure thereof would not have a Mitek Material Adverse
Effect:
(i) All
Mitek
Marks that have been registered with the United States Patent and Trademark
Office, are currently in compliance with all formal Legal Requirements
(including the timely post-registration filing of affidavits of use and
incontestability and renewal applications), and are valid and enforceable and
are not subject to any maintenance fees or taxes or actions falling due within
ninety (90) days after the Closing Date.
(ii) No
Mitek
Mark has been or is now involved in any opposition, invalidation or cancellation
Proceeding and no such action is, to Mitek’s Knowledge, threatened with respect
to any of the Mitek Marks.
(iii) There
is,
to Mitek’s Knowledge, no potentially interfering trademark or trademark
application of any other Person related to any Mitek Marks.
(iv) To
Mitek’s Knowledge, no Mitek Mark is infringed or has been challenged or
threatened in any way. None of the Mitek Marks infringes or is alleged to
infringe any trade name, trademark or service mark of any other
Person.
(f) Part
5.23(f) contains a complete and accurate list of all Mitek Copyrights. With
respect to subsections (i) and (ii) below, except where the failure to do so
or
failure thereof would not have a Mitek Material Adverse Effect:
(i) All
of
the registered Mitek Copyrights are currently in compliance with formal Legal
Requirements, and are valid and enforceable, and are not subject to any
maintenance fees or taxes or actions falling due within ninety (90) days after
the date of Closing.
(ii) To
Mitek’s Knowledge, no Mitek Copyright is infringed or has been challenged or
threatened in any way. None of the subject matter of any of the Mitek Copyrights
infringes or is alleged to infringe any copyright of any Third Party or is
a
derivative work based upon the work of any other Person.
(g) Mitek
has
taken reasonable precautions to protect the secrecy, confidentiality and value
of its material Mitek Trade Secrets. No Mitek Trade Secret is subject to any
adverse claim or has been challenged or, to Mitek’s Knowledge, threatened in any
way or infringes any intellectual property right of any other
Person.
(h) Part
5.23(h) contains a complete and accurate list of all Mitek Net Names. With
respect to subsections (i), (ii), (iii) and (iv) below, except where the failure
to do so or failure thereof would not have a Mitek Material Adverse
Effect:
(i) All
Mitek
Net Names have been registered in the name of Mitek and are in compliance with
all formal Legal Requirements.
(ii) No
Mitek
Net Name has been or is now involved in any dispute, opposition, invalidation
or
cancellation Proceeding and no such action is, to Mitek’s Knowledge, threatened
with respect to any Mitek Net Name.
(iii) To
the
Knowledge of Mitek, there is no domain name application pending of any other
person which would or would potentially interfere with or infringe any Mitek
Net
Name.
(iv) To
the
Knowledge of Mitek, no Mitek Net Name is infringed or has been challenged,
interfered with or threatened in any way. No Mitek Net Name infringes,
interferes with or is alleged to interfere with or infringe the trademark,
copyright or domain name of any other Person.
5.24 Relationships
With Related Persons.
Except
as disclosed in Part 5.24, no Related Person of Mitek has, or since January
1,
2003, has had, any interest in any of Mitek’s assets. No Related Person of Mitek
owns, or since January 1, 2003, has owned, of record or as a beneficial owner,
an equity interest or any other financial or profit interest in any Person
that
has had business dealings or a material financial interest in any transaction
with Mitek other than business dealings or transactions disclosed in Part 5.24,
each of which has been conducted in the Ordinary Course of Business with Mitek
at substantially prevailing market prices and on substantially prevailing market
terms. Except as set forth in Part 5.24, no Related Person of Mitek is a party
to any Contract with, or has any claim or right against, Mitek.
5.25 Brokers
or Finders.
Except
as disclosed in Part 5.25, neither Mitek nor any of its Representatives have
incurred any obligation or liability, contingent or otherwise, for brokerage
or
finders’ fees or agents’ commissions or other similar payments in connection
with the Contemplated Transactions.
5.26 SEC
Reports.
(a) Mitek
has
filed all reports, schedules, forms, certifications, statements and other
documents required to be filed by Mitek with the SEC (the “Mitek SEC
Documents”). All Mitek SEC Documents are available from the SEC on the EDGAR
System or in the Mitek Data Room.
(b) As
of its
respective date, each Mitek SEC Document complied in all material respects
with
the requirements of the Exchange Act or the Securities Act, as the case may
be,
and the rules and regulations of the SEC promulgated thereunder applicable
to
such Mitek SEC Document, and did not contain any untrue statement of a material
fact or omit to state a material fact required to be stated therein or necessary
in order to make the statements therein, in light of the circumstances under
which they were made, not misleading. Except to the extent that information
contained in any Mitek SEC Document has been revised or superseded by a later
filed Mitek SEC Document, none of the Mitek SEC Documents contains any untrue
statement of a material fact or omits to state any material fact required to
be
stated therein or necessary in order to make the statements therein, in light
of
the circumstances under which they were made, not misleading. The consolidated
financial statements of Mitek included in the Mitek SEC Documents comply as
to
form in all material respects with applicable accounting requirements and the
published rules and regulations of the SEC with respect thereto, have been
prepared in accordance with GAAP (except, in the case of unaudited statements,
as permitted by Form 10-QSB of the SEC) applied on a consistent basis during
the
periods involved (except as may be indicated in the notes thereto) and fairly
present the consolidated financial position of Mitek as of the dates thereof
and
the consolidated results of its operations and cash flows for the periods shown
(subject, in the case of unaudited statements, to normal year-end audit
adjustments). The principal executive officer of Mitek and the principal
financial officer of Mitek have made all certifications required by Sections
302
and 906 of the Sarbanes-Oxley Act of 2002 and the rules and regulations of
the
SEC promulgated thereunder (the “Sarbanes-Oxley Act”) with respect to the Mitek
SEC Documents. For purposes of the preceding sentence, “principal executive
officer” and “principal financial officer” shall have the meanings given to such
terms in the Sarbanes-Oxley Act. As used in this Section 5.26, the term “file”
shall be broadly construed to include any manner in which a document or
information is furnished, supplied or otherwise made available to the
SEC.
5.27 NASDAQ
Listing.
Mitek
represents that shares of Common Stock were delisted from the NASDAQ SmallCap
Market following a hearing before a Nasdaq Listing Qualifications Panel on
April
22, 2004, and that Nasdaq informed Mitek the delisting was due to Mitek’s
failure to satisfy the $2.5 million shareholder’s equity requirement as of
December 31, 2003. Mitek further represents that it knows of no other reasons
for delisting or impediments to relisting other than the normal requirements
of
the NASDAQ SmallCap Market.
5.28 The
Mitek Data Room.
Mitek
has established a limited access, coded data room through the services of
Merrill Corporation as a repository for certain of Mitek’s documents and
information in electronically readable and retrievable form. The phrase “The
Mitek Data Room contains. . .” means that the document, list, schedule or other
information or matter referred to as being contained in the Mitek Data Room
is a
true and complete copy of the original of the referenced document, is a complete
and accurate listing, schedule or other presentation of information or matter
to
which reference is made (unless otherwise clearly noted or explained in such
reference), is listed in and may be located by referring to the index for the
contents of the Mitek Data Room and is readable by computer access and may
be
reproduced in full by printer.
5.29 Disclosure.
No
representation or warranty or other statement made by Mitek in this Agreement,
the Mitek Disclosure Letter, any supplement to the Mitek Disclosure Letter,
any
certificate delivered by Mitek pursuant to this Agreement and any information
provided by Mitek for use in the Registration Statement or the Proxy Statement
or otherwise in connection with the Contemplated Transactions contains any
untrue statement or omits to state a material fact necessary to make any of
them, in light of the circumstances in which it was made, not
misleading.
6. COVENANTS
OF PARASCRIPT PRIOR TO CLOSING.
6.1
Access
and Investigation.
Between
the date of this Agreement and the Closing Date, and upon reasonable advance
notice received from Mitek, Parascript shall during regular business hours,
(a)
afford
Mitek and its Representatives and prospective investors and/or lenders and
their
Representatives (collectively, “Mitek Group”) full and free access to
Parascript’s personnel, properties, Contracts, Governmental Authorizations,
books and Records and other documents and data, such rights of access to be
exercised in a manner that does not unreasonably interfere with the operations
of Parascript; (b)
furnish
Mitek Group with copies of all such Contracts, Governmental Authorizations,
books and Records and other existing documents and data as Mitek may reasonably
request; (c)
furnish
Mitek Group with such additional financial, operating and other relevant data
and information as Mitek may reasonably request; and (d)
otherwise cooperate and assist, to the extent reasonably requested by Mitek,
with Mitek’s investigation of the properties, assets and financial condition
related to Parascript. In addition, Mitek shall have the right to have the
Real
Property of Parascript and Tangible Personal Property of Parascript inspected
by
Mitek Group, at Mitek’s sole cost and expense, for purposes of determining the
physical condition and legal characteristics of such Real Property and Tangible
Personal Property, upon reasonable advance notice and during regular business
hours of Parascript.
6.2 Operation
of the Business of Parascript.
Between
the date of this Agreement and the Closing, Parascript shall, except for actions
related to the Contemplated Transactions, including the AIS
Separation:
(a) conduct
its business only in its Ordinary Course of Business;
(b) use
its
commercially reasonable efforts subject to its business judgment to preserve
intact its current business organization, keep available the services of its
officers, employees and agents and maintain its relations and good will with
suppliers, customers, landlords, creditors, employees, agents and others having
business relationships with it;
(c) make
no
distributions of cash in excess of $1,694,472, other than distributions in
the
aggregate amount of Three Hundred Sixty Thousand Dollars ($360,000) per month
to
certain Members in Parascript’s Ordinary Course of Business and the
distributions provided for in Section 7.5;
(d) confer
with Mitek prior to implementing material operational decisions outside
Parascript’s Ordinary Course of Business or Parascript’s current business
plan;
(e) otherwise
verbally report periodically to Mitek upon Mitek’s reasonable request concerning
the overall status of its business, operations and finances;
(f)
make
no
material changes in management personnel without prior consultation with
Mitek;
(g) maintain
Parascript’s assets in a state of repair and condition that complies with Legal
Requirements and is consistent with Parascript’s Ordinary Course of
Business;
(h) keep
in
full force and effect, without amendment, all material rights relating to
Parascript’s business;
(i)
comply
with all Legal Requirements and contractual obligations applicable to the
operations of Parascript’s business in all material respects;
(j)
continue
in full force and effect its current insurance coverage;
(k) except
as
required to comply with ERISA or to maintain qualification under Section 401(a)
of the Code, not amend, modify or terminate any Parascript Employee Plan without
the express written consent of Mitek, and except as required under the
provisions of any Parascript Employee Plan, not make any contributions to or
with respect to any Parascript Employee Plan without the express written consent
of Mitek;
(l) cooperate
with Mitek and assist Mitek in identifying the Governmental Authorizations
required by Mitek to operate the business from and after the Closing Date and
either transferring existing Governmental Authorizations of Parascript to Mitek,
where permissible, or obtaining new Governmental Authorizations for
Mitek;
(m) upon
request from time to time, execute and deliver all documents, make all truthful
oaths, testify in any Proceedings and do all other acts that may be reasonably
necessary or desirable in the opinion of Mitek to consummate the Contemplated
Transactions, all without further consideration; and
(n) maintain
in the Ordinary Course of Business all books and Records of Parascript relating
to Parascript’s business.
6.3 Negative
Covenant.
Except
as otherwise expressly permitted herein or as necessary or desirable regarding
the AIS Separation, between the date of this Agreement and the Closing Date,
Parascript shall not, without the prior written Consent of Mitek which shall
not
be unreasonably withheld, conditioned or delayed,
(a) take
any
affirmative action, or fail to take any reasonable action within its control,
as
a result of which any of the changes or events listed in Sections 3.14 or 3.18
would be likely to occur;
(b) enter
into any compromise or settlement of any litigation, proceeding or governmental
investigation relating to Parascript’s assets, the business of Parascript or
Parascript’s Liabilities.
(c) increase
the compensation payable to or to become payable to any executive
officer;
(d) acquire
or agree to acquire, by merging or consolidating with, by purchasing an equity
interest in or a portion of the assets of, or by any other manner, any business
or any corporation, partnership, association or other business organization
or
division thereof, or otherwise acquire or agree to acquire any assets of any
other person (other than the purchase of assets from suppliers or vendors in
Parascript’s Ordinary Course of Business);
(e) sell,
lease, exchange, mortgage, pledge, transfer or otherwise dispose of, or agree
to
sell, lease, exchange, mortgage, pledge, transfer or otherwise dispose of,
any
of its material assets or any material assets of any of its
subsidiaries;
(f) release
any third party from its obligations, or grant any consent, under any existing
standstill provision relating to a Competing Transaction or otherwise under
any
confidentiality or other agreement, or fail to fully enforce any such
agreement;
(g) change
any of its methods of accounting in effect at December 31, 2005, or make or
rescind any express or deemed election relating to Taxes, settle or compromise
any claim, action, suit, litigation, proceeding, arbitration, investigation,
audit or controversy relating to Taxes (except where the amount of such
settlements or controversies, individually or in the aggregate, does not exceed
Twenty Five Thousand Dollars ($25,000)), or change any of its methods of
reporting income or deductions for federal income tax purposes from those
employed in the preparation of the federal income tax returns for the taxable
year ended December 31, 2005, except, in each case, as may be required by law
or
GAAP;
(h) incur
any
obligation for borrowed money or purchase money indebtedness or guarantee,
whether or not evidenced by a note, bond, debenture or similar instrument,
except in the Ordinary Course of Business consistent with past practice, and
in
no event in excess of the limit on Advances (as defined in the Loan Agreement)
under the Loan Agreement in the aggregate;
(i) enter
into any material arrangement, agreement or contract with any third party which
provides for an exclusive arrangement with that third party or is substantially
more restrictive on Parascript or substantially less advantageous to Parascript
than arrangements, agreements or contracts existing on the date
hereof;
(j) adopt
a
plan of complete or partial liquidation, dissolution, merger, consolidation,
restructuring, recapitalization or other material reorganization of
Parascript;
(k) pay,
discharge or satisfy any claims, liabilities or obligations (absolute, accrued,
asserted or unasserted, contingent or otherwise), other than the payment,
discharge or satisfaction of any such claims, liabilities or obligations: (i)
incurred in its Ordinary Course of Business, or (ii) which are legally required
to be paid, discharged or satisfied;
(l) knowingly
take, or agree to commit to take, any action that would make any representation
or warranty of Parascript contained herein inaccurate in any respect at, or
as
of any time prior to, the Closing Date;
(m) agree
to
or approve any commitment, including any authorization for expenditure or
agreement to acquire property, obligating Parascript for an amount in excess
of
Five Hundred Thousand Dollars ($500,000); or
(n) agree
in
writing or otherwise to do any of the foregoing.
6.4 Required
Approvals.
As
promptly as practicable after the date of this Agreement, Parascript shall
make
all filings, including, but not limited to, all foreign filings, required by
Legal Requirements to be made by it in order to consummate the Contemplated
Transactions. Parascript also shall cooperate with Mitek and its Representatives
with respect to all filings that Mitek elects to make or, pursuant to Legal
Requirements, shall be required to make in connection with the Contemplated
Transactions. Parascript also shall cooperate with Mitek and its Representatives
in obtaining all Parascript Consents.
6.5 Notification.
Between
the date of this Agreement and the Closing, Parascript shall promptly
notify Mitek in writing if it becomes aware of (a)
any fact
or condition that causes or constitutes a Breach of any of Parascript’s
representations and warranties contained in Article 3 made as of the date
of this Agreement or (b)
the
occurrence after the date of this Agreement of any fact or condition that would
be reasonably likely to (except as expressly contemplated by this Agreement)
cause or constitute a Breach of any such representation or warranty had that
representation or warranty been made as of the time of the occurrence of, or
Parascript’s discovery of, such fact or condition. Should any such fact or
condition require any change to the Parascript Disclosure Letter, Parascript
shall promptly deliver to Mitek a supplement to the Parascript Disclosure Letter
specifying such change. Such delivery shall not affect any rights of Mitek
under
Sections 11.2
(Effect
of Termination), 11.3
(Fees,
Expenses and Other Payments) or Article 14 (Indemnification; Remedies). During
the same period, Parascript also shall promptly notify Mitek of the occurrence
of any Breach of any covenant of Parascript in this Article 6 or of the
occurrence of any event that may make the satisfaction of the conditions in
Article 9 impossible or unlikely.
6.6 No
Shopping.
Until
such time as this Agreement shall be terminated pursuant to Section 11.1,
Parascript shall not, and shall cause Parascript’s Representatives not to,
directly or indirectly solicit, initiate, encourage or entertain any inquiries
or proposals from, discuss or negotiate with, provide any nonpublic information
to or consider the merits of any inquiries or proposals from any Person (other
than Mitek) relating to any Acquisition Proposal. Parascript shall notify Mitek
of any such inquiry or proposal within twenty-four (24) hours of receipt or
awareness of the same by Parascript. Notwithstanding the foregoing, prior to
the
approval of this Agreement by the Members of such Parascript, this Section
6.6
shall not prohibit Parascript from furnishing nonpublic information regarding
Parascript to, or entering into discussions with, any person, group or entity
in
response to any such inquiry or proposal that is submitted to Parascript by
such
person, group or entity (and not withdrawn) if the boards of directors (or
similar governing body) of Parascript concludes in good faith, after having
taken into account the advice of its outside legal counsel, that such action
is
required in order for the board of directors (or similar governing body) of
Parascript to comply with its fiduciary obligations to Parascript’s Members
under applicable Law.
6.7 Best
Efforts.
Parascript shall use its Best Efforts to cause the conditions in Article 9
to be
satisfied.
6.8 Interim
Financial Statements.
Until
the Closing Date, Parascript shall deliver to Mitek within ten (10) days after
the end of each month a copy of Parascript’s unaudited financial statements for
such month prepared in a manner and containing information consistent with
Parascript’s current practices and certified by such Parascript’s chief
financial officer as to compliance with Section 3.4.
6.9 Payment
of Liabilities.
Parascript shall pay or otherwise satisfy in the Ordinary Course of Business
all
of its Liabilities as such Liabilities become due and payable. Mitek and
Parascript hereby waive compliance with the bulk-transfer provisions of the
Uniform Commercial Code (or any similar law) (“Bulk Sales Laws”) in connection
with the Contemplated Transactions.
7. ADDITIONAL
AGREEMENTS.
7.1 Preparation
of the Proxy Statement; Mitek Stockholders Meeting; Parascript Members
Meeting.
(a) As
soon
as practicable following the date of this Agreement, Mitek shall, with the
cooperation and participation of Parascript, which shall include the prompt
provision of information reasonably requested by Mitek, prepare and after
receipt of approval by Parascript which approval shall not be unreasonably
withheld, conditioned or delayed, file with the SEC the proxy statement in
preliminary form (the “Proxy Statement”), and each of Parascript and Mitek shall
use its commercially reasonable efforts to respond as promptly as practicable
to
any comments of the SEC with respect thereto. Mitek shall use its Best Efforts
to (i) prepare and file with the SEC the definitive Proxy Statement,
(ii) cause the Proxy Statement and the prospectus to be included in the
Registration Statement (as that term is defined below), including any amendment
or supplement thereto, and (iii) to cause the definitive Proxy Statement to
be mailed to Mitek’s stockholders as promptly as practicable after the Registration
Statement is declared effective by the SEC. Mitek shall also take any action
required to be taken under any applicable state securities laws in connection
with the issuance of Mitek common stock in the Contemplated Transactions. The
parties shall notify each other promptly of the receipt of any comments from
the
SEC or its staff and of any request by the SEC or its staff for amendments
or
supplements to the Proxy Statement or for additional information and shall
supply each other with copies of all correspondence between such or any of
its
representatives, on the one hand, and the SEC or its staff, on the other hand,
with respect to the Proxy Statement or the Contemplated
Transactions.
(b) As
soon
as practicable following the date of this Agreement, Mitek, with the cooperation
and participation of Parascript, which shall include the prompt provision of
information reasonably requested by Mitek, shall prepare and, after receipt
of
approval by Parascript, which approval shall not be unreasonably withheld,
conditioned or delayed, file with the SEC a Registration Statement on Form
S-4
(the “Registration Statement”), in which the Proxy Statement shall be included
as part of the prospectus, and the parties hereto shall each use their Best
Efforts to have the Registration Statement declared effective by the SEC as
promptly as practicable after such filing. Mitek shall after consultation with
Parascript, respond promptly to any comments made by the SEC with respect to
the
Registration Statement. Mitek shall allow Parascript’s full participation in the
preparation of the Registration Statement and any amendment or supplement
thereto and shall consult with Parascript and its advisors concerning any
comments from the SEC with respect thereto.
(c) If,
prior
to the Closing, any event occurs with respect to Parascript, or any change
occurs with respect to other information supplied by Parascript for inclusion
in
the Proxy Statement or Registration Statement, which is required to be described
in an amendment of, or a supplement to, the Proxy Statement or Registration
Statement, Parascript shall promptly notify Mitek of such event, and Parascript
and Mitek shall cooperate in the prompt filing with the SEC of any necessary
amendment or supplement to the Proxy Statement or Registration Statement and,
as
required by Law, in disseminating the information contained in such amendment
or
supplement to Mitek’s stockholders.
(d) If,
prior
to the Closing, any event occurs with respect to Mitek, or any change occurs
with respect to other information supplied by Mitek for inclusion in the Proxy
Statement or Registration Statement, which is required to be described in an
amendment of, or a supplement to, the Proxy Statement or Registration Statement,
Mitek shall promptly notify Parascript of such event, and Mitek and Parascript
shall cooperate in the prompt filing with the SEC of any necessary amendment
or
supplement to the Proxy Statement or Registration Statement and, as required
by
Law, in disseminating the information contained in such amendment or supplement
to Mitek’s stockholders.
(e) Mitek
shall, promptly after the date hereof, take all action necessary to duly call,
give notice of, convene and hold a meeting of its stockholders (the “Mitek
Stockholders Meeting”) as soon as practicable after the Registration Statement
is declared effective. Mitek shall use its Best Efforts to cause the Proxy
Statement to be mailed to Mitek’s stockholders as soon as practicable after the
Registration Statement is declared effective. Mitek shall, through its board
of
directors, recommend to its stockholders that they approve the Contemplated
Transactions, the Merger, the Mitek Name Change, the Amendment to the
Certificate of Incorporation increasing the number of authorized shares of
Mitek’s common stock from 40,000,000 to 200,000,000 (as such number may be
proportionally adjusted as a result of the reverse stock split referred to
in
Section 12.1) (the “Certificate Amendment”) and the composition of the Board of
Directors as set forth in Section 10.11, the amendment of the current Mitek
Systems, Inc. 2006 Stock Option Plan or adoption of a new stock option plan
that
increases the number of shares of Mitek common stock available thereunder to
23,000,000 (as such number may be proportionally adjusted as a result of the
reverse stock split referred to in Section 12.1) shares, except to the extent
that Mitek’s board of directors shall have withdrawn its approval or
recommendation of this Agreement and the Contemplated Transactions, which
withdrawal may be made only if deemed by Mitek’s board of directors to be
necessary in order to comply with its fiduciary duties. Notwithstanding any
other provision thereof, Mitek shall not be restricted from complying with
any
of its obligations under the Exchange Act.
(f) Parascript
shall take all action necessary to duly call, give notice of, convene and hold
a
meeting of its Members (the “Parascript Meeting”), as soon as practicable after
the Registration Statement is declared effective. Parascript shall use its
commercially reasonable efforts to cause the Proxy Statement to be mailed to
the
Members as soon as practicable after the Registration Statement is declared
effective. Parascript shall, through its Managing Member or equivalent governing
body, recommend to the Members that they approve the Contemplated Transactions
and the Merger, except to the extent that Parascript’s Managing Member or
equivalent governing body shall have withdrawn its approval or recommendation
of
this Agreement and the Contemplated Transactions, which withdrawal may be made
only if deemed by Parascript’s Managing Member or equivalent governing body to
be necessary in order to comply with its fiduciary duties.
7.2 Initial
Disclosure Letter.
Concurrently with the execution of this Agreement, Parascript shall deliver
a
Parascript Disclosure Letter to Mitek and Mitek shall deliver a Mitek Disclosure
Letter to Parascript. Such Parascript Disclosure Letter and Mitek Disclosure
Letter (each an “Initial Disclosure Letter” and collectively, the “Initial
Disclosure Letters”) shall (i)
be
arranged in sections and subsections corresponding to the sections and
subsections contained in Sections 3
and 5,
respectively, and the disclosure in any section or subsection of the Initial
Disclosure Letters shall qualify only the corresponding section or subsection
in
Section 3
or
Section 5, as the case may be, unless it is reasonably apparent that the
disclosure in any section or subsection of such Initial Disclosure Letters
should apply to one or more other sections or subsections thereof, (ii) constitute
representations and warranties of the respective parties, and (iii) be
updated, amended and supplemented, as appropriate through the Supplemental
Disclosure Letter(s) (as defined below) through the Closing, so that the
Parascript Disclosure Letter and Mitek Disclosure Letter shall, as of the
Closing, contain accurate, true and correct information and data, and shall
be
executed by Parascript, on one hand, or Mitek on the other, and dated the
Closing Date. Terms used and defined in this Agreement shall have the same
definition when used in the Initial Disclosure Letter and the Supplemental
Disclosure Letter. If there is any inconsistency between the statements in
this
Agreement and those in such Disclosure Letter (other than an exception expressly
set forth as such in such Disclosure Letter with respect to a specifically
identified representation or warranty), the statements in this Agreement will
control.
7.3 Supplemental
Disclosure Letter.
Parascript and Mitek agree that, with respect to their respective Initial
Disclosure Letter, they shall have the continuing obligation until the Closing
Date to supplement, modify or amend promptly their respective Initial Disclosure
Letter with respect to (a)
any
matter occurring after the date hereof that, if existing or occurring on or
before the date of this Agreement, would have been required to be set forth
or
described in the Initial Disclosure Letter (the “New Matters”), and (b)
other
matters which are not New Matters but should have been set forth or described
in
the Initial Disclosure Letter as of the date hereof (the “Other Matters”). Any
such supplement, modification or amendment (each a “Supplemental Disclosure
Letter” and, collectively, the “Supplemental Disclosure Letters”) (i)
that
reflects a New Matter shall qualify the representations and warranties of
Parascript or Mitek, as the case may be, for all purposes of this Agreement,
and
(ii)
that
reflects one or more Other Matters shall not qualify any of the representations
or warranties of Parascript or Mitek, as the case may be, for any purpose under
this Agreement, and shall be provided solely for informational purposes and
(iii) shall constitute representations and warranties of the respective
parties. On or before the Closing Date, Parascript will prepare and deliver
to
Mitek and Mitek will prepare and deliver to Parascript a copy of the
Supplemental Disclosure Letter revised to reflect any supplement, modification
or amendment required pursuant to this Section 7.3.
Parascript and Mitek shall deliver their respective Supplemental Disclosure
Letter at least five (5) Business Days before the Closing Date. If no
Supplemental Disclosure Letter satisfying the foregoing requirements is provided
by Parascript or Mitek, as the case may be, the Initial Disclosure Letter as
delivered upon the execution of this Agreement shall continue to
apply.
If there
is any inconsistency between the statements in this Agreement and those in
such
Disclosure Letter (other than an exception expressly set forth as such in such
Disclosure Letter with respect to a specifically identified representation
or
warranty), the statements in this Agreement will control.
7.4 Authorization
of the Member Representative.
(a) The
Member Representative is authorized and empowered to act as a representative
for
the benefit of the each Member as the exclusive agent and attorney-in-fact
with
the power and authority to act on behalf of each Member in connection with
and
to facilitate the consummation of the Merger and the other transactions
contemplated herein, including pursuant to the Escrow Agreement, which shall
include the power and authority:
(i) to
execute and deliver the Escrow Agreement (with such modifications or changes
therein as to which the Member Representative, in its sole discretion, shall
have consented) and to agree to such amendments or modifications thereto as
the
Member Representative, in its sole discretion, determines to be
desirable;
(ii) to
execute and deliver such waivers and consents in connection with this Agreement
and the Escrow Agreement and the consummation of the transactions contemplated
hereby and thereby as the Member Representative, in its sole discretion, may
deem necessary or desirable;
(iii) as
the
Member Representative, to enforce and protect the rights and interests of the
Members (including, if applicable, the Member Representative, in its capacity
as
a Member or affiliate of a Member) and to enforce and protect the rights and
interests of the Member Representative arising out of or under or in any manner
relating to this Agreement and the Escrow Agreement, and each other agreement,
document, instrument or certificate referred to herein or therein or the
transactions provided for herein (including in connection with any and all
claims for reimbursement or indemnification as the case may be), and to take
any
and all actions that the Member Representative believes are necessary or
appropriate under the Escrow Agreement or this Agreement for and on behalf
of
the Members, including defending any claims by any Mitek Indemnified Person
or
the Surviving Company, consenting to, compromising or settling any such claims,
conducting negotiations with any Mitek Indemnified Person, the Surviving Company
and their respective representatives regarding such claims, and, in connection
therewith, to investigate, defend, contest or litigate any claim initiated
by
any Mitek Indemnified Person, the Surviving Company, or any other Person, or
by
any federal, state or local Governmental Body against the Member Representative
or any Member, and receive process on behalf of any or all Members in any such
claim and compromise or settle on such terms as the Member Representative shall
determine to be appropriate, and give receipts, releases and discharges with
respect to, any such claim; file any proofs of debt, claims and petitions as
the
Member Representative may deem advisable or necessary; settle or compromise
any
claims asserted under the Escrow Agreement; and file and prosecute appeals
from
any decision, judgment or award rendered in any such claim;
(iv) to
refrain from enforcing any right of the Members or any of them or the Member
Representative arising out of or under or in any manner relating to this
Agreement or the other documents contemplated herein; provided,
however,
that no
such failure to act on the part of the Member Representative, except as
otherwise provided in this Agreement or in the Escrow Agreement, shall be deemed
a waiver of any such right or interest by the Member Representative or by the
Members unless such waiver is in writing signed by the waiving party;
and
(v) to
make,
execute, acknowledge and deliver all such other agreements, guarantees, orders,
receipts, endorsements, notices, requests, instructions, certificates, stock
powers, letters and other writings, and, in general, to do any and all things
and to take any and all action that the Member Representative, in its sole
and
absolute discretion, may consider necessary or proper or convenient in
connection with or to carry out the transactions contemplated by this Agreement
or the other documents contemplated herein.
(b) The
Member Representative shall not be entitled to any fee, commission or other
compensation for the performance of its services hereunder, but shall be
entitled to the payment of all its expenses incurred as the Member
Representative. In connection with the foregoing, at the Closing, the Surviving
Company shall transfer $50,000 (the “Expense Funds”) to the Member
Representative, to be used by the Member Representative to pay expenses incurred
by the Member Representative in its capacity as the Member Representative.
Once
the Member Representative determines, in its sole discretion, that the Member
Representative will not incur any additional expenses in its capacity as the
Member Representative, then the Member Representative will appropriately
distribute the remaining unused Expense Funds, if any, to the Members. In
connection with this Agreement and the other documents contemplated herein,
and
in exercising or failing to exercise all or any of the powers conferred upon
the
Member Representative hereunder, the Member Representative shall (i) incur
no responsibility whatsoever to any Members by reason of any error in judgment
or other act or omission performed or omitted hereunder or in connection with
any other Merger Document, excepting only responsibility for any act or failure
to act which represents gross negligence or willful misconduct, and (ii) be
entitled to rely on the advice of counsel, public accountants or other
independent experts experienced in the matter at issue, and any error in
judgment or other act or omission of the Member Representative pursuant to
such
advice shall in no event subject the Member Representative to liability to
any
Members. Each Member shall indemnify, pro rata based on the amount of
consideration such holder received in connection with the Merger in respect
of
such holder’s Units, the Member Representative against all losses, damages,
liabilities, claims, obligations, costs and expenses, including reasonable
attorneys’, accountants’ and other experts’ fees and the amount of any judgment
against them, of any nature whatsoever (including any and all expense whatsoever
reasonably incurred in investigating, preparing or defending against any
litigation, commenced or threatened or any claims whatsoever), arising out
of or
in connection with any claim, investigation, challenge, action or proceeding
or
in connection with any appeal thereof, relating to the acts or omissions of
the
Member Representative hereunder, or under the Escrow Agreement or otherwise.
The
foregoing indemnification shall not apply in the event of any action or
proceeding which finally adjudicates the liability of the Member Representative
hereunder for its gross negligence or willful misconduct. In the event of any
indemnification under this section, upon written notice from the Member
Representative to the Members as to the existence of a deficiency toward the
payment of any such indemnification amount, each Member shall promptly deliver
to the Member Representative full payment of his or her ratable share of the
amount of such deficiency based upon such holder’s share of the number of Units
outstanding immediately prior to the Closing.
(c) All
of
the indemnities, immunities and powers granted to the Member Representative
under this Agreement shall survive the Effective Time or any termination of
this
Agreement or the Escrow Agreement.
(d) Mitek
and
Surviving Company shall have the right to rely upon all actions taken or omitted
to be taken by the Member Representative pursuant to this Agreement and the
Escrow Agreement, all of which actions or omissions shall be legally binding
upon the Members.
(e) The
grant
of authority provided for herein (i) is coupled with an interest and shall
be irrevocable and survive the death, incompetency, bankruptcy or liquidation
of
any Member and (ii) shall survive the consummation of the
Merger.
7.5 Tax
Distributions.
(a) Prior
to
the Closing Date, in the event Parascript, from time to time, determines to
make
tax distributions to Members with respect to Taxable Income (as defined below),
Parascript shall, at least five (5) Business Days prior to such a tax
distribution, provide to Mitek a statement, along with supporting workpapers
(each, a “Tax Distribution Statement”) which shall set forth the estimated
amount of Parascript’s taxable income (as such term is defined under
Section 702(a)(8) of the Code) for the relevant period, with the first such
period beginning on January 1, 2006, and the last such period ending on the
Closing Date (for the avoidance of doubt, the taxable income so determined
shall
not include any taxable income resulting from the consummation of the Merger)
(the “Taxable Income”). The Taxable Income reflected on each Tax Distribution
Statement shall be determined in a manner consistent with past practice.
Notwithstanding any other provision in this Agreement, from time to time at
or
before the Closing Date, Parascript shall be entitled to distribute to, and/or
withhold and pay to an applicable taxing authority on behalf of Members, an
amount, if any, equal to 30 percent of the Taxable Income as shown on the
applicable Tax Distribution Statement (the “Tax Distribution
Amount”).
(b) Following
the determination of the Final Taxable Income (as defined below), in the event
that there is a Positive Adjustment Amount (as defined below), Mitek shall
pay
to the Members by making a lump sum payment to the Member Representative, or
a
person designated by the Member Representative, of the Positive Adjustment
Amount, on an equal per-Unit basis, such an amount in cash equal to the amount
of the Positive Adjustment Amount. In the event that there is a Negative
Adjustment Amount (as defined below), Mitek shall be entitled to receive from
the Escrow a distribution of a number of Escrow Shares having a value (as
determined under the Escrow Agreement) equal to the Negative Adjustment Amount.
A Positive Adjustment Amount will be the excess (if positive) of
(i) 30 percent of the Final Taxable Income less (ii) the Tax
Distribution Amount. A Negative Adjustment Amount will be excess (if negative)
of (i) 30 percent of the Final Taxable Income less (ii) the Tax
Distribution Amount. “Final Taxable Income” shall be amount of Parascript’s
taxable income (as such term is defined under Section 702(a)(8) of the
Code) for the period from January 1, 2006 through the Closing Date as such
amount is determined on the Final Parascript Tax Return for federal income
tax
purposes prepared in accordance with Section 13.2(b) hereof and, if
applicable, the Parascript Federal Tax Return for the year 2006 (for the
avoidance of doubt, the taxable income so determined shall not include any
taxable income resulting from the consummation of the Merger).
8. COVENANTS
OF MITEK PRIOR TO CLOSING.
8.1 Access
and Investigation.
Between
the date of this Agreement and the Closing Date, and upon reasonable advance
notice received from Parascript, Mitek shall during regular business hours,
(a)
afford
Parascript and its Representatives (collectively, “Parascript Group”) full and
free access, to Mitek’s personnel, properties, Contracts, Governmental
Authorizations, books and Records and other documents and data, such rights
of
access to be exercised in a manner that does not unreasonably interfere with
the
operations of Mitek; (b)
furnish
Parascript Group with copies of all such Contracts, Governmental Authorizations,
books and Records and other existing documents and data as Parascript may
reasonably request; (c)
furnish
Parascript Group with such additional financial, operating and other relevant
data and information as Parascript may reasonably request; and (d)
otherwise cooperate and assist, to the extent reasonably requested by
Parascript, with Parascript’s investigation of the properties, assets and
financial condition related to Mitek. In addition, Parascript shall have the
right to have the Real Property of Mitek and Tangible Personal Property of
Mitek
inspected by Parascript Group, at Parascript’s sole cost and expense, for
purposes of determining the physical condition and legal characteristics of
such
Real Property and Tangible Personal Property, upon reasonable advance notice
and
during regular business hours of Mitek.
8.2 Operation
of the Business of Mitek.
Between
the date of this Agreement and the Closing, Mitek shall:
(a) conduct
its business only in its Ordinary Course of Business;
(b) use
its
commercially reasonable efforts subject to its business judgment to preserve
intact its current business organization, keep available the services of its
officers, employees and agents and maintain its relations and good will with
suppliers, customers, landlords, creditors, employees, agents and others having
business relationships with it;
(c) confer
with Parascript prior to implementing material operational decisions outside
Mitek’s Ordinary Course of Business or Mitek’s current business
plan;
(d) otherwise
verbally report periodically to Parascript upon Parascript’s reasonable request
concerning the overall status of its business, operations and
finances;
(e) make
no
material changes in management personnel without prior consultation with
Parascript;
(f) maintain
its assets in a state of repair and condition that complies with Legal
Requirements and is consistent with Mitek’s Ordinary Course of
Business;
(g) keep
in
full force and effect, without amendment, all material rights relating to
Mitek’s business;
(h) comply
with all Legal Requirements and contractual obligations applicable to the
operations of Mitek’s business in all material respects;
(i) continue
in full force and effect its current insurance coverage;
(j) except
as
required to comply with ERISA or to maintain qualification under Section 401(a)
of the Code, not amend, modify or terminate any material Mitek Employee Plan
without the express written Consent of Parascript, and except as required under
the provisions of any Mitek Employee Plan, not make any contributions to or
with
respect to any Mitek Employee Plan without the express written Consent of
Parascript;
(k) maintain
in the Ordinary Course of Business all books and Records of Mitek relating
to
Mitek’s business;
(l) maintain
the quotation of Common Stock on the NASDAQ Over-the-Counter Bulletin Board,
and
timely file all reports, forms, and other documents required by the SEC under
the Exchange Act and Securities Act, by Nasdaq and by any state regulatory
authorities under applicable rules and regulations. Each such report, form
and
document shall comply in all material respects with such applicable rules and
regulations and none of such filings shall contain any untrue statement of
material fact or omit to state a material fact required to be stated or
necessary to make such statements, in light of the circumstances under which
they were made, not misleading.
8.3 Negative
Covenants.
Except
as otherwise expressly permitted herein, between the date of this Agreement
and
the Closing Date, Mitek shall not, without the prior written Consent of
Parascript which shall not be unreasonably withheld, conditioned or delayed,
(a) take
any
affirmative action, or fail to take any reasonable action within its control,
as
a result of which any of the changes or events listed in Sections 5.14 or 5.18
would be likely to occur;
(b) make
any
material modification to any Material Mitek Contracts or Governmental
Authorizations;
(c) enter
into any compromise or settlement of any litigation, proceeding or governmental
investigation relating to Mitek’s assets, the business of Mitek or Mitek’s
Liabilities;
(d) increase
the compensation payable to or to become payable to any director or executive
officer;
(e) unless
obligated therefore pursuant to contract, policy or practice as of the date
hereof, grant any severance or termination pay to, or enter into or amend any
employment or severance agreement with, any director, officer or
employee;
(f) establish,
adopt or enter into any employee benefit plan or arrangement;
(g) except
as
may be required by applicable law, amend, or take any other actions with respect
to, any of the Mitek Employee Plans;
(h) declare
or pay any dividend on, or make any other distribution in respect of,
outstanding shares of capital stock;
(i) issue,
deliver, award, grant or sell, or authorize or propose the issuance, delivery,
award, grant or sale (including the grant of any security interests, liens,
claims, pledges, limitations in voting rights, charges or other encumbrances)
of, any shares of any class of capital stock (including shares held in
treasury), any securities convertible into or exercisable or exchangeable for
any such shares, or any rights, warrants or options to acquire any such shares
(except for the issuance of shares upon the exercise of outstanding stock
options or the vesting of restricted stock in accordance with the terms of
outstanding stock awards);
(j) amend
or
otherwise modify the terms of any such rights, warrants or options;
(k) take
any
action to accelerate the exercisability of stock options;
(l) acquire
or agree to acquire, by merging or consolidating with, by purchasing an equity
interest in or a portion of the assets of, or by any other manner, any business
or any corporation, partnership, association or other business organization
or
division thereof, or otherwise acquire or agree to acquire any assets of any
other person (other than the purchase of assets from suppliers or vendors in
the
Ordinary Course of Business and consistent with past practice);
(m) sell,
lease, exchange, mortgage, pledge, transfer or otherwise dispose of, or agree
to
sell, lease, exchange, mortgage, pledge, transfer or otherwise dispose of,
any
of its material assets or any material assets of any of its subsidiaries,
(n) release
any third party from its obligations, or grant any consent, under any existing
standstill provision relating to a Competing Transaction or otherwise under
any
confidentiality or other agreement, or fail to fully enforce any such
agreement;
(o) adopt
or
propose to adopt any amendments to its charter or bylaws;
(p) change
any of its methods of accounting in effect at December 31, 2005, or (B)
make or rescind any express or deemed election relating to Taxes, settle or
compromise any claim, action, suit, litigation, proceeding, arbitration,
investigation, audit or controversy relating to Taxes (except where the amount
of such settlements or controversies, individually or in the aggregate, does
not
exceed Twenty Five Thousand Dollars ($25,000)), or change any of its methods
of
reporting income or deductions for federal income tax purposes from those
employed in the preparation of the federal income tax returns for the taxable
year ended December 31, 2005, except, in each case, as may be required by law
or
generally accepted accounting principles;
(q) incur
any
obligation for borrowed money or purchase money indebtedness or guarantee,
whether or not evidenced by a note, bond, debenture or similar instrument,
except in the Ordinary Course of Business consistent with past practice and
in
no event in excess of One Hundred Thousand Dollars ($100,000) in the
aggregate;
(r) enter
into any material arrangement, agreement or contract with any third party which
provides for an exclusive arrangement with that third party or is substantially
more restrictive on Mitek or substantially less advantageous to Mitek than
arrangements, agreements or contracts existing on the date hereof;
(s) adopt
a
plan of complete or partial liquidation, dissolution, merger, consolidation,
restructuring, recapitalization or other material reorganization of
Mitek;
(t) pay,
discharge or satisfy any claims, liabilities or obligations (absolute, accrued,
asserted or unasserted, contingent or otherwise), other than the payment,
discharge or satisfaction of any such claims, liabilities or obligations: (i)
incurred in the Ordinary Course of Business consistent with past practice,
or
(ii) which are legally required to be paid, discharged or
satisfied;
(u) knowingly
take, or agree to commit to take, any action that would make any representation
or warranty of Mitek contained herein materially inaccurate, or as of any time
prior to, the Closing Date;
(v) agree
to
or approve any commitment, including any authorization for expenditure or
agreement to acquire property, obligating Mitek for an amount in excess of
Five
Hundred Thousand Dollars ($500,000); or
(w) agree
in
writing or otherwise to do any of the foregoing.
8.4 Required
Approvals.
As
promptly as practicable after the date of this Agreement, Mitek shall make
all
filings required by Legal Requirements to be made by it in order to consummate
the Contemplated Transactions. Mitek also shall cooperate with Parascript and
its Representatives with respect to all filings that Parascript elects to make
or, pursuant to Legal Requirements, shall be required to make in connection
with
the Contemplated Transactions. Mitek also shall cooperate with Parascript and
its Representatives in obtaining all Material Consents.
8.5 Notification.
Between
the date of this Agreement and the Closing, Mitek shall promptly
notify Parascript in writing if it becomes aware of (a)
any fact
or condition that causes or constitutes a Breach of any of Mitek’s
representations and warranties contained in Article 5 and made as of the
date of this Agreement or (b)
the
occurrence after the date of this Agreement of any fact or condition that would
be reasonably likely to (except as expressly contemplated by this Agreement)
cause or constitute a Breach of any such representation or warranty had that
representation or warranty been made as of the time of the occurrence of, or
Mitek’s discovery of, such fact or condition. Should any such fact or condition
require any change to the Disclosure Letter, Mitek shall promptly deliver to
Parascript a supplement to the Disclosure Letter specifying such change. Such
delivery shall not affect any rights of Parascript under Sections 11.2,
11.3
or
Article 14. During the same period, Mitek also shall promptly notify Parascript
of the occurrence of any Breach of any covenant of Mitek in this Article 8
or of
the occurrence of any event that may make the satisfaction of the conditions
in
Article 10 impossible or unlikely.
8.6 No
Shopping.
Until
such time as this Agreement shall be terminated pursuant to Section 11.1,
Mitek
shall not, and shall cause Mitek’s Representatives not to, directly or
indirectly solicit, initiate, encourage or entertain any inquiries or proposals
from, discuss or negotiate with, provide any nonpublic information to or
consider the merits of any inquiries or proposals from any Person (other than
Parascript) relating to any Acquisition Proposal. Mitek shall notify Parascript
of any such inquiry or proposal within twenty-four (24) hours of receipt or
awareness of the same by Mitek. Notwithstanding the foregoing, prior to the
approval of this Agreement by the stockholders of Mitek, this Section 8.6 shall
not prohibit Mitek from furnishing nonpublic information regarding Mitek to,
or
entering into discussions with, any Person, group or entity in response to
any
such inquiry or proposal that is submitted to Mitek by such Person, group or
entity (and not withdrawn) if the Board of Directors of Mitek concludes in
good
faith, after having taken into account the advice of its outside legal counsel,
that such action is required in order for the Board of Directors of Mitek to
comply with its fiduciary obligations to Mitek’s stockholders under applicable
Law.
8.7 Best
Efforts.
Mitek
shall use its Best Efforts to cause the conditions in Article 10 to be
satisfied.
8.8 Payment
of Liabilities.
Mitek
shall pay or otherwise satisfy in its Ordinary Course of Business all of its
Liabilities as such Liabilities become due and payable.
9. CONDITIONS
PRECEDENT TO MITEK’S OBLIGATION TO CLOSE.
Mitek’s
obligation to consummate the Merger and to take the other actions required
to be
taken by Mitek at the Closing is subject to the satisfaction, at or prior to
the
Closing, of each of the following conditions (any of which may be waived by
Mitek, in whole or in part):
9.1 Accuracy
of Representations.
All of
Parascript’s representations and warranties in this Agreement (considered
collectively), and each of these representations and warranties (considered
individually), shall have been accurate in all material respects as of the
date
of this Agreement and shall be accurate in all material respects as of the
time
of the Closing as if then made.
9.2 Parascript’s
Performance.
All of
the covenants and obligations that Parascript is required to perform or to
comply with pursuant to this Agreement at or prior to the Closing (considered
collectively), and each of these covenants and obligations (considered
individually), shall have been duly performed and complied with in all material
respects.
9.3 Consents.
Each of
the Consents identified in Exhibit
9.3
(the
“Parascript Consents”) shall have been obtained and shall be in full force and
effect.
9.4 Additional
Documents.
Parascript shall have caused the documents and instruments required by Section
2.10(a)
and the
following documents to be delivered (or tendered subject only to Closing) to
Mitek:
(a) The
Articles of Merger, duly executed by Parascript;
(b) The
Articles of Organization and all amendments thereto of Parascript, duly
certified as of a recent date by the Secretary of State of the State of
Wyoming;
(c) Certificates
dated as of a date not earlier than the third business day prior to the Closing
as to the good standing of Parascript, executed by the appropriate officials
of
the State of Wyoming and each jurisdiction in which Parascript is licensed
or
qualified to do business as a limited liability company as specified in Part
3.1(a); and
(d) Such
other documents as Mitek may reasonably request for the purpose of:
(i) evidencing
the accuracy of any of Parascript’s representations and warranties set forth in
Article 3;
(ii) evidencing
the performance by Parascript of, or the compliance by each Parascript with,
any
covenant or obligation required to be performed or complied with by
Parascript;
(iii) evidencing
the satisfaction of any condition referred to in this Section 9.4;
(iv) confirming
that in connection with the financing transaction referred to in
Section 9.10 and 10.10 hereof, all information regarding Parascript that
Parascript has provided to Mitek and/or such lender is true and correct in
all
material respects, other than information that could be considered a “forward
looking statement” as defined in Section 27A(i)(l) of the Securities Act;
or
(v) otherwise
facilitating the consummation or performance of any of the Contemplated
Transactions.
9.5 No
Proceedings.
No
Governmental Body of competent jurisdiction shall have enacted, issued,
promulgated, enforced or entered any Order, statute, rule or regulation which
is
in effect and which has the effect of making the Contemplated Transactions
unlawful or otherwise prohibiting consummation of the Contemplated
Transactions.
9.6 No
Conflict.
Neither
the consummation nor the performance of any of the Contemplated Transactions
will, directly or indirectly (with or without notice or lapse of time),
contravene or conflict with or result in a violation of or cause Mitek to suffer
any material adverse consequence under any applicable Legal Requirement or
Order
then in effect, excluding Bulk Sales Laws.
9.7 Governmental
Authorizations.
Mitek
shall have received such Governmental Authorizations as are necessary to allow
Mitek to consummate the Merger.
9.8 Silicon
Valley Bank Loan.
On or
prior to the Closing Date, Mitek shall have received, in a form reasonably
acceptable to it, a payoff letter and release for Parascript’s Liability to
Silicon Valley Bank as set forth in Part 2.4 of the Parascript Disclosure
Letter.
9.9 Assignment
of Assets, Liabilities and Contracts.
On or
prior to the Closing Date, Parascript shall cause or have caused such assets,
Liabilities and Contracts as relate to Parascript’s business and which are
currently the assets or obligations of Parascript Management, Inc., a Wyoming
corporation, Total Recognition Products, LLC, a Colorado limited liability
company, Total Recognition Systems, LLC, a Colorado limited liability company,
Governmental Postal Recognition Systems, LLC, a Colorado limited liability
company, and Parascript International, Inc., a Colorado corporation, to be
transferred and assigned to Parascript and Parascript shall cause or have caused
either the transfer of ownership of the entities set forth above (other than
Parascript Management, Inc.) to an entity other than Parascript, or the
dissolution of the entities set forth above (other than Parascript Management,
Inc.).
9.10 Financing.
Mitek
shall have entered into definitive agreements to obtain, on terms and conditions
satisfactory to it, and shall have obtained long-term financing in an amount
not
less than $85,000,000 and not to exceed $90,000,000 (which amount shall not
include any revolving line of credit, working capital loan or similar
arrangement acceptable to Parascript) in order to consummate the Contemplated
Transactions (the “Financing Amount”), and such financing transaction or
transactions shall be consummated concurrently with the Closing.
9.11 Material
Adverse Change.
Since
the date of this Agreement, there shall have been no change, occurrence or
circumstance in the business, assets, Liabilities, financial condition or
results of operations of Parascript having or reasonably likely to have,
individually or in the aggregate, a material adverse effect on the business,
operations, assets or condition of Parascript.
9.12 Certificate
Amendment.
The
Certificate Amendment shall have been approved by the Mitek stockholders at
the
Mitek Stockholders’ Meeting.
9.13 Appointment
to Audit Committee.
The
three directors who shall serve on the Audit Committee of Mitek’s Board of
Directors shall be appointed and agree to serve.
9.14 Affiliates.
Prior
to the Closing Date, Parascript shall deliver to Mitek a letter identifying
all
Persons who hold membership Units in Parascript immediately prior to the Closing
and are expected by Parascript to be affiliates of Mitek for purposes of Rule
145 under the Securities Act immediately following the Closing. Parascript
shall
use its Best Efforts to cause each such Person to deliver on or prior to the
Closing Date a written agreement in substantially the form of Exhibit 9.14
hereto (the “Affiliate Letters”).
9.15 [RESERVED].
9.16 AIS
License.
On or
prior to the Closing Date, Parascript shall have delivered to Mitek a license
agreement between Parascript and AIS in a form satisfactory to
Mitek.
10. CONDITIONS
PRECEDENT TO PARASCRIPT’S OBLIGATION TO CLOSE.
Parascript’s obligation to consummate the Merger and to take the other actions
required to be taken by Parascript at the Closing is subject to the
satisfaction, at or prior to the Closing, of each of the following conditions
(any of which may be waived by Parascript in whole or in part):
10.1 Accuracy
of Representations.
All of
Mitek’s representations and warranties in this Agreement (considered
collectively), and each of these representations and warranties (considered
individually), shall have been accurate in all material respects as of the
date
of this Agreement and shall be accurate in all material respects as of the
time
of the Closing as if then made.
10.2 Mitek’s
Performance.
All of
the covenants and obligations that Mitek is required to perform or to comply
with pursuant to this Agreement at or prior to the Closing (considered
collectively), and each of these covenants and obligations (considered
individually), shall have been performed and complied with in all material
respects.
10.3 Consents
and Release.
Each of
the Consents identified in Exhibit 10.3
(the
“Mitek Consents”), the Parascript Consents, and Consents to the assignment to
Parascript and to Mitek of all Contracts of Manager shall have been obtained
and
shall be in full force and effect.
10.4 Additional
Documents.
Mitek
and Merger Subsidiary shall have caused the documents and instruments required
by Section 2.10(b)
and the
following documents to be delivered (or tendered subject only to Closing) to
Parascript:
(a) The
Articles of Merger, duly executed by Merger Subsidiary;
(b) The
certificate of incorporation and all amendments thereto of Mitek, duly certified
as of a recent date by the Secretary of State of the State of Delaware;
(c) Certificates
dated as of a date not earlier than the third business day prior to the Closing
as to the good standing of Mitek and payment of all applicable state Taxes
by
Mitek, executed by the appropriate officials of the State of Delaware and each
jurisdiction in which Mitek is licensed or qualified to do business as a
corporation as specified in Part 5.1; and
(d) Such
documents as Parascript may reasonably request for the purpose of:
(i) evidencing
the accuracy of any representation or warranty of Mitek set forth in
Article 5;
(ii) evidencing
the performance by Mitek of, or the compliance by Mitek with, any covenant
or
obligation required to be performed or complied with by Mitek;
(iii) evidencing
the satisfaction of any condition referred to in this Article 10;
(iv) confirming
that in connection with the financing transaction referred to in
Section 9.10 and 10.10 hereof, all information regarding Mitek that Mitek
has provided to Parascript and/or such lender is true and correct in all
material respects, other than information that could be considered a “forward
looking statement” as defined in Section 27A(i)(l) of the Securities Act;
or
(v) otherwise
facilitating the consummation or performance of any of the contemplated
transactions.
10.5 No
Proceedings.
No
Governmental Body of competent jurisdiction shall have enacted, issued,
promulgated, enforced or entered any Order, statute, rule or regulation which
is
in effect and which has the effect of making the Contemplated Transactions
unlawful or otherwise prohibiting consummation of the Contemplated
Transactions.
10.6 No
Conflict.
Neither
the consummation nor the performance of any of the Contemplated Transactions
will, directly or indirectly (with or without notice or lapse of time),
contravene or conflict with or result in a violation of or cause Mitek or
Parascript to suffer any material adverse consequence under any applicable
Legal
Requirement or Order then in effect, excluding Bulk Sales Laws.
10.7 Governmental
Authorizations.
Mitek
shall have received such Governmental Authorizations as are necessary to allow
Mitek to consummate the Merger.
10.8 Employees.
(a) The
Mitek
Employment Agreements have not been breached by Mitek.
(b) Mitek
or
Parascript shall have made a written offer of employment to all of the Persons
providing services to Parascript in form and substance reasonably acceptable
to
Parascript.
10.9 Certificate
Amendment.
The
Certificate Amendment shall have been approved by the Mitek stockholders at
the
Mitek Stockholders’ Meeting.
10.10
Financing.
Mitek
shall have entered into definitive agreements to obtain, on terms and conditions
reasonably satisfactory to Parascript, and shall have obtained long-term
financing in an amount not less than $85,000,000 and not to exceed $90,000,000
(which amount shall not include any revolving line of credit, working capital
loan or similar arrangement acceptable to Parascript) in order to consummate
the
Contemplated Transactions (the “Financing Amount”), and such financing
transaction or transactions shall be consummated concurrently with the
Closing.
10.11 Board
Composition; Chief Executive Officer.
(a) Mitek
and
Mitek’s Board of Directors shall have increased the size of Mitek’s Board of
Directors to seven (7) members and caused the nomination and election to the
Board of Directors of two (2) individuals designated by Mitek’s Board of
Directors, who shall be John M. Thornton and James DeBello, two (2) individuals
designated by Parascript, who shall be Aron Katz and Jeffrey Gilb, and three
individuals as follows: one (1) nominee of Mitek, subject to the approval of
Parascript; one (1) nominee of Parascript, subject to the approval of Mitek;
and
one (1) nominee of Plainfield Offshore Holdings VIII Inc., subject to the
approval of Mitek and Parascript. Each of the foregoing three (3) nominees
shall
meet the independent director definition under the rules of the NASD and under
any Legal Requirement in order to implement the transactions contemplated
herein.
(b) Mitek’s
Board of Directors shall have appointed Jeffrey Gilb as Mitek’s President and
Chief Operating Officer. Mitek’s Board of Directors shall also have amended
Mitek’s Bylaws to provide for the duties and responsibilities of Mitek’s
Chairman of the Board, Chief Executive Officer, President and Chief Operating
Officer as provided for in Exhibit 10.11
hereof.
10.12 Name
Change.
Mitek
holds the documents necessary to effectuate the Mitek Name Change immediately
after the Closing.
10.13 Material
Adverse Change.
Since
the date of this Agreement, there shall have been no change, occurrence or
circumstance in the business, assets, liabilities, financial condition or
results of operations of Mitek having or reasonably likely to have, individually
or in the aggregate, a material adverse effect on the business, operations,
assets or condition of Mitek.
10.14 Registration
Statement.
The
Registration Statement shall have been declared and shall continue to be
effective by the SEC.
10.15 Appointment
of Audit Committee.
The
three directors who shall serve on the Audit Committee of Mitek’s Board of
Directors shall be appointed and agree to serve.
11. TERMINATION.
11.1
Termination
Events.
By
notice given prior to or at the Closing, subject to Section 11.2,
this
Agreement may be terminated as follows:
(a) by
Mitek
if a material Breach of any provision of this Agreement has been committed
by
Parascript, is not cured by Parascript within thirty (30) days of the delivery
of a written notice of such material Breach by Mitek to Parascript, and such
material Breach has not been waived by Mitek;
(b) by
Parascript if a material Breach of any provision of this Agreement has been
committed by Mitek, is not cured by Mitek within thirty (30) days of the
delivery of a written notice of such material Breach by Parascript to Mitek,
and
such material Breach has not been waived by Parascript;
(c) by
Mitek
if any condition in Article 9 is or becomes impossible (other than through
the
failure of Mitek to comply with its obligations under this Agreement), and
Mitek
has not waived such condition on or before such date;
(d) by
Parascript if any condition in Article 10 is or becomes impossible (other than
through the failure of Parascript to comply with its obligations under this
Agreement), and Parascript has not waived such condition on or before such
date;
(e) by
Mitek
if Mitek determines reasonably and in good faith that the Supplemental
Disclosure Letter delivered by Parascript reflects any material adverse change
to the business, financial condition, or results of operations of Parascript.
Notwithstanding anything in Section 11.2 to the contrary, if such matter
disclosed in the Supplemental Disclosure Letter of Parascript constitutes a
New
Matter, then termination shall be Mitek’s sole remedy;
(f) by
Parascript, if Parascript determines reasonably and in good faith that the
Supplemental Disclosure Letter delivered by Mitek reflects any material adverse
change to the business, financial condition or results of operations of Mitek.
Notwithstanding anything in Section 11.2 to the contrary, if such matter
disclosed in the Supplemental Disclosure Letter of Mitek constitutes a New
Matter, then termination shall be Parascript’s sole remedy;
(g) by
mutual
consent of Mitek and Parascript;
(h) by
Mitek
if the Closing has not occurred on or before March 31, 2007, or such later
date as the parties may agree upon, unless Mitek is in material Breach of this
Agreement;
(i) by
Parascript if the Closing has not occurred on or before March 31, 2007, or
such later date as the parties may agree upon, unless Parascript is in material
Breach of this Agreement;
(j)
by
either
Mitek or Parascript, if the Contemplated Transactions shall fail to receive
the
requisite vote for approval and adoption by the stockholders of Mitek or the
Members;
(k) by
Parascript, if (i) the Board of Directors of Mitek withdraws, modifies or
changes its recommendation of the Contemplated Transactions in a manner adverse
to Parascript or shall have resolved to do any of the foregoing; (ii) the Board
of Directors of Mitek shall have recommended to the stockholders of Mitek any
Competing Transaction or shall have resolved to do so; (iii) a tender offer
or
exchange offer for 20% or more of the outstanding shares of capital stock of
Mitek is commenced, and the Board of Directors of Mitek does not recommend
that
stockholders not tender their shares into such tender or exchange offer or;
(iv)
any Person (other than Parascript or an affiliate thereof, or any stockholder
of
Parascript as of the date of this Agreement) shall have acquired beneficial
ownership or the right to acquire beneficial ownership of, or any “group” (as
such term is defined under Section 13(d) of the Exchange Act and the rules
and
regulations promulgated thereunder), shall have been formed which beneficially
owns, or has the right to acquire beneficial ownership of, 20% or more of the
then outstanding shares of capital stock of Mitek;
(l) by
Mitek,
if the Manager or managing board of Parascript (or any equivalent managing
body)
shall have recommended to the Members of Parascript any Competing Transaction
or
shall have resolved to do so.
11.2 Effect
Of Termination.
Each
party’s right of termination under Section 11.1
is in
addition to any other rights it may have under this Agreement or otherwise,
and
the exercise of such right of termination will not be an election of remedies.
If this Agreement is terminated pursuant to Section 11.1,
all
obligations of the parties under this Agreement will terminate, except that
the
obligations of the parties in this Section 11.2,
Section
11.3 and Articles 15 (Confidentiality) and 16 (General Provisions) (except
for
those in Section 16.5) will survive, provided,
however,
that,
if this Agreement is terminated because of a Breach of this Agreement, the
terminating party’s right to pursue all legal remedies will survive such
termination unimpaired.
11.3 Fees,
Expenses and Other Payments.
(a) Except
as
set forth in this Section 11.3,
all
fees and Expenses incurred in connection with this Agreement and the
transactions contemplated hereby shall be paid by the Party incurring such
Expenses, whether or not the transactions contemplated herein are
consummated.
(b) If
Parascript shall terminate this Agreement pursuant to Section 11.1(k) or Mitek
shall terminate this Agreement pursuant to Section 11.1(l), then the
non-terminating party shall promptly, but in no event later than ten (10)
Business Days after the date of such termination, pay the terminating party
an
amount equal to One Million Dollars ($1,000,000) by wire transfer of immediately
available funds.
(c) If
this
Agreement is terminated by Mitek pursuant to Section 11.1(a), then Parascript
shall reimburse Mitek for all its Expenses up to, but not in excess of, Five
Hundred Thousand Dollars ($500,000) not later than ten (10) Business Days after
the date of such termination.
(d) If
this
Agreement is terminated by Parascript pursuant to Section 11.1(b), then Mitek
shall reimburse Parascript for all its Expenses up to, but not in excess of,
Five Hundred Thousand Dollars ($500,000) not later than ten (10) Business Days
after the date of such termination.
(e) The
payments by one party to the other under this Section 11.3
shall be
in satisfaction of all amounts and claims that either party may have against
the
other party in respect of the event(s) giving rise to the right to
payment.
12. POST-CLOSING
COVENANTS OF PARTIES.
12.1 Reverse
Stock Split.
Mitek
will effect a reverse split of its common stock in a manner reasonably agreed
upon by the parties. Mitek will use commercially reasonable efforts in
accordance with applicable law to submit this matter to a vote of its
stockholders at the Mitek Stockholders Meeting or as soon thereafter as is
reasonably practicable.
12.2 NASDAQ
Listing.
Mitek
shall use its Best Efforts to meet as soon as possible after Closing all
applicable listing requirements to the listing and quotation of the Common
Stock
on the NASDAQ Capital Market, and as soon as Mitek meets all such applicable
listing requirements, Mitek will use its Best Efforts to file for such
relisting.
12.3 Governance
and Management.
Immediately after Closing, Mitek’s Chief Executive Officer will be the Chief
Executive Officer of Mitek and the Surviving Company. Immediately after Closing,
Parascript’s Chief Executive Officer will become President and Chief Operating
Officer of Mitek and the Surviving Company, with the functional responsibilities
of leading Mitek’s operations, including sales, business development, marketing,
product management, product research and development and management of financial
resources as they relate to operations and the other rights and responsibilities
provided for in Exhibit 10.11
hereof.
12.4 Change
of Fiscal Year.
Mitek
will use commercially reasonable efforts to change its fiscal year end to
December 31 as soon as is reasonably practicable following the
Closing.
13. ADDITIONAL
COVENANTS.
13.1 Employees
and Employee Benefits.
(a) It
is
contemplated that all of the employees currently providing services to
Parascript will become employees of Mitek. Prior to Closing, the parties will
formally document their agreement regarding such employees, which agreement
will
address salaries and benefits, retirement and savings plans and general employee
provisions.
(b) Mitek
shall assume sponsorship of the Parascript Employee Plans effective as of the
Closing Date. Participation in the Parascript Employee Plans by such employees
will continue uninterrupted.
(c) As
soon
as administratively feasible following the Closing, Mitek shall merge the Mitek
Systems, Inc. 401(k) Retirement Savings Plan, (the “Mitek 401(k) Plan”) and the
Parascript 401(k) Plan (the “Parascript 401(k) Plan”).
(d) As
soon
as administratively feasible following the Closing, Mitek shall merge the Mitek
Systems, Inc. Flexible Benefits Plan (the “Mitek Cafeteria Plan”) and the
Parascript Management, Inc. Flexible Benefits Plan (the “Parascript Cafeteria
Plan”). Participant elections made for the plan year that includes the Closing
Date (the “Plan Year”) will continue to be effective on and after the Closing
Date. Participant reimbursements made during the Plan Year prior to the Closing
Date will be carried forward.
(e) Mitek
will take all actions necessary to continue to provide continuation coverage,
as
required under COBRA, following the Closing Date to any former employee that
provided services to Parascript (or dependent of any employee or former employee
of Parascript) whose COBRA qualifying event occurred on or before the Closing
Date at a time when the individual was covered by such Parascript Employee
Plan.
Parascript will provide Mitek with a list of all Persons currently or formerly
associated with Parascript who have elected continuation coverage under COBRA
under Parascript’s health plan, and who are still in their available
continuation period, as well as a list of all such Persons whose qualifying
event has occurred before the Closing, and who are in their COBRA election
period, but who have not yet made such election. Parascript will provide the
foregoing information to Mitek at least seven (7) days prior to Closing and
will
update such information on the Closing Date, if necessary.
13.2 Tax
Matters.
(a) Overview.
Parascript shall not elect to be treated for federal income tax purposes as
a
corporation or as an association taxable as a corporation for any period or
partial period up to and including the Closing Date. For federal and applicable
state income tax purposes, all of Parascript’s and its Subsidiaries’ taxable
income, gains, losses, deductions, expenses and credits, up to and including
the
Closing Date, shall be allocated to the Members. Thereafter, all taxable income,
gains, losses, deductions and expenses of the Surviving Company shall be
allocated to Mitek.
(b) Preparation
of Income Tax Returns.
After
Closing, the Member Representative shall prepare (or cause to be prepared)
and
deliver to Mitek
proposed
forms of the federal and applicable state income Tax Returns for Parascript
for
the period ending on or prior to the Closing Date, and all related schedules
including, but not limited to, forms K-1 (the “Final Parascript Tax Returns”).
The Final Parascript Tax Returns shall be prepared in accordance with
Parascript’s past practice in preparing its income Tax Returns previously filed;
provided that Parascript shall make an election in accordance with Code
§ 754 effective for the taxable year that ends on the date of the Closing
and shall not seek to revoke that election at any time. With respect to each
Final Company Tax Return (i) no later than 60
days
following
the date
of Closing
the
Member Representative shall deliver to Mitek a copy of the prepared Tax Return,
(ii) Mitek shall have the opportunity to examine the Tax Return and the
associated work papers, schedules and other documents prepared in connection
with the preparation of the Tax Return and (iii) after approval thereof by
Mitek, which shall not be unreasonably withheld, Mitek shall cause the Surviving
Company to timely file the Tax Return.
(c) Cooperation.
The
Surviving Company and Mitek shall cooperate fully as and to the extent
reasonably requested by the Member Representative in connection with the
preparation and filing of any income Tax Return, and any claim, audit,
litigation or other proceeding, with respect to income Tax items of Parascript
for any period or partial period that ends on or prior to the Closing Date.
The
Surviving Company shall make available to the Member Representative such records
as the Member Representative may reasonably request for the preparation of
any
Tax Return of Members, Parascript or its Subsidiaries or the substantiation
of
any position or claim thereon. The parties shall cooperate with each other
in
the handling of any audit referenced in this Section 13.2 (any subsequent
proceedings arising out of the audit, including, but not limited to, litigation
proceedings). Mitek shall cause the Surviving Company to make available to
the
Member Representative
any
records that the
Member Representative
may
reasonably request to enable it
to
respond to and/or handle the audit or any subsequent proceedings. Mitek agrees
that the Surviving Company shall retain all tax and financial accounting records
of Parascript for periods on or before the Closing Date for at least six (6)
years after the Closing Date.
(d) Treatment
of Surviving Company.
From
and after the Closing, Mitek shall not take any action that will cause the
Surviving Company to not be treated as a disregarded entity for federal income
tax purposes immediately after Closing. For federal income tax purposes, except
as required by applicable changes in law, the parties shall treat the Merger
in
accordance with the principles of Revenue Ruling 99-6, Situation 2. On
the Final Parascript Tax Return, Parascript shall be entitled to claim
deductions for Parascript Payments that are deductible, and neither Mitek nor
the Surviving Company shall claim current deductions for Parascript Payment
on
its federal income tax return.
(e) Ad
Valorem Taxes.
Parascript shall cause AIS Holdings to assume any ad valorem Taxes and
assessments (including any special or supplemental assessments) on Parascript’s
assets allocable to periods ending on or before the Closing (without regard
to
when such Taxes are assessed or payable), and Mitek shall pay any ad valorem
Taxes and assessments (including any special or supplemental assessments) on
Parascript’s assets allocable to periods beginning on or after the Closing
(without regard to when such Taxes are assessed or payable). For purposes of
this Section 13.2(b), in the case of any ad valorem Taxes that are imposed
on a
periodic basis and are payable for a Tax period that includes (but does not
end
on) the Closing, the portion of such Tax related to the Tax period ending on
the
Closing will be deemed to be the amount of such Tax for the entire Tax period
multiplied by a fraction, the numerator of which is the number of days in the
Tax period ending on the Closing and the denominator of which is the number
of
days in the entire Tax period. If AIS Holdings and Mitek are unable to
determine the exact amount of Taxes for proration at Closing, or if the Taxes
or
assessments for periods ending on or before the Closing are reassessed
subsequent to Closing, it is agreed that they will make the appropriate
financial adjustments at the time the assessment is determined.
13.3 [RESERVED.]
13.4 [RESERVED.]
13.5 [RESERVED.]
13.6 [RESERVED.]
13.7 Retention
of and Access to Records.
After
the Closing Date, Mitek shall retain for a period consistent with Mitek’s
record-retention policies and practices those Records of Parascript delivered
to
Mitek. Mitek also shall provide the Members and their Representatives reasonable
access thereto, during normal business hours and upon reasonable prior written
notice, to enable them to prepare financial statements or tax returns or deal
with tax audits.
13.8 Further
Assurances.
The
parties shall cooperate reasonably with each other and with their respective
Representatives in connection with any steps required to be taken as part of
their respective obligations under this Agreement, and shall (a)
furnish
upon request to each other such further information; (b)
execute
and deliver to each other such other documents; and (c)
do such
other acts and things, all as the other party may reasonably request for the
purpose of carrying out the intent of this Agreement and the Contemplated
Transactions.
14. INDEMNIFICATION;
REMEDIES.
14.1 Survival.
The
representations and warranties and covenants of Parascript to be performed
prior
to the Closing contained in this Agreement shall survive the date of Closing
for
a period of one year. The representations and warranties and covenants of Mitek
to be performed prior to the Closing contained in this Agreement shall not
survive the date of Closing.
14.2 Indemnification
and Reimbursement of Mitek.
After
the Closing, if Mitek and its Representatives, shareholders, subsidiaries and
Related Persons (collectively, the “Mitek Indemnified Persons”), suffers any
loss, liability, claim, damage, expense (including costs of investigation and
defense and reasonable attorneys’ fees and expenses) or diminution of value,
whether or not involving a Third-Party Claim (collectively, “Damages”), arising
from or in connection with:
(a) any
Breach of any representation or warranty made by Parascript in (i)
Article 3 of this Agreement, (ii)
Parascript’s Initial Disclosure Letter, (iii)
Parascript’s Supplemental Disclosure Letter, (iv)
the
certificates delivered by Parascript pursuant to Section 2.10
(for
this purpose, each such certificate will be deemed to have stated that
Parascript’s representations and warranties in this Agreement fulfill the
requirements of Section 9.1
as of
the Closing Date as if made on the Closing Date, unless the certificate
expressly states that the matters disclosed in a Supplemental Disclosure Letter
have caused a condition specified in Section 9.1
not to
be satisfied), (v)
any
transfer instrument or (vi)
any
other certificate, document, writing or instrument delivered by Parascript
pursuant to this Agreement;
or
(b) any
Breach of any covenant or obligation of Parascript in this Agreement or in
any
other certificate, document, writing or instrument delivered by Parascript
pursuant to this Agreement;
then
subject to the other provisions of this Article 14, such Mitek Indemnified
Persons shall be entitled to be reimbursed the amount of such Damages from
the
Escrow Shares.
14.3 Decision
to Seek Indemnification.
The
decision of Mitek to seek indemnification hereunder shall be decided by the
vote
or written consent of the audit committee of Mitek after Closing.
14.4 Limitations
on Amount and
Recovery.
(a) A
Mitek
Indemnified Person shall not be entitled to recover for any Damages pursuant
to
Section 14.2 unless and until the aggregate amount of Damages asserted by
all of the Mitek Indemnified Persons exceed $500,000 (the “Indemnification
Threshold”), and then the Indemnified Person shall be entitled to recover for
Damages only in excess of the Indemnification Threshold.
(b) Parascript
and Mitek agree that in no event shall the liability for indemnification under
this Section 14 exceed the number of Escrow Shares and recovery shall only
be
pursuant to the Escrow Agreement.
14.5 Time
Limitations.
If the
Closing occurs, Mitek may recover Escrow Shares with respect to a Breach of
(i)
a
covenant or obligation to be performed or complied with by Parascript prior
to
the Closing Date or (ii)
a
representation or warranty by Parascript, only if on or before the first year
anniversary of the Closing Date, Mitek notifies the Member
Representative and
the
Escrow Agent pursuant to the terms of the Escrow Agreement in writing of such
a
claim specifying the factual basis of such claim in reasonable detail to the
extent then known by Mitek. After the expiration of such one-year period, no
further claim for indemnification may be made.
14.6 Escrow.
Upon
notice to the Member Representative specifying
in reasonable detail the basis therefor, Mitek shall give notice of a claim
under the Escrow Agreement for any amount to which it may be entitled under
this
Article 14.
14.7 Third-Party
Claims.
(a) Promptly
after receipt by a Mitek Indemnified Person of notice of the assertion of a
Third-Party Claim against it, such Mitek Indemnified Person shall give notice
to
the Member Representative of the assertion of such Third-Party Claim, provided
that the failure to notify the Member Representative will not relieve the
indemnification obligation under Section 14.2, except to the extent that the
Member Representative demonstrates that the defense of such Third-Party Claim
is
prejudiced by the Mitek Indemnified Person’s failure to give such notice.
(b) If
a
Mitek Indemnified Person gives notice to the Member Representative pursuant
to
Section 14.7(a) of the assertion of a Third-Party Claim, the Member
Representative shall be entitled to participate in the defense of such
Third-Party Claim and, to the extent that it wishes, to assume the defense
of
such Third-Party Claim with counsel reasonably satisfactory to the Mitek
Indemnified Person. After notice from the Member Representative to the Mitek
Indemnified Person of its election to assume the defense of such Third-Party
Claim, the Member Representative shall not, so long as it diligently conducts
such defense, be liable to the Mitek Indemnified Person under this Article
14
for any fees of other counsel or any other expenses with respect to the defense
of such Third-Party Claim, in each case subsequently incurred by the Mitek
Indemnified Person in connection with the defense of such Third-Party Claim,
other than reasonable costs of investigation directed by the Member
Representative to be performed. If the Member Representative assumes the defense
of a Third-Party Claim, no compromise or settlement of such Third-Party Claims
may be effected by the Member Representative without the Mitek Indemnified
Person’s Consent unless (A)
the sole
relief provided is monetary damages that are paid in full by the Member
Representative; and (B) the Mitek Indemnified Person shall have no liability
with respect to any compromise or settlement of such Third-Party Claims effected
without its Consent. If notice is given to the Member Representative of the
assertion of any Third-Party Claim and the Member Representative does not,
within ten (10) days after the Mitek Indemnified Person’s notice is received by
the Member Representative, give notice to the Mitek Indemnified Person of its
election to assume the defense of such Third-Party Claim, the indemnified
parties will be bound by any determination made in such Third-Party Claim or
any
compromise or settlement effected by the Mitek Indemnified Person.
(c) Notwithstanding
the foregoing, if a Mitek Indemnified Person determines in good faith that
there
is a reasonable probability that a Third-Party Claim may materially adversely
affect it or its Related Persons other than as a result of monetary damages
for
which it would be entitled to indemnification under this Agreement, the Mitek
Indemnified Person may, by notice to the Member Representative, assume the
exclusive right to defend, compromise or settle such Third-Party Claim, but
the
indemnified parties will not be bound by any determination of any Third-Party
Claim so defended for the purposes of this Agreement or any compromise or
settlement effected without its Consent (which may not be unreasonably withheld)
or be obligated in any way to indemnify.
(d) Notwithstanding
the provisions of Section 16.4, Parascript and the Member Representative hereby
consent to the nonexclusive jurisdiction of any court in which a Proceeding
in
respect of a Third-Party Claim is brought against any Mitek Indemnified Person
for purposes of any claim that a Mitek Indemnified Person may have under this
Agreement with respect to such Proceeding or the matters alleged therein and
agree that process may be served on Parascript with respect to such a claim
anywhere in the world.
(e) With
respect to any Third-Party Claim subject to indemnification under this Article
14, (i)
both the
Mitek Indemnified Person and the Member Representative, as the case may be,
shall keep the other Person fully informed of the status of such Third-Party
Claim and any related Proceedings at all stages thereof where such Person is
not
represented by its own counsel, and (ii)
the
parties agree (each at its own expense) to render to each other such assistance
as they may reasonably require of each other and to cooperate in good faith
with
each other in order to ensure the proper and adequate defense of any Third-Party
Claim.
(f) With
respect to any Third-Party Claim subject to indemnification under this Article
14, the parties agree to cooperate in such a manner as to preserve in full
(to
the extent possible) the confidentiality of all Confidential Information and
the
attorney-client and work-product privileges. In connection therewith, each
party
agrees that: (i)
it will
use its Best Efforts, in respect of any Third-Party Claim in which it has
assumed or participated in the defense, to avoid production of Confidential
Information (consistent with applicable law and rules of procedure), and
(ii)
all
communications between any party hereto and counsel responsible for or
participating in the defense of any Third-Party Claim shall, to the extent
possible, be made so as to preserve any applicable attorney-client or
work-product privilege.
14.8 Other
Claims.
A claim
for indemnification for any matter not involving a Third-Party Claim may be
asserted by notice to the party from whom indemnification is sought and shall
be
paid promptly after such notice.
14.9 Waiver
of Contribution and Indemnification.
No
Person satisfying or discharging an indemnification obligation under this
Article 14 shall have a right of contribution or indemnification against any
other Person and by executing this Agreement expressly waives such rights
against any other Person who or which may have also joined in representations,
warranties and/or covenants hereunder.
15. CONFIDENTIALITY.
15.1 Definition
of Confidential Information.
(a) As
used
in this Article 15, the term “Confidential Information” includes any and all of
the following information of Parascript or Mitek that has been or may hereafter
be disclosed in any form, whether in writing, orally, electronically or
otherwise, or otherwise made available by observation, inspection or otherwise
by either party (Mitek on the one hand or Parascript, collectively, on the
other
hand) or its Representatives (collectively, a “Disclosing Party”) to the other
party or its Representatives (collectively, a “Receiving Party”):
(i) all
information that is a trade secret under applicable trade secret or other
law;
(ii) all
information concerning product specifications, data, know-how, formulae,
compositions, processes, designs, sketches, photographs, graphs, drawings,
samples, inventions and ideas, past, current and planned research and
development, current and planned manufacturing or distribution methods and
processes, customer lists, current and anticipated customer requirements, price
lists, market studies, business plans, computer hardware, Software and computer
software and database technologies, systems, structures and
architectures;
(iii) all
information concerning the business and affairs of the Disclosing Party (which
includes historical and current financial statements, financial projections
and
budgets, tax returns and accountants’ materials, historical, current and
projected sales, capital spending budgets and plans, business plans, strategic
plans, marketing and advertising plans, publications, client and customer lists
and files, contracts, the names and backgrounds of key personnel and personnel
training techniques and materials, however documented), and all information
obtained from review of the Disclosing Party’s documents or property or
discussions with the Disclosing Party regardless of the form of the
communication; and
(iv) all
notes, analyses, compilations, studies, summaries and other material prepared
by
the Receiving Party to the extent containing or based, in whole or in part,
upon
any information included in the foregoing.
(b) Any
trade
secrets of a Disclosing Party shall also be entitled to all of the protections
and benefits under applicable trade secret law and any other applicable law.
If
any information that a Disclosing Party deems to be a trade secret is found
by a
court of competent jurisdiction not to be a trade secret for purposes of this
Article 15,
such
information shall still be considered Confidential Information of that
Disclosing Party for purposes of this Article 15
to the
extent included within the definition. In the case of trade secrets, each of
Mitek, Parascript and Members hereby waives any requirement that the other
party
submit proof of the economic value of any trade secret or post a bond or other
security.
15.2 Restricted
Use Of Confidential Information.
(a) Each
Receiving Party acknowledges the confidential and proprietary nature of the
Confidential Information of the Disclosing Party and agrees that such
Confidential Information (i)
shall be
kept confidential by the Receiving Party; (ii)
shall
not be used for any reason or purpose other than to evaluate and consummate
the
Contemplated Transactions; and (iii)
without
limiting the foregoing, shall not be disclosed by the Receiving Party to any
Person, except in each case as otherwise expressly permitted by the terms of
this Agreement or with the prior written consent of an authorized representative
of Parascript with respect to Confidential Information of Parascript (each,
a
“Parascript Contact”) or an authorized representative of Mitek with respect to
Confidential Information of Mitek (each, a “Mitek Contact”). Each of Mitek and
Parascript shall disclose the Confidential Information of the other party only
to its Representatives who require such material for the purpose of evaluating
the Contemplated Transactions and are informed by Mitek or Parascript, as the
case may be, of the obligations of this Article 15 with respect to such
information. Each of Mitek and Parascript shall (iv)
enforce
the terms of this Article 15 as to its respective Representatives; (v)
take
such action to the extent necessary to cause its Representatives to comply
with
the terms and conditions of this Article 15; and (vi)
be
responsible and liable for any Breach of the provisions of this Article 15
by it
or its Representatives.
(b) Unless
and until this Agreement is terminated, Parascript shall maintain as
confidential any Confidential Information (including for this purpose any
information of Parascript of the type referred to in Sections 15.1(a)(i),
15.1(a)(ii)
and
15.1(a)(iii)),
whether or not disclosed to Mitek, of Parascript relating to any of Parascript’s
assets or Parascript’s Liabilities. Notwithstanding the preceding sentence,
Parascript may use any Confidential Information of Parascript before the Closing
in the Ordinary Course of Business in connection with the transactions permitted
by Section 6.2.
(c) From
and
after the Closing, the provisions of Section 15.2(a)
above
shall not apply to or restrict in any manner Mitek’s use of any Confidential
Information of Parascript relating to any of Parascript’s assets or Parascript’s
Liabilities.
15.3 Exceptions.
Sections 15.2(a)
and
15.2(b)
do not
apply to that part of the Confidential Information of a Disclosing Party that
a
Receiving Party demonstrates (a)
was, is
or becomes generally available to the public other than as a result of a Breach
of this Article 15 or the Confidentiality Agreement by the Receiving Party
or
its Representatives; (b)
was or
is developed by the Receiving Party independently of and without reference
to
any Confidential Information of the Disclosing Party; or (c)
was, is
or becomes available to the Receiving Party on a nonconfidential basis from
a
Third Party not bound by a confidentiality agreement or any legal, fiduciary
or
other obligation restricting disclosure. Parascript shall not disclose any
Confidential Information of Parascript relating to any of Parascript’s assets or
Parascript’s Liabilities in reliance on the exceptions in clauses (b) or (c)
above.
15.4 Legal
Proceedings.
If a
Receiving Party becomes compelled in any Proceeding or is requested by a
Governmental Body having regulatory jurisdiction over the Contemplated
Transactions to make any disclosure that is prohibited or otherwise constrained
by this Article 15, that Receiving Party shall provide the Disclosing Party
with
prompt notice of such compulsion or request so that it may seek an appropriate
protective order or other appropriate remedy or waive compliance with the
provisions of this Article 15. In the absence of a protective order or other
remedy, the Receiving Party may disclose that portion (and only that portion)
of
the Confidential Information of the Disclosing Party that, based upon advice
of
the Receiving Party’s counsel, the Receiving Party is legally compelled to
disclose or that has been requested by such Governmental Body, provided,
however, that the Receiving Party shall use reasonable efforts to obtain
reliable assurance that confidential treatment will be accorded by any Person
to
whom any Confidential Information is so disclosed. The provisions of this
Section 15.4
do not
apply to any Proceedings between the parties to this Agreement.
15.5 Return
or Destruction of Confidential Information.
If this
Agreement is terminated, each Receiving Party shall (a)
destroy
all Confidential Information of the Disclosing Party prepared or generated
by
the Receiving Party without retaining a copy of any such material; (b)
promptly
deliver to the Disclosing Party all other Confidential Information of the
Disclosing Party, together with all copies thereof, in the possession, custody
or control of the Receiving Party or, alternatively, with the written consent
of
a Parascript Contact or a Mitek Contact (whichever represents the Disclosing
Party) destroy all such Confidential Information; and (c)
certify
all such destruction in writing to the Disclosing Party, provided, however,
that
the Receiving Party may retain a list that contains general descriptions of
the
information it has returned or destroyed to facilitate the resolution of any
controversies after the Disclosing Party’s Confidential Information is
returned.
15.6 Attorney-Client
Privilege.
The
Disclosing Party is not waiving, and will not be deemed to have waived or
diminished, any of its attorney work product protections, attorney-client
privileges or similar protections and privileges as a result of disclosing
its
Confidential Information (including Confidential Information related to pending
or threatened litigation) to the Receiving Party, regardless of whether the
Disclosing Party has asserted, or is or may be entitled to assert, such
privileges and protections. The parties (a)
share a
common legal and commercial interest in all of the Disclosing Party’s
Confidential Information that is subject to such privileges and protections;
(b)
are or
may become joint defendants in Proceedings to which the Disclosing Party’s
Confidential Information covered by such protections and privileges relates;
(c)
intend
that such privileges and protections remain intact should either party become
subject to any actual or threatened Proceeding to which the Disclosing Party’s
Confidential Information covered by such protections and privileges relates;
and
(d)
intend
that after the Closing the Receiving Party shall have the right to assert such
protections and privileges. No Receiving Party shall admit, claim or contend,
in
Proceedings involving either party or otherwise, that any Disclosing Party
waived any of its attorney work-product protections, attorney-client privileges
or similar protections and privileges with respect to any information, documents
or other material not disclosed to a Receiving Party due to the Disclosing
Party
disclosing its Confidential Information (including Confidential Information
related to pending or threatened litigation) to the Receiving
Party.
16. GENERAL
PROVISIONS.
16.1 Expenses.
Each of
Mitek and Parascript shall bear and be responsible for its fees and Expenses
in
connection with the preparation and negotiation of this Agreement and the
Contemplated Transactions, provided, however, in the event of the Closing,
Mitek
will bear its fees and Expenses and will pay Parascript’s fees and Expenses,
each incurred in connection with the preparation, negotiation, execution and
performance of this Agreement and the Contemplated Transactions, including
all
fees and Expense of its or their Representatives, and the fees and Expenses
of
the escrow agent under the Escrow Agreement.
16.2 Public
Announcements.
Any
public announcement, press release or similar publicity with respect to this
Agreement or the Contemplated Transactions will be issued, if at all, at such
time and in such manner as Mitek and Parascript agree; provided, however, that
if the parties have not or cannot agree to the content of an announcement by
the
date Mitek is obligated by Legal Requirements to disclose the substance of
the
disputed announcement, then Mitek shall be free to make such disclosure in
such
filing(s) as may be required of Mitek under such Legal Requirements. Except
with
the prior consent of Mitek or Parascript, as applicable, or as otherwise
required by law, neither Parascript, Mitek nor any of their Representatives
shall disclose to any Person (a)
the fact
that any Confidential Information of Parascript or Members has been disclosed
to
Mitek or its Representatives, that Mitek or its Representatives have inspected
any portion of the Confidential Information of Parascript or Members, that
any
Confidential Information of Mitek has been disclosed to Parascript, Members
or
their Representatives or that Parascript, Members or their Representatives
have
inspected any portion of the Confidential Information of Mitek or (b)
any
information about the Contemplated Transactions, including the status of such
discussions or negotiations, the execution of any documents (including this
Agreement) or any of the terms of the Contemplated Transactions or the related
documents (including this Agreement). Parascript and Mitek will consult with
each other concerning the means by which Parascript’s and Mitek’s employees,
customers, suppliers and others having dealings with Parascript or Mitek will
be
informed of the Contemplated Transactions, and each of Parascript and Mitek
will
have the right to be present for any such communication.
16.3 Notices.
All
notices, Consents, waivers and other communications required or permitted by
this Agreement shall be in writing and shall be deemed given to a party when
(a)
delivered to the appropriate address by hand or by nationally recognized
overnight courier service (costs prepaid); (b)
sent by
facsimile or e-mail with confirmation of transmission by the transmitting
equipment; or (c)
received
or rejected by the addressee, if sent by certified mail, return receipt
requested, in each case to the following addresses, facsimile numbers or e-mail
addresses and marked to the attention of the Person (by name or title)
designated below (or to such other address, facsimile number, e-mail address
or
Person as a party may designate by notice to the other parties):
Parascript
(before the Closing): Parascript, LLC
Attention:
Jeffrey Gilb
Fax
no.:
(303) 381-3101
E-mail
address: jeff.gilb@parascript.com
with
a
mandatory copy to: Davis Graham & Stubbs LLP
Attention:
Jeffrey R. Brandel, Esq.
Fax
no.:
(303) 892-7400
E-mail
address: jeff.brandel@dgslaw.com
Member
Representative: Parascript Management, Inc.
Fax
no.:
(303) 381-3101
E-mail
address: jeff.gilb@parascript.com
with
a
mandatory copy to: Davis Graham & Stubbs LLP
Attention:
Jeffrey R. Brandel, Esq.
Fax
no.:
(303) 892-7400
E-mail
address: jeff.brandel@dgslaw.com
Mitek:
Mitek Systems, Inc.
Attention:
James B. DeBello
Fax
no.:
(858) 503-7816
E-mail
address: jdebello@miteksystems.com
with
a
mandatory copy to: Duane Morris LLP
Attention:
Robert G. Copeland, Esq.
Fax
no.:
(619) 744-2201
E-mail
address: rcopeland@duanemorris.com
16.4 Arbitration.
Any
controversy or claim arising out of or relating to this Agreement or any related
agreement shall be settled solely by arbitration in accordance with the
following provisions:
(a) The
agreement of the parties to arbitrate covers all disputes of every kind relating
to or arising out of this Agreement, any related agreement or any of the
Contemplated Transactions. Disputes include actions for breach of contract
with
respect to this Agreement or any related agreement, as well as any claim based
upon tort or any other causes of action relating to the Contemplated
Transactions, such as claims based upon an allegation of fraud or
misrepresentation and claims based upon a federal or state statute. In addition,
the arbitrators selected according to the procedures set forth below shall
determine the arbitrability of any matter brought to them, and their decision
shall be final and binding on the parties.
(b) The
forum
for the arbitration shall be Denver, Colorado.
(c) The
governing law for the arbitration shall be the law of the State of Delaware,
without reference to its conflicts of laws provisions.
(d) There
shall be three arbitrators, unless the parties are able to agree on a single
arbitrator. In the absence of such agreement within ten (10) days after the
initiation of an arbitration proceeding, Parascript shall select one arbitrator
and Mitek shall select one arbitrator and those two arbitrators shall then
select, within ten (10) days, a third arbitrator. If those two arbitrators
are
unable to select a third arbitrator within such ten (10) day period, a third
arbitrator shall be appointed by the commercial panel of JAMS. The decision
in
writing of at least two of the three parties shall be final and binding on
the
parties.
(e) The
arbitration shall be administered by JAMS.
(f) The
rules
of the arbitration shall be the Comprehensive Arbitration Rules of JAMS, as
modified by any other instructions that the parties may agree upon at the time,
except that each party shall have the right to conduct discovery in any manner
and to the extent authorized by the Federal Rules of Civil Procedure as
interpreted by the federal courts. If there is any conflict between those Rules
and the provisions of this Section, the provisions of this Section shall
prevail.
(g) The
arbitrators shall be bound by and shall strictly enforce the terms of this
Agreement and may not limit, expand or otherwise modify its terms. The
arbitrators shall make a good faith effort to apply substantive applicable
law,
but an arbitration decision shall not be subject to review because of errors
of
law. The arbitrators shall be bound to honor claims of privilege or work-product
doctrine recognized at law, but the arbitrators shall have the discretion to
determine whether any such claim of privilege or work-product doctrine
applies.
(h) The
arbitrators’ decision shall provide a reasoned basis for the resolution of any
dispute and any award. The arbitrators shall not have the power to award damages
in connection with any dispute in excess of actual compensatory damages and
shall not multiply actual damages or award consequential or punitive
damages.
(i) Each
party shall bear its own fees and expenses with respect to the arbitration
and
any proceeding related thereto and the parties shall share equally the fees
of
JAMS and the arbitrators.
(j) The
arbitrators shall have power and authority to award any remedy or judgment
that
could be awarded by a court of law in the state of Colorado. The award rendered
by arbitration shall be final and binding upon the parties, and judgment upon
the award may be entered in any court of competent jurisdiction in the United
States.
16.5 Enforcement
of Agreement.
The
parties hereto acknowledge and agree that the other party or parties would
be
irreparably damaged if any of the provisions of this Agreement are not performed
in accordance with their specific terms and that any Breach of this Agreement
by
the other party or parties could not be adequately compensated in all cases
by
monetary damages alone. Accordingly, in addition to any other right or remedy
to
which the other party or parties may be entitled, at law or in equity, it shall
be entitled to enforce any provision of this Agreement by a decree of specific
performance and to temporary, preliminary and permanent injunctive relief to
prevent Breaches or threatened Breaches of any of the provisions of this
Agreement, without posting any bond or other undertaking.
16.6 Waiver;
Remedies Cumulative.
Except
as otherwise provided for herein, the rights and remedies of the parties to
this
Agreement are cumulative and not alternative. Neither any failure nor any delay
by any party in exercising any right, power or privilege under this Agreement
or
any of the documents referred to in this Agreement will operate as a waiver
of
such right, power or privilege, and no single or partial exercise of any such
right, power or privilege will preclude any other or further exercise of such
right, power or privilege or the exercise of any other right, power or
privilege. To the maximum extent permitted by applicable law, (a)
no claim
or right arising out of this Agreement or any of the documents referred to
in
this Agreement can be discharged by one party, in whole or in part, by a waiver
or renunciation of the claim or right unless in writing signed by the other
party; (b)
no
waiver that may be given by a party will be applicable except in the specific
instance for which it is given; and (c)
no
notice to or demand on one party will be deemed to be a waiver of any obligation
of that party or of the right of the party giving such notice or demand to
take
further action without notice or demand as provided in this Agreement or the
documents referred to in this Agreement.
16.7 Entire
Agreement and Modification.
This
Agreement amends, restates and replaces in its entirety the Original Agreement,
and supersedes all prior agreements, whether written or oral, between the
parties with respect to its subject matter (including any letter of intent,
any
confidentiality agreement between Mitek and Parascript) and constitutes (along
with the Disclosure Letter, Exhibits and other documents delivered pursuant
to
this Agreement) a complete and exclusive statement of the terms of the agreement
between the parties with respect to its subject matter. This Agreement may
not
be amended, supplemented, or otherwise modified except by a written agreement
executed by the party to be charged with the amendment.
16.8 Assignments,
Successors and No Third-Party Rights.
No
party may assign any of its rights or delegate any of its obligations under
this
Agreement without the prior written consent of the other parties, except that
Mitek may assign any of its rights and delegate any of its obligations under
this Agreement to any Subsidiary of Mitek and may collaterally assign its rights
hereunder to any financial institution providing financing in connection with
the Contemplated Transactions. Subject to the preceding sentence, this Agreement
will apply to, be binding in all respects upon and inure to the benefit of
the
successors and permitted assigns of the parties. Nothing expressed or referred
to in this Agreement will be construed to give any Person other than the parties
to this Agreement any legal or equitable right, remedy or claim under or with
respect to this Agreement or any provision of this Agreement, except such rights
as shall inure to a successor or permitted assignee pursuant to this Section
16.8.
16.9 Severability.
If any
provision of this Agreement is held invalid or unenforceable by any court of
competent jurisdiction, the other provisions of this Agreement will remain
in
full force and effect. Any provision of this Agreement held invalid or
unenforceable only in part or degree will remain in full force and effect to
the
extent not held invalid or unenforceable.
16.10 Construction.
The
headings of Articles and Sections in this Agreement are provided for convenience
only and will not affect its construction or interpretation. All references
to
“Articles,” “Sections” and “Parts” refer to the corresponding Articles, Sections
and Parts of this Agreement and the Disclosure Letter.
16.11 Time
of Essence.
With
regard to all dates and time periods set forth or referred to in this Agreement,
time is of the essence.
16.12 Governing
Law.
The
WLLCA
shall govern all issues concerning the effectiveness of the Merger. All other
questions concerning the construction, validity and interpretation of this
Agreement and the exhibits and schedules hereto shall be governed by and
construed in accordance with the laws of the state of Delaware, without
regard to conflicts-of-laws principles that would require the application of
any
other law.
16.13 Execution
of Agreement.
This
Agreement may be executed in one or more counterparts, each of which will be
deemed to be an original copy of this Agreement and all of which, when taken
together, will be deemed to constitute one and the same agreement. The exchange
of copies of this Agreement and of signature pages by facsimile transmission
shall constitute effective execution and delivery of this Agreement as to the
parties and may be used in lieu of the original Agreement for all purposes.
Signatures of the parties transmitted by facsimile shall be deemed to be their
original signatures for all purposes.
[SIGNATURE
PAGE FOLLOWS]
IN
WITNESS WHEREOF, the parties have executed this Agreement as of the date first
written above.
|
MITEK:
|
|
|
|
MITEK
SYSTEMS, INC., a Delaware corporation
|
|
|
|
|
|
By:
|
/s/
James B. DeBello |
|
|
James
B. DeBello,
|
|
|
President
and Chief Executive Officer
|
|
|
|
MERGER
SUBSIDIARY:
|
|
|
|
MITEK
ACQUISITION SUB, LLC, a Wyoming limited liability
company
|
|
|
|
|
|
By:
|
/s/
James B. DeBello |
|
|
James
B. DeBello,
|
|
|
President
and Chief Executive Officer
|
|
|
|
PARASCRIPT:
|
|
|
|
PARASCRIPT,
LLC, a Wyoming limited liability company
|
|
|
|
|
|
By:
|
/s/
Jeffrey Gilb |
|
|
Jeffrey
Gilb,
|
|
|
President
and Chief Executive Officer
|
|
|
|
MEMBER
REPRESENTATIVE:
|
|
|
|
PARASCRIPT
MANAGEMENT, INC., a Wyoming corporation
|
|
|
|
|
|
By:
|
/s/
Jeffrey Gilb |
|
Name: Jeffrey
Gilb,
Title:
Director
|